Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
AASS	"LKRSDH, LORSDH"	ENSG00000008311	"Aminoadipate-semialdehyde synthase"	Q9UDR5	7	122064583-122144308	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 44.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 145.9;Hepatocytes: 113.9;Oligodendrocyte precursor cells: 106.1;Oligodendrocytes: 132.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 41.5;NTERA-2: 55.3;SuSa: 37.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020637, HPA020728, HPA020734"	Enhanced		Approved	Nucleoplasm,Vesicles,Mitochondria		Yes	No		19000		"Cluster 15: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria	"Nucleoplasm, Vesicles"	"HPA020637: AB_1844415, HPA020728: AB_1844416, HPA020734: AB_1844417"	"unprognostic (4.84e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.91e-4)"	"unprognostic (6.08e-2)"	"unprognostic (1.49e-2)"	"unprognostic (8.00e-2)"	"prognostic favorable (9.81e-4)"	"unprognostic (4.48e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.76e-3)"	"unprognostic (8.56e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.67e-1)"	9.7	5.9	10.0	1.8	12.2	0.2	8.4	10.3	14.4	8.2	15.5	5.2	0.9	9.5	7.5	3.2	11.7	2.1	9.2	9.4	10.6	13.9	44.3	6.3	1.4	11.6	11.0	25.2	4.8	7.1	3.5	3.2	11.4	5.4	1.4	3.7	3.5	4.8	8.6	2.8	3.6	4.4	10.1	2.9	5.5	2.2	11.0	1.5	4.7	6.2	1.4	6.9	6.2	11.8	0.1	0.0	21.9	41.5	27.3	13.5	9.4	5.4	8.0	7.3	9.1	12.6	0.1	0.0	0.2	6.6	8.3	4.1	33.5	16.8	9.6	0.0	12.2	9.4	4.3	12.5	22.0	0.0	2.9	12.2	0.5	9.2	7.1	18.9	19.8	12.1	2.7	15.5	5.1	0.1	0.9	0.0	55.3	0.1	1.7	11.8	16.3	0.3	5.3	2.4	2.7	0.7	1.5	0.0	5.3	37.8	0.5	0.0	8.1	13.6	3.4	7.0	8.3	3.5	3.0	0.0	4.9	0.8	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.0	12.2	10.3	14.4	9.4	10.6	11.6	11.0	11.4	10.1	11.0	11.8	16.0	9.6	37.8	145.9	2.1	6.2	9.0	2.8	14.8	7.0	8.7	6.3	9.7	14.3	5.6	14.7	16.7	11.6	1.5	0.6	0.0	2.7	12.2	4.1	24.0	11.7	3.0	5.2	5.0	1.8	3.3	14.4	5.6	7.7	3.8	18.1	24.7	113.9	1.5	11.8	4.4	2.6	2.0	2.2	2.5	7.4	19.0	1.4	12.4	35.6	0.0	8.9	0.0	106.1	132.5	2.3	2.5	24.5	1.6	4.7	5.4	8.6	0.9	3.3	19.7	38.9	15.8	12.4	2.4	7.8	4.7	5.1	2.1	8.0	1.9	4.8
ACBD7	"bA455B2.2, FLJ38219"	ENSG00000176244	"Acyl-CoA binding domain containing 7"	Q8N6N7	10	15075475-15088776	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 37.8;choroid plexus: 17.1"	"Cell type enriched"	"Detected in some"	5	"Astrocytes: 28.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"JURKAT: 28.7;MOLT-4: 29.2;U-698: 21.8"	"Region enriched"	"Detected in all"	5	"olfactory bulb: 17.6"	"Low region specificity"	"Detected in all"			"HPA043326, HPA062478"			Approved	Vesicles,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Vesicles, Cytosol"		"HPA043326: AB_2678429, HPA062478: AB_2684777"	"unprognostic (2.15e-1)"	"unprognostic (8.94e-2)"	"unprognostic (7.79e-3)"	"unprognostic (6.53e-3)"	"unprognostic (7.30e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.34e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.18e-4)"	"unprognostic (9.72e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.90e-2)"	0.3	0.3	34.9	0.4	36.0	1.4	4.2	28.8	37.8	0.2	17.1	0.4	0.9	0.3	0.8	0.4	1.9	0.4	0.2	31.6	29.7	0.4	0.4	0.4	0.7	33.7	37.1	0.4	0.4	0.3	0.6	0.3	26.3	0.4	0.4	7.7	2.3	0.5	0.9	1.3	0.5	0.2	27.2	0.4	0.5	3.0	35.1	6.7	1.7	0.0	0.5	0.3	0.1	23.2	3.4	0.8	12.7	7.0	1.0	0.6	1.8	0.8	0.7	1.9	3.0	3.8	4.2	2.9	4.3	2.5	2.6	0.6	6.9	1.8	2.9	6.0	10.2	3.4	1.1	2.3	0.1	0.4	1.3	0.3	0.1	1.0	0.1	3.2	2.9	28.7	2.4	3.6	2.5	10.5	29.2	4.5	6.3	1.0	2.0	16.4	4.3	6.9	1.6	1.0	9.7	6.6	2.7	8.6	1.1	4.7	10.9	0.6	1.6	0.7	6.6	1.3	2.8	10.4	19.1	21.8	2.1	0.5	0.7	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.8	0.3	0.1	0.3	0.1	0.0	34.9	36.0	28.8	37.8	31.6	29.7	33.7	37.1	26.3	27.2	35.1	23.2	0.1	0.0	0.6	28.1	0.1	0.1	0.1	0.0	0.6	0.2	0.5	0.6	0.0	0.0	0.0	0.0	2.1	0.0	0.5	0.2	0.0	0.0	5.3	2.6	0.1	0.4	1.8	0.0	0.3	0.0	0.1	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	2.3	0.0	0.1	0.0	1.0	0.0	0.6	0.0	1.5	0.1	0.0	1.1	0.0	0.0	0.1	0.0	0.1	1.6	0.8	0.0	0.3	0.3	2.9	0.4	0.5	0.0	0.1	0.2	0.1	0.1	0.1
ACP6	"ACPL1, LPAP"	ENSG00000162836	"Acid phosphatase 6, lysophosphatidic"	Q9NPH0	1	147629652-147670524	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 74.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 108.9;RPTEC TERT1: 119.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028560	Uncertain				"Intracellular and membrane"	NA	NA		64000	"Cluster 35: T-regs - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA028560: AB_10602427"	"unprognostic (3.17e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.85e-1)"	"unprognostic (8.50e-3)"	"unprognostic (3.36e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.52e-2)"	"unprognostic (3.94e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (6.44e-4)"	6.3	13.6	6.2	4.2	6.3	5.0	17.8	5.6	6.6	11.8	7.9	11.4	7.4	8.3	16.2	7.8	12.7	6.8	8.4	5.9	6.3	17.5	13.2	7.3	3.9	6.3	6.9	9.3	11.0	21.9	15.2	4.2	6.2	12.6	9.7	3.6	10.4	11.2	6.7	9.3	8.8	6.0	6.0	6.0	12.4	5.7	6.1	7.9	15.2	6.0	6.9	11.2	6.7	5.7	21.1	8.5	7.1	12.7	4.5	4.3	20.2	4.8	14.8	14.8	17.5	10.2	31.9	6.1	17.4	10.4	11.4	35.6	9.6	32.0	15.4	8.2	16.1	21.9	11.8	19.4	13.2	3.9	0.8	6.3	23.3	7.7	15.4	17.6	15.2	30.2	10.5	3.4	17.0	15.8	16.5	10.0	17.0	108.9	62.9	11.7	6.1	70.9	119.7	41.3	5.8	7.1	17.5	12.5	36.5	15.9	20.3	6.0	10.7	4.6	8.6	0.9	15.1	13.4	21.3	2.8	8.7	0.3	25.8	0.1	2.3	13.4	4.6	0.8	7.9	2.6	7.5	6.1	5.4	2.8	8.2	7.0	3.5	0.3	0.3	3.4	14.8	2.7	6.2	6.3	5.6	6.6	5.9	6.3	6.3	6.9	6.2	6.0	6.1	5.7	2.1	19.2	13.9	74.4	2.9	1.1	6.1	7.4	7.4	3.1	6.3	6.3	7.0	10.0	6.7	16.5	0.0	19.7	7.0	3.7	17.6	7.5	6.0	9.1	2.3	2.4	9.1	4.2	14.2	15.3	7.2	2.4	10.7	9.4	1.3	15.2	5.3	10.9	4.6	0.0	20.6	8.5	8.2	4.8	6.7	1.5	5.9	2.9	3.6	15.0	3.4	8.8	4.1	18.1	10.4	18.7	5.4	4.1	3.8	4.9	6.3	14.4	11.9	1.1	13.1	5.7	7.7	7.5	4.7	9.1	1.3	8.1	9.6	7.3	8.5	5.8
ACSBG1	"BG1, BGM, FLJ30320, hBG1, hsBG, KIAA0631, MGC14352"	ENSG00000103740	"Acyl-CoA synthetase bubblegum family member 1"	Q96GR2	15	78167468-78245688	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 56.6;skin 1: 14.3"	"Cell type enriched"	"Detected in some"	5	"Astrocytes: 158.0"	"Cancer enriched"	"Detected in some"	4	"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.1;SK-MEL-30: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041642, CAB045955, HPA058869"	Approved		Approved	Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 64: Astrocytes - Nervous system maintenance"	Vesicles		"CAB045955: AB_11124196, HPA041642: AB_2677593, HPA058869: AB_2683840"	"unprognostic (1.28e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.29e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.96e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.42e-2)"	0.1	5.5	23.0	0.4	42.6	2.4	1.6	30.5	24.0	0.5	0.0	1.1	0.4	0.2	0.7	0.3	2.8	0.2	0.8	19.6	35.9	0.5	0.4	0.5	0.4	46.0	39.9	0.3	0.2	0.0	0.5	0.1	47.7	0.8	0.1	0.6	0.3	0.2	0.2	14.3	0.5	0.2	45.8	0.3	0.3	3.7	36.6	3.4	0.2	0.0	0.1	0.3	0.5	56.6	0.3	0.0	0.6	0.9	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.3	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.5	0.3	0.6	0.3	0.0	0.2	0.6	0.2	0.0	0.1	0.1	0.2	0.0	0.4	0.2	0.4	0.0	0.1	0.2	0.5	3.1	0.2	0.1	0.1	0.4	0.2	0.0	0.4	0.2	0.3	0.1	0.4	1.5	0.3	0.1	0.2	0.4	0.2	0.2	0.1	0.1	0.3	0.1	0.3	0.1	0.2	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	1.0	0.0	0.3	23.0	42.6	30.5	24.0	19.6	35.9	46.0	39.9	47.7	45.8	36.6	56.6	0.1	0.0	2.0	158.0	0.6	1.1	0.6	0.3	0.6	1.9	0.2	0.1	3.0	0.0	2.7	0.0	4.2	0.2	0.5	0.3	0.0	0.0	1.8	4.4	0.3	0.2	0.0	4.6	0.7	0.0	0.2	0.7	0.5	0.3	0.0	0.1	0.0	0.0	0.1	0.0	1.0	0.2	0.0	0.0	0.0	1.7	0.3	4.0	1.8	2.8	0.1	0.2	1.0	7.5	26.9	0.2	0.0	0.0	0.9	0.3	0.1	0.2	19.1	3.3	0.0	0.3	1.0	2.0	10.0	0.4	0.6	0.4	0.5	1.6	0.1	0.7
ACSS3	FLJ21963	ENSG00000111058	"Acyl-CoA synthetase short chain family member 3"	Q9H6R3	12	80936414-81261210	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 40.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 46.5;Astrocytes: 167.8;Early spermatids: 52.9;Hepatocytes: 53.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	14	"basophil: 7.0;neutrophil: 2.2"	"Lineage enriched"	"Detected in single"	70	"granulocytes: 7.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 14.3;ASC TERT1: 16.1;Hep G2: 42.6;hTERT-RPE1: 14.0;RH-30: 19.1;SK-BR-3: 18.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039353, HPA047956, HPA061517"	Approved		Supported	Mitochondria		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria		"HPA039353: AB_2676460, HPA047956: AB_2680223, HPA061517: AB_2684549"	"unprognostic (8.59e-2)"	"unprognostic (9.29e-4)"	"unprognostic (1.47e-1)"	"unprognostic (9.37e-3)"	"unprognostic (2.46e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.68e-1)"	"unprognostic (7.79e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (6.16e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.00e-4)"	22.7	14.5	5.2	1.5	5.1	0.1	7.3	5.2	5.3	8.3	9.3	2.2	0.7	9.1	12.1	1.5	8.0	8.1	6.8	4.7	4.9	25.9	40.0	6.4	1.5	5.5	6.4	16.7	2.0	13.7	4.4	4.0	5.2	5.7	1.0	4.8	12.1	5.5	3.5	1.7	1.5	6.3	4.9	2.1	1.4	2.3	6.5	1.1	8.8	5.7	1.1	2.8	5.0	5.5	0.0	0.2	3.4	0.0	14.3	16.1	0.1	2.2	11.0	1.7	1.9	0.4	0.1	0.0	0.0	5.0	5.2	0.1	0.0	0.0	1.0	0.0	2.2	0.0	0.0	42.6	4.8	0.1	0.0	10.8	0.0	0.5	0.0	14.0	0.4	0.0	0.0	0.0	7.8	1.0	0.1	0.2	4.8	0.0	0.0	0.0	19.1	2.7	0.1	0.1	3.1	0.0	0.0	18.0	0.1	7.1	7.9	0.5	0.0	2.8	2.7	0.2	1.2	0.1	0.1	0.1	3.5	0.0	3.4	7.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	5.2	5.1	5.2	5.3	4.7	4.9	5.5	6.4	5.2	4.9	6.5	5.5	1.3	22.4	46.5	167.8	0.2	0.9	9.5	0.0	2.2	37.8	5.6	3.0	21.8	14.3	3.2	12.9	4.2	1.5	0.1	0.1	5.9	6.4	52.9	3.9	14.8	1.5	0.0	0.0	1.5	2.9	0.8	12.1	0.0	2.7	0.0	8.8	1.8	53.6	0.7	28.6	1.6	0.1	0.0	3.2	0.6	9.4	23.9	0.8	0.0	35.6	0.1	16.4	0.0	16.6	0.7	0.1	0.1	23.7	0.0	3.0	1.1	31.7	3.7	5.3	6.6	18.6	9.9	4.6	0.6	0.4	0.1	0.5	0.6	13.2	1.2	3.7
ADCYAP1R1	"PAC1, PAC1R, PACAPR"	ENSG00000078549	"ADCYAP receptor type I"	P41586	7	31052308-31111479	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 148.0"	"Group enriched"	"Detected in some"	4	"Astrocytes: 57.1;Inhibitory neurons: 45.7"	"Cancer enriched"	"Detected in some"	11	"glioma: 45.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 3.7;NTERA-2: 4.8;SCLC-21H: 4.1;SH-SY5Y: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030739, HPA049877"	Enhanced		Enhanced	Vesicles		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Vesicles		"HPA030739: AB_2732461, HPA049877: AB_2680928"	"unprognostic (5.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.16e-2)"	"prognostic favorable (5.78e-4)"	"unprognostic (2.17e-1)"	"unprognostic (8.36e-2)"	"unprognostic (4.93e-2)"	"unprognostic (5.75e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.67e-3)"	"unprognostic (6.43e-4)"	"unprognostic (1.09e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.75e-4)"	7.4	11.4	91.8	2.3	79.8	0.0	4.0	53.4	57.6	13.1	3.5	7.1	0.8	5.3	1.5	2.9	29.5	1.3	3.8	69.7	106.5	0.1	0.2	0.8	0.1	96.0	102.7	1.8	1.6	1.6	9.8	0.0	88.9	1.8	1.3	2.7	2.2	3.2	1.3	1.1	2.2	3.7	67.9	0.5	3.5	1.6	148.0	0.8	2.1	8.0	0.8	1.8	4.3	43.7	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	7.4	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.6	0.8	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.8	79.8	53.4	57.6	69.7	106.5	96.0	102.7	88.9	67.9	148.0	43.7	4.2	0.0	0.0	57.1	0.0	0.5	0.0	0.0	0.0	1.7	0.2	0.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.2	0.7	0.0	0.0	10.8	0.0	0.0	4.6	0.0	6.3	0.0	1.2	0.0	0.0	0.0	0.0	45.7	0.0	0.0	0.0	0.7	0.9	11.5	0.0	1.8	2.8	0.0	0.0	0.0	11.6	1.5	0.0	0.0	5.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	5.8	0.3	1.5	0.0	0.3	0.0	0.2	0.1	0.0	0.1
ADGRA3	"FLJ38547, GPR125, PGR21"	ENSG00000152990	"Adhesion G protein-coupled receptor A3"	Q8IWK6	4	22345071-22516066	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 58.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 221.7;Hepatocytes: 120.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 74.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008904	Uncertain				"Intracellular and membrane"	NA	NA		280000	"Cluster 15: NK-cells - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA008904: AB_1849258"	"unprognostic (3.70e-1)"	"unprognostic (9.01e-2)"	"unprognostic (5.32e-3)"	"unprognostic (8.27e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.91e-2)"	"unprognostic (8.77e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.01e-3)"	"unprognostic (2.79e-3)"	8.1	9.5	22.9	3.7	21.5	1.9	10.9	21.6	19.2	10.9	43.8	17.1	7.2	15.1	9.6	5.2	21.6	7.6	10.8	21.8	27.2	10.4	58.3	5.0	1.2	24.5	34.7	8.9	12.5	12.2	7.3	9.2	24.2	12.0	17.1	5.9	8.2	11.5	17.6	4.4	7.0	14.0	26.8	2.7	9.6	6.8	25.6	5.1	25.1	11.4	2.6	5.7	4.9	24.1	19.6	14.4	36.5	30.6	29.0	13.0	32.7	23.5	25.7	15.5	8.4	16.5	38.1	3.0	11.7	11.2	21.5	21.1	23.2	33.4	22.1	0.0	16.3	1.7	11.3	37.0	9.7	17.1	0.0	12.3	40.9	10.1	17.5	29.5	23.7	12.2	17.9	0.6	26.1	8.7	15.3	0.5	40.3	18.3	14.6	70.7	74.6	4.9	18.8	19.9	27.1	31.3	9.8	0.8	16.7	25.1	10.1	14.8	0.5	23.2	16.6	10.6	22.4	2.7	0.0	0.1	12.7	12.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	22.9	21.5	21.6	19.2	21.8	27.2	24.5	34.7	24.2	26.8	25.6	24.1	2.4	3.2	4.1	221.7	1.1	0.0	13.4	0.0	11.4	11.8	12.0	14.6	14.5	21.5	5.0	16.5	20.9	21.8	2.3	18.8	0.0	18.4	7.9	50.1	23.2	3.1	12.2	9.1	12.3	11.8	7.9	10.2	10.2	41.4	0.0	28.5	6.1	120.4	3.4	0.0	18.9	18.8	0.0	5.4	0.0	7.4	9.6	1.8	0.0	9.4	0.4	6.2	0.0	54.3	3.5	20.3	12.2	9.8	0.2	21.0	10.6	5.4	2.2	13.5	0.0	25.7	8.0	1.3	7.2	2.5	0.0	7.3	1.3	11.7	22.2	11.1
ADGRV1	"DKFZp761P0710, FEB4, GPR98, KIAA0686, MASS1, USH2C, VLGR1"	ENSG00000164199	"Adhesion G protein-coupled receptor V1"	Q8WXG9	5	90529344-91164437	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"	"G-protein coupled receptor, Hydrolase, Receptor, Transducer"	"Deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"adrenal gland: 533.0"	"Cell type enriched"	"Detected in many"	8	"Astrocytes: 2207.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 15.5;HAP1: 23.0;K-562: 9.8;NTERA-2: 11.6;SCLC-21H: 11.1;SuSa: 15.0;U-266/70: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067503	Approved		Approved	"Lipid droplets"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Lipid droplets"		"HPA067503: AB_2685856"	"unprognostic (1.29e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.95e-3)"	"unprognostic (7.50e-3)"	"unprognostic (9.73e-7)"	"unprognostic (1.87e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.48e-2)"	"unprognostic (7.14e-2)"	0.0	533.0	36.9	0.0	47.8	0.6	3.6	12.7	40.3	0.9	22.4	1.0	0.3	0.1	0.7	2.4	0.2	12.3	0.2	39.1	11.6	21.5	42.3	2.1	0.0	9.4	12.8	0.2	1.5	0.8	15.1	4.1	9.4	1.3	1.0	18.2	2.3	0.2	0.2	2.1	0.5	0.0	7.3	0.3	1.1	1.4	18.3	0.8	17.5	0.0	0.4	10.4	1.9	26.1	0.5	2.1	15.5	0.0	0.0	0.1	0.2	0.3	0.1	0.0	0.0	1.7	0.2	0.3	0.4	0.0	0.4	0.2	23.0	0.2	0.0	1.0	4.3	4.1	2.0	1.4	0.0	0.3	0.1	0.0	4.8	0.0	0.1	0.1	0.0	0.1	9.8	2.6	0.0	2.1	0.1	0.2	11.6	2.9	4.2	0.0	0.4	2.1	0.0	0.5	11.1	2.7	3.4	2.2	0.2	15.0	5.9	0.0	0.8	0.4	1.9	0.5	1.1	13.4	4.1	0.6	0.7	0.2	0.0	3.2	0.9	2.8	1.0	0.7	1.7	1.5	1.1	1.4	0.5	2.9	1.7	0.9	4.6	1.1	0.5	1.2	1.6	0.2	36.9	47.8	12.7	40.3	39.1	11.6	9.4	12.8	9.4	7.3	18.3	26.1	0.4	25.6	26.5	2207.3	0.0	0.0	6.1	0.0	1.8	28.0	15.5	7.4	2.4	2.8	5.6	5.5	264.8	3.0	0.4	0.6	1.9	1.9	43.5	3.3	0.3	1.1	7.3	0.0	54.0	4.2	2.6	1.1	4.6	1.9	0.0	6.7	0.0	12.4	0.2	10.1	21.9	0.4	0.0	0.8	0.0	54.8	0.6	0.5	0.0	51.5	1.2	8.9	1.0	40.2	7.4	1.7	1.2	0.4	0.1	2.1	0.1	24.2	7.3	84.4	0.0	0.3	0.4	3.6	4.5	2.9	0.0	4.1	0.6	0.2	1.2	9.0
ANKDD1A	FLJ25870	ENSG00000166839	"Ankyrin repeat and death domain containing 1A"	Q495B1	15	64911902-64958691	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 209.6;Leydig cells: 61.8;Peritubular cells: 78.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 24.1;RT4: 17.7;U-266/84: 25.4"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in all"		"cerebellum: 13.8"	HPA040757	Approved		Approved	Nucleoplasm	"Secreted - unknown location"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA040757: AB_10960566"	"unprognostic (3.72e-4)"	"unprognostic (1.86e-1)"	"unprognostic (6.07e-3)"	"unprognostic (3.25e-2)"	"unprognostic (4.78e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.22e-3)"	"unprognostic (5.11e-3)"	"unprognostic (5.57e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.15e-7)"	"unprognostic (1.06e-1)"	"unprognostic (1.98e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.64e-2)"	3.6	9.0	5.1	2.6	4.5	2.7	1.5	2.0	5.4	2.3	0.1	1.3	1.2	2.2	1.9	3.6	4.0	2.9	2.2	3.8	2.5	0.8	0.4	2.6	4.8	4.7	2.7	3.8	4.4	4.4	1.2	1.6	2.2	2.3	0.4	2.8	2.4	2.1	1.2	3.3	1.8	1.6	2.1	10.7	1.7	3.6	3.5	0.8	2.6	0.1	1.3	3.0	2.0	2.5	1.2	3.7	1.6	1.6	2.7	2.1	6.9	1.6	4.4	1.7	2.5	2.1	1.7	1.6	1.9	3.8	1.4	1.3	3.7	0.3	1.4	0.7	1.1	1.5	4.6	1.5	2.0	1.2	2.5	1.6	0.5	1.1	0.6	0.9	1.2	1.7	0.3	24.1	0.5	3.5	0.6	2.6	2.2	0.6	1.7	0.8	1.0	12.1	0.2	17.7	3.2	4.5	1.0	1.2	1.8	1.5	1.2	1.5	1.8	3.2	3.3	2.8	1.6	6.4	25.4	1.2	3.6	3.0	1.0	0.5	0.4	0.0	1.0	0.9	0.3	0.4	0.5	1.4	0.7	0.3	0.3	0.4	0.7	3.1	0.9	0.0	2.1	0.4	5.1	4.5	2.0	5.4	3.8	2.5	4.7	2.7	2.2	2.1	3.5	2.5	8.0	0.0	1.3	209.6	1.5	5.6	4.2	1.1	4.0	11.2	0.7	1.0	1.4	1.5	1.3	0.0	12.5	3.1	3.8	0.1	0.0	0.9	1.1	1.7	9.6	12.7	1.2	0.0	37.7	2.3	5.6	6.5	0.0	3.6	5.7	1.1	5.3	0.0	5.4	3.3	24.6	0.0	2.0	6.0	25.4	4.1	61.8	7.1	10.6	19.7	1.1	28.9	5.2	30.2	10.7	2.8	0.1	78.6	6.2	2.7	0.0	0.3	0.2	8.2	13.1	11.8	7.1	2.6	1.3	0.8	3.7	2.2	3.0	3.3	0.1	5.2
ANO8	"KIAA1623, TMEM16H"	ENSG00000074855	"Anoctamin 8"	Q9HCE9	19	17323223-17334855	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 73.1;Inhibitory neurons: 19.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049206	Uncertain					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA049206: AB_2680675"	"unprognostic (5.12e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.46e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.89e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.48e-2)"	"unprognostic (4.59e-2)"	6.2	21.0	11.1	4.6	9.9	2.6	6.7	10.0	14.6	5.0	2.8	4.7	4.4	3.8	1.1	11.6	4.9	5.3	5.3	10.6	9.6	7.6	7.1	6.4	4.4	13.2	12.1	3.8	6.9	6.6	4.5	3.4	12.3	4.8	2.3	4.1	7.7	2.7	8.4	18.4	4.7	2.8	11.2	5.5	8.2	3.1	12.7	5.2	6.0	4.9	2.8	3.5	6.4	9.4	6.3	5.5	14.8	16.8	4.4	3.1	24.5	6.3	3.6	3.2	3.6	2.4	13.2	0.5	6.5	6.2	4.5	5.7	3.1	5.1	1.9	27.8	7.6	4.2	18.0	3.7	2.2	0.9	6.9	3.5	4.7	4.2	3.0	8.2	2.4	9.9	3.1	6.2	2.1	4.8	5.6	1.6	8.4	7.1	21.9	9.2	3.1	7.5	5.3	10.3	5.4	17.8	6.8	6.4	5.2	5.4	9.2	2.8	2.5	7.4	4.1	22.9	6.9	10.7	9.2	1.0	11.7	7.8	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	11.1	9.9	10.0	14.6	10.6	9.6	13.2	12.1	12.3	11.2	12.7	9.4	4.4	6.4	1.7	73.1	1.0	0.9	0.4	0.7	2.2	5.2	10.3	9.9	2.4	1.5	1.1	0.0	4.2	3.9	3.4	2.1	0.0	1.8	0.2	2.3	1.6	1.4	0.0	0.4	12.6	1.6	8.7	1.6	10.2	4.6	5.7	5.9	1.1	3.5	1.7	1.7	19.3	2.4	2.0	1.9	1.4	0.3	2.1	2.2	0.0	9.4	0.8	2.5	0.0	12.5	7.8	1.8	0.3	0.7	3.0	0.8	2.3	0.9	0.7	2.7	0.0	1.5	2.4	0.3	0.8	2.1	1.4	2.6	2.2	4.7	2.2	0.8
APC	"DP2, DP2.5, DP3, PPP1R46"	ENSG00000134982	"APC regulator of WNT signaling pathway"	P25054	5	112707498-112846239	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"		"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 52.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 536.4;Bipolar cells: 196.9;Excitatory neurons: 165.8;Inhibitory neurons: 236.4;Oligodendrocyte precursor cells: 196.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013349, HPA013362"	Supported		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA013349: AB_1844913, HPA013362: "	"unprognostic (4.80e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.09e-3)"	"unprognostic (1.62e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.96e-1)"	6.9	4.6	28.4	6.2	26.0	9.1	5.7	23.1	31.0	5.7	0.1	6.7	6.2	5.6	3.3	7.7	4.3	4.9	7.2	52.8	27.4	6.2	5.7	6.2	5.6	32.1	30.7	6.6	4.1	8.5	3.9	5.1	39.0	5.2	6.2	20.0	3.8	4.1	8.5	5.7	8.5	7.5	16.0	6.1	5.0	5.1	37.9	8.5	5.9	11.8	5.9	5.4	3.6	20.9	11.3	10.1	16.8	12.2	13.4	11.3	6.7	17.9	8.5	9.7	11.5	8.2	8.9	22.0	17.0	23.1	15.5	9.0	17.4	14.6	15.9	13.2	12.2	16.8	14.9	6.2	6.6	8.4	8.6	9.3	9.8	16.6	10.8	6.8	13.6	10.2	20.9	7.2	14.3	7.8	9.6	4.2	6.0	6.1	3.6	8.1	20.8	10.7	8.9	14.1	17.0	10.1	16.9	6.5	7.1	6.8	9.1	6.7	22.8	19.6	9.5	19.5	13.6	5.6	9.5	8.2	10.8	15.3	11.2	11.8	2.5	4.9	2.9	1.3	2.4	2.8	1.5	1.9	2.1	3.1	2.4	2.4	11.4	2.9	2.4	2.7	1.5	1.0	28.4	26.0	23.1	31.0	52.8	27.4	32.1	30.7	39.0	16.0	37.9	20.9	40.6	51.3	23.6	536.4	21.9	11.2	8.9	10.1	19.9	196.9	13.1	14.9	56.6	18.6	20.1	0.0	66.7	5.4	28.9	28.6	0.0	18.7	10.5	20.1	27.6	31.2	27.5	17.4	165.8	19.5	6.5	25.9	19.4	29.7	19.0	28.7	26.7	13.9	16.3	79.1	236.4	17.2	2.0	18.9	12.4	5.5	17.7	27.8	17.8	85.3	30.7	23.4	23.7	196.6	150.8	20.3	34.7	19.5	22.9	10.4	37.2	5.1	18.0	41.5	39.5	44.1	34.0	19.2	30.4	26.5	11.6	2.9	22.4	27.1	16.0	8.9
APC2	APCL	ENSG00000115266	"APC regulator of WNT signaling pathway 2"	O95996	19	1446302-1473244	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"		"Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 64.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 142.4;Bipolar cells: 50.4;Excitatory neurons: 26.8;Horizontal cells: 45.4;Inhibitory neurons: 27.5;Muller glia cells: 29.4;Oligodendrocyte precursor cells: 28.1"	"Cancer enriched"	"Detected in some"	27	"glioma: 17.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.8;SCLC-21H: 9.3;SH-SY5Y: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078002			Supported	"Cytokinetic bridge,Midbody,Cytosol"		Yes	No				"Cluster 70: Brain - Nervous system development"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Cytokinetic bridge, Midbody"	Cytosol	"HPA078002: AB_2686874"	"unprognostic (1.78e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.88e-5)"	"unprognostic (3.64e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.45e-2)"	"unprognostic (9.49e-3)"	"unprognostic (7.39e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.98e-3)"	0.1	2.4	41.5	0.0	27.3	0.0	0.0	41.4	42.4	0.1	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.1	0.3	37.1	20.8	0.0	0.0	0.0	0.0	64.5	42.3	0.0	0.3	0.0	6.2	0.0	54.9	0.1	0.0	2.7	0.2	0.0	0.2	0.1	0.4	0.1	38.3	0.0	0.3	1.0	54.6	0.0	0.1	0.0	0.0	0.1	0.2	49.0	0.2	0.6	7.8	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.1	0.0	0.5	0.2	0.1	0.0	0.0	1.0	0.1	0.0	0.4	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.6	0.0	0.0	9.3	31.7	1.1	0.0	0.5	0.1	0.1	0.0	0.0	0.4	0.6	0.1	0.1	1.7	0.5	0.2	0.7	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.5	27.3	41.4	42.4	37.1	20.8	64.5	42.3	54.9	38.3	54.6	49.0	0.3	0.0	0.0	142.4	0.3	0.0	0.2	0.2	1.2	50.4	0.4	0.4	3.4	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.5	0.5	0.5	0.0	0.0	26.8	0.0	0.1	0.3	0.0	0.6	0.0	0.2	0.0	0.0	0.1	45.4	27.5	0.0	0.0	0.0	0.0	0.7	0.3	0.1	0.0	3.7	0.0	29.4	2.1	28.1	17.8	0.0	0.0	0.7	0.0	0.1	0.2	0.2	0.0	11.1	0.0	0.6	0.4	0.4	0.7	2.4	0.0	0.0	0.3	0.2	0.1	0.2
ARHGAP24	"DKFZP564B1162, FilGAP, FLJ33877"	ENSG00000138639	"Rho GTPase activating protein 24"	Q8N264	4	85475150-86002668	"Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein, GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 99.8"	"Group enriched"	"Detected in many"	4	"Astrocytes: 1364.3;Microglial cells: 905.0"	"Cancer enhanced"	"Detected in all"		"renal cancer: 9.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 15.9;memory B-cell: 47.3;naive B-cell: 36.8;plasmacytoid DC: 12.7"	"Group enriched"	"Detected in many"	5	"B-cells: 47.3;dendritic cells: 12.7;monocytes: 15.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 109.0;ASC TERT1: 65.5;HHSteC: 63.6;HUVEC TERT2: 121.9;RPTEC TERT1: 67.2;TIME: 87.0;U-138 MG: 59.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014288	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane, Cytosol"		"HPA014288: AB_1844994"	"unprognostic (2.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.81e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.75e-3)"	"unprognostic (4.28e-3)"	"unprognostic (3.66e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.91e-2)"	"unprognostic (6.45e-2)"	"prognostic favorable (1.67e-11)"	"unprognostic (1.75e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.50e-2)"	"unprognostic (8.75e-4)"	14.6	2.2	6.5	7.5	5.1	18.7	9.2	6.2	5.8	5.5	3.9	7.4	7.3	9.4	4.6	6.1	4.1	10.9	27.3	5.7	6.6	99.8	9.5	15.7	10.5	15.7	11.5	5.5	30.1	8.1	5.4	22.4	17.2	5.4	6.1	8.4	10.6	7.2	10.2	7.0	10.3	14.1	12.1	16.4	26.0	3.4	10.4	7.5	27.8	7.7	15.5	9.1	5.6	19.1	3.0	6.2	4.4	0.1	109.0	65.5	4.8	21.5	28.5	5.2	8.4	0.1	0.0	2.8	7.4	48.8	6.4	0.0	0.2	9.0	11.0	0.0	1.2	3.6	0.6	0.2	63.6	0.4	0.0	48.4	0.9	10.3	4.7	23.9	121.9	0.0	6.6	0.4	46.1	0.0	0.1	0.0	0.3	1.5	11.3	0.6	22.4	11.8	67.2	0.0	2.3	2.3	2.5	3.5	7.8	4.7	0.4	0.2	87.0	59.9	1.2	4.4	0.3	0.3	0.0	3.9	10.1	2.2	19.9	0.0	15.9	0.0	0.0	3.0	0.0	47.3	0.0	0.0	3.8	36.8	0.0	0.0	5.5	0.0	2.3	12.7	0.0	3.1	6.5	5.1	6.2	5.8	5.7	6.6	15.7	11.5	17.2	12.1	10.4	19.1	14.0	57.7	28.8	1364.3	142.1	8.2	3.9	35.6	10.2	6.6	1.2	4.7	26.4	47.1	18.3	46.0	6.2	54.8	9.9	1.0	226.9	9.4	30.5	1.2	12.9	9.5	2.4	0.0	12.2	11.8	26.2	24.7	25.0	1.4	1.3	6.7	4.2	9.5	10.5	111.0	51.3	3.3	6.1	33.7	21.3	8.8	16.8	26.3	19.6	905.0	34.0	27.7	0.0	27.2	21.8	7.4	2.9	12.4	2.0	2.3	0.2	205.9	24.8	6.6	6.6	50.0	21.3	8.1	5.9	4.0	6.3	232.9	4.1	18.4	5.0	1.9
ARHGAP5	"GFI2, p190-B, p190BRhoGAP, RhoGAP5"	ENSG00000100852	"Rho GTPase activating protein 5"	Q13017	14	32076114-32159728	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 381.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046993, HPA056507"	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Endoplasmic reticulum, Cytosol"		"HPA046993: AB_2679895, HPA056507: AB_2683158"	"unprognostic (1.79e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.66e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.63e-2)"	"prognostic favorable (3.97e-8)"	"unprognostic (9.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.00e-2)"	23.7	27.3	54.3	19.8	55.5	10.9	27.3	66.4	53.6	26.2	12.1	29.5	35.3	28.0	24.7	66.5	23.2	32.7	62.8	47.5	52.7	43.0	31.8	28.0	14.6	42.9	52.0	47.3	29.7	48.1	10.0	37.1	43.2	30.5	26.3	57.8	59.8	29.3	14.0	30.8	38.9	23.4	45.6	42.9	29.4	46.5	50.6	18.3	68.5	24.7	18.5	32.8	15.7	80.4	61.0	48.5	47.3	69.8	60.7	42.4	27.3	37.1	45.6	22.1	32.9	62.2	58.0	17.9	32.1	47.0	37.2	63.3	46.0	39.9	42.7	18.0	26.6	26.9	30.1	91.2	41.5	16.5	15.5	47.5	78.8	20.7	77.1	54.3	27.4	33.3	24.3	51.8	36.3	31.9	36.4	0.8	23.7	67.1	57.7	38.9	58.2	3.5	48.4	159.5	73.2	28.6	99.6	52.7	74.6	52.5	54.8	1.1	44.6	40.8	60.6	33.9	27.6	19.7	41.5	2.8	20.5	17.5	113.1	2.2	1.4	0.0	3.1	0.7	3.8	6.1	5.5	3.0	5.3	5.3	5.7	3.5	0.5	5.9	1.2	7.6	5.0	2.0	54.3	55.5	66.4	53.6	47.5	52.7	42.9	52.0	43.2	45.6	50.6	80.4	50.9	192.3	71.9	381.9	40.7	94.2	144.2	52.1	130.9	97.2	52.8	53.3	301.2	58.6	70.2	58.8	114.7	27.5	27.0	85.0	54.8	50.2	42.0	92.1	77.9	42.9	61.8	28.6	81.7	46.1	14.5	65.1	59.7	136.3	5.1	30.0	37.5	51.1	19.0	65.6	140.7	56.8	46.8	19.0	45.4	66.8	104.4	44.2	67.6	65.6	18.6	103.3	14.4	139.7	205.6	75.0	93.5	100.4	35.7	104.2	89.6	60.1	78.4	92.7	59.2	103.1	65.9	128.5	75.6	94.0	70.3	13.4	29.2	77.3	51.1	180.9
ARHGEF4	"ASEF, KIAA1112, STM6"	ENSG00000136002	"Rho guanine nucleotide exchange factor 4"	Q9NR80	2	130836914-131047263	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.3;skin 1: 39.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 333.3;Excitatory neurons: 83.0;Inhibitory neurons: 83.5;Oligodendrocyte precursor cells: 143.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD8 T-cell: 1.4"	"Group enriched"	"Detected in many"	12	"dendritic cells: 1.0;T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 39.9;hTCEpi: 78.9;REH: 20.3;SCLC-21H: 52.9"									HPA018267	Approved					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA018267: AB_1845006"	"unprognostic (2.30e-3)"	"unprognostic (8.84e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.44e-1)"	"unprognostic (2.60e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.68e-2)"	"prognostic favorable (7.00e-4)"	"unprognostic (3.93e-3)"	"unprognostic (9.71e-3)"	5.6	5.0	53.1	1.0	56.8	0.0	2.1	32.5	67.3	11.2	27.3	7.0	0.2	2.9	1.6	34.0	8.4	2.9	1.4	63.1	38.1	0.4	0.9	3.1	0.3	44.4	39.7	7.8	17.9	2.5	15.4	0.2	39.9	5.2	0.8	10.2	5.7	9.3	9.0	39.8	1.3	4.1	41.5	0.2	3.1	5.2	44.6	1.8	6.1	2.6	2.5	4.5	19.9	46.0	4.8	2.0	0.9	16.6	0.1	0.0	0.4	5.3	0.3	0.3	0.2	0.9	1.5	0.0	0.5	2.1	3.6	39.9	2.4	10.5	0.0	0.0	2.2	0.0	7.0	0.0	0.6	0.0	0.1	0.0	78.9	1.2	5.8	0.1	0.1	0.1	0.0	0.0	0.0	2.5	0.0	0.0	5.8	0.7	7.2	20.3	0.2	0.8	3.2	0.1	52.9	7.0	0.8	8.3	0.6	1.6	0.5	0.5	0.0	0.0	0.3	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.2	0.5	0.0	0.0	0.5	1.4	0.0	0.0	0.0	1.0	0.5	0.1	53.1	56.8	32.5	67.3	63.1	38.1	44.4	39.7	39.9	41.5	44.6	46.0	0.1	25.6	0.0	333.3	0.0	17.3	1.2	4.8	15.4	18.8	0.9	5.5	3.2	1.5	2.9	0.0	37.5	1.0	2.9	0.3	0.0	0.8	10.9	7.5	1.0	0.5	0.0	2.7	83.0	0.0	0.3	3.5	2.6	5.4	0.0	3.1	0.7	0.4	0.4	28.6	83.5	0.9	0.0	0.6	2.4	8.2	5.0	0.3	5.4	11.2	0.7	3.7	0.0	143.7	28.3	1.5	0.0	10.9	0.0	1.2	0.3	0.9	6.6	13.9	0.0	3.1	1.1	1.1	4.2	17.4	19.9	0.3	0.8	0.4	0.4	0.8
ART1	"ART2, ARTC1, CD296"	ENSG00000129744	"ADP-ribosyltransferase 1"	P52961	11	3645128-3664416	"CD markers, Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	57	"skeletal muscle: 47.4;tongue: 36.8"	"Cell type enhanced"	"Detected in single"		"Microglial cells: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051148	Uncertain					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA051148: AB_2681363"	"unprognostic (3.73e-1)"							"unprognostic (4.58e-2)"		"unprognostic (3.12e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.06e-1)"		"unprognostic (1.73e-1)"		0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.4	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.1	47.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	36.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.4	0.5	0.3	0.2	0.3	0.3	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ATP13A4	"DKFZp761I1011, FLJ37958"	ENSG00000127249	"ATPase 13A4"	Q4VNC1	3	193398967-193593111	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 64.5;parathyroid gland: 58.4;thyroid gland: 51.9"	"Group enriched"	"Detected in many"	4	"Astrocytes: 409.4;Oligodendrocyte precursor cells: 163.3"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 23.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051932			Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA051932: "	"unprognostic (4.97e-2)"	"unprognostic (1.50e-3)"	"unprognostic (4.86e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.72e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (1.55e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.29e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.00e-1)"	0.1	0.3	19.5	0.2	20.9	0.2	22.7	18.1	20.1	2.8	28.2	2.0	0.3	0.1	64.5	20.1	2.4	4.6	0.1	18.0	17.0	0.7	0.6	27.3	0.4	18.5	21.5	0.3	5.3	58.4	4.8	0.1	17.9	0.1	3.4	2.5	7.2	2.4	0.5	16.9	0.3	0.1	15.2	0.3	9.6	0.5	21.6	0.3	51.9	0.0	4.8	0.1	6.7	15.8	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.6	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	19.5	20.9	18.1	20.1	18.0	17.0	18.5	21.5	17.9	15.2	21.6	15.8	0.2	64.1	30.5	409.4	1.1	0.1	0.0	1.7	0.0	1.6	6.1	3.6	0.4	11.5	15.3	0.0	0.0	1.2	0.5	1.6	0.0	3.3	0.4	4.0	0.7	0.1	0.0	0.0	5.8	0.2	0.1	0.2	17.3	6.4	1.3	0.3	1.4	0.1	0.2	1.7	10.9	1.9	0.0	0.3	0.5	1.0	0.0	0.5	1.8	13.1	0.0	0.5	0.0	163.3	20.6	1.3	1.7	0.4	0.2	0.0	0.0	0.4	8.5	1.0	0.0	0.1	0.2	0.7	1.5	2.2	1.6	0.7	0.9	0.1	2.2	0.1
ATP13A5	FLJ16025	ENSG00000187527	"ATPase 13A5"	Q4VNC0	3	193274789-193378820	"Predicted membrane proteins"		Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"breast: 17.3;choroid plexus: 38.5;salivary gland: 11.7"	"Group enriched"	"Detected in some"	5	"Astrocytes: 37.9;Oligodendrocyte precursor cells: 26.2"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.3"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in single"		"SK-BR-3: 1.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA031771, HPA031772, HPA031774"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"	Nucleoplasm	"HPA031771: AB_2674038, HPA031772: , HPA031774: AB_2674039"	"unprognostic (7.98e-2)"	"unprognostic (3.01e-4)"		"unprognostic (2.06e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.93e-1)"		"unprognostic (1.67e-4)"	"unprognostic (3.03e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.14e-2)"		"unprognostic (1.73e-1)"	"unprognostic (7.15e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.10e-2)"		0.0	0.1	2.3	0.0	1.9	0.2	17.3	1.5	2.7	0.0	38.5	0.0	0.0	0.1	0.8	0.7	0.1	0.0	0.2	3.1	1.8	0.2	0.0	0.5	0.1	1.6	2.3	0.2	0.1	0.2	0.3	0.0	1.5	0.0	0.0	0.8	11.7	0.0	1.3	3.9	0.0	0.0	0.8	0.0	1.6	0.4	2.4	0.0	1.3	0.1	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	2.3	1.9	1.5	2.7	3.1	1.8	1.6	2.3	1.5	0.8	2.4	1.8	0.1	0.0	0.5	37.9	0.0	0.0	0.0	0.3	0.0	0.0	5.8	5.8	0.7	0.0	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.5	0.1	0.0	0.1	0.0	0.0	1.1	0.2	0.0	0.4	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	1.9	0.0	0.0	0.0	26.2	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
ATP1A2	"FHM2, MHP2"	ENSG00000018625	"ATPase Na+/K+ transporting subunit alpha 2"	P50993	1	160115759-160143591	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"	Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 515.9;skeletal muscle: 882.2;tongue: 478.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 515.8;Cardiomyocytes: 158.7;Microglial cells: 141.5;Muller glia cells: 73.0;Oligodendrocyte precursor cells: 94.0;Sertoli cells: 85.5"	"Cancer enriched"	"Detected in many"	18	"glioma: 91.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 51.9;HHSteC: 14.6;RH-30: 16.8;U-87 MG: 10.3"	"Low region specificity"	"Detected in all"							CAB022230	Enhanced					NA	NA		170000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"			"CAB022230: "	"unprognostic (1.08e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.83e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.85e-2)"	"unprognostic (8.63e-4)"	"unprognostic (1.70e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.16e-2)"	"unprognostic (5.32e-3)"	37.4	4.1	401.5	1.5	480.5	0.0	27.4	419.8	412.8	9.3	164.9	55.8	3.6	5.6	12.5	33.5	14.5	8.0	144.6	337.4	398.5	3.9	1.2	6.4	0.3	429.5	478.8	18.9	1.4	0.3	32.3	3.3	375.3	28.5	8.1	58.5	18.2	28.5	882.2	4.7	15.9	7.8	365.0	1.8	15.7	5.8	515.9	0.6	3.5	478.0	0.5	29.9	9.8	327.7	0.0	0.0	51.9	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.1	4.6	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	401.5	480.5	419.8	412.8	337.4	398.5	429.5	478.8	375.3	365.0	515.9	327.7	1.4	0.0	0.0	515.8	0.1	0.5	1.6	0.0	0.6	1.3	2.5	0.9	158.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.2	1.2	11.1	0.0	0.0	5.5	0.0	0.0	4.8	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	1.3	1.4	28.9	0.5	0.0	141.5	0.5	73.0	0.0	94.0	2.5	0.0	0.0	39.5	0.0	0.8	0.0	0.1	0.1	3.9	85.5	54.9	45.8	0.3	0.2	0.2	0.6	0.1	0.1	5.8	0.0	0.6
B4GALNT4	"FLJ25045, NGalNAc-T1"	ENSG00000182272	"Beta-1,4-N-acetyl-galactosaminyltransferase 4"	Q76KP1	11	369499-382117	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.3;ovary: 27.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 133.2;Bipolar cells: 23.8;Excitatory neurons: 31.2;Horizontal cells: 33.7;Inhibitory neurons: 32.3;Muller glia cells: 45.6;Oligodendrocyte precursor cells: 28.1;Oligodendrocytes: 32.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 35.4;NTERA-2: 32.0;SCLC-21H: 39.5;SH-SY5Y: 47.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043276, HPA053126"	Uncertain		Uncertain	Nucleoplasm,Vesicles,Cytosol	"Intracellular and membrane"	NA	No				"Cluster 35: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Cytosol"	Vesicles	"HPA043276: , HPA053126: AB_2682049"	"unprognostic (6.11e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.92e-3)"	"unprognostic (5.36e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.99e-3)"	"unprognostic (1.52e-10)"	"unprognostic (9.01e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.92e-4)"	"unprognostic (1.25e-1)"	0.9	0.6	23.1	0.9	17.2	0.0	3.3	5.1	33.3	17.2	0.0	5.9	0.6	14.1	0.6	2.3	11.9	0.5	1.6	23.8	12.9	1.0	0.3	0.5	0.3	19.3	20.7	27.8	1.1	2.6	17.9	0.0	14.9	6.3	0.2	5.3	2.0	1.2	0.0	2.1	2.9	1.0	8.4	0.3	2.1	1.5	15.1	0.3	0.5	0.0	0.3	1.8	6.3	13.4	0.0	4.8	35.4	20.4	0.0	0.1	8.4	6.5	1.7	2.9	0.8	3.7	0.0	0.0	4.8	0.7	5.6	1.4	4.8	8.5	0.8	0.0	12.3	0.0	13.4	11.4	0.4	0.0	8.7	0.6	5.0	0.2	3.8	12.7	0.4	1.9	11.5	0.0	0.0	10.8	0.4	0.0	32.0	0.6	14.0	0.0	0.0	4.9	0.4	0.0	39.5	47.6	2.4	1.7	0.5	3.7	14.0	0.0	9.0	2.0	11.1	3.5	0.4	0.1	1.7	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	17.2	5.1	33.3	23.8	12.9	19.3	20.7	14.9	8.4	15.1	13.4	0.1	0.0	0.0	133.2	0.2	0.8	1.5	1.4	0.6	23.8	6.5	8.9	12.5	0.0	0.1	1.8	4.2	0.1	0.3	0.1	0.0	1.3	0.0	0.6	7.1	0.6	1.8	0.0	31.2	0.0	0.0	2.4	0.0	1.1	0.0	6.9	0.0	0.0	0.2	33.7	32.3	0.1	2.0	0.0	0.0	0.0	3.1	0.1	3.6	2.8	0.2	45.6	0.0	28.1	32.5	0.2	0.0	1.2	0.0	2.6	0.0	0.0	0.1	8.6	0.0	0.0	3.3	0.1	0.2	0.1	0.3	0.3	0.1	0.6	0.5	0.4
BBS2	BBS	ENSG00000125124	"Bardet-Biedl syndrome 2"	Q9BXC9	16	56466836-56520087	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision"		"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 144.3;Oligodendrocytes: 97.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041315	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA041315: AB_10960892"	"unprognostic (1.43e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.68e-1)"	"prognostic favorable (2.83e-6)"	"unprognostic (2.16e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.95e-2)"	20.3	78.3	90.1	9.3	102.5	6.0	29.5	93.2	117.7	31.1	80.7	23.6	13.5	25.9	47.1	23.2	32.7	21.6	32.8	87.5	89.4	41.7	13.2	20.2	18.4	94.4	90.4	40.7	15.7	53.7	38.1	16.1	96.2	26.9	16.9	86.5	20.0	27.0	41.5	36.4	17.7	24.0	89.4	21.0	17.2	28.6	91.5	18.3	28.1	50.8	16.2	21.1	29.7	107.9	22.3	19.7	29.6	29.9	47.1	56.9	17.4	10.7	40.9	23.1	29.8	11.0	18.0	22.1	17.6	24.3	19.0	25.3	11.7	36.4	36.0	4.9	26.3	10.4	19.4	28.1	30.7	12.1	11.4	35.4	26.7	18.3	16.8	49.0	50.0	16.7	4.7	2.7	28.9	15.2	16.8	14.1	7.9	14.9	32.7	12.9	8.3	25.7	36.2	18.1	20.7	15.5	51.9	20.2	27.8	23.7	17.2	14.3	43.3	18.3	11.6	8.3	5.7	10.4	8.7	17.1	31.6	10.5	13.7	9.9	9.6	24.5	15.6	13.6	15.8	11.4	18.7	20.6	11.8	12.4	24.4	23.2	2.7	7.4	22.4	3.4	16.4	14.0	90.1	102.5	93.2	117.7	87.5	89.4	94.4	90.4	96.2	89.4	91.5	107.9	11.5	0.0	24.3	144.3	9.6	11.2	15.6	19.1	23.9	21.5	10.7	11.3	24.4	5.7	18.7	11.0	25.0	14.3	6.6	8.7	7.9	7.1	21.1	22.4	10.7	12.3	6.7	4.6	41.0	5.8	7.3	18.6	7.7	16.9	10.1	27.0	12.1	6.9	11.2	20.2	39.6	10.3	24.4	11.3	6.3	19.7	18.0	8.9	10.6	26.2	9.0	26.6	7.2	71.4	97.8	6.0	10.4	20.7	4.1	4.7	11.5	20.0	56.1	34.6	19.7	16.7	12.0	18.4	20.7	13.1	14.1	7.5	10.5	59.2	11.1	10.0
BCKDHB		ENSG00000083123	"Branched chain keto acid dehydrogenase E1 subunit beta"	P21953	6	80106647-80346270	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 78.4"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 296.5;Early spermatids: 110.9;Inhibitory neurons: 94.9;Oligodendrocyte precursor cells: 98.5;Oligodendrocytes: 101.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031580, HPA031956"	Approved		Supported	Nucleoplasm,Nucleoli,Mitochondria	"Intracellular and membrane"	Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria	"Nucleoplasm, Nucleoli"	"HPA031580: AB_10696054, HPA031956: "	"unprognostic (4.23e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.50e-3)"	"unprognostic (9.37e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.03e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.32e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.65e-2)"	"prognostic favorable (5.54e-9)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.49e-2)"	19.7	10.7	7.3	7.6	8.3	8.2	22.3	11.5	7.8	11.7	11.6	22.5	11.5	9.2	7.1	10.3	11.5	7.8	18.8	8.8	7.0	31.8	78.4	7.3	8.8	10.7	9.2	14.6	12.9	19.7	7.2	4.8	13.1	15.9	20.7	7.9	26.6	11.3	10.9	8.5	12.4	9.4	11.8	6.3	17.6	13.1	8.7	9.1	15.5	15.3	9.1	11.2	7.6	16.0	13.8	5.1	18.8	25.3	18.6	16.1	14.9	9.7	19.8	15.4	21.0	8.3	18.5	38.9	10.1	23.1	18.0	13.6	10.6	12.7	21.5	48.8	15.6	19.4	12.6	11.3	20.7	27.7	8.3	15.6	12.8	10.7	13.3	13.8	18.6	29.8	16.6	33.8	35.0	7.6	10.3	16.3	14.0	30.1	6.5	25.5	58.3	33.8	43.2	20.7	12.6	17.8	16.2	13.4	9.9	20.6	17.3	21.1	8.0	9.2	6.3	8.5	13.0	24.0	25.2	12.9	11.3	20.4	14.2	3.4	4.2	1.0	10.1	5.1	13.3	10.6	8.3	8.5	8.3	12.7	11.0	11.6	0.8	17.4	5.9	12.9	20.3	6.1	7.3	8.3	11.5	7.8	8.8	7.0	10.7	9.2	13.1	11.8	8.7	16.0	8.4	9.6	21.0	296.5	11.5	8.5	12.5	21.1	15.9	7.8	19.6	14.7	29.3	8.6	18.0	5.5	2.1	17.0	9.1	17.5	27.4	8.2	110.9	8.3	10.3	8.0	12.0	10.3	72.0	10.4	8.3	13.7	15.3	17.6	16.5	19.2	11.0	66.5	12.2	3.3	94.9	31.3	10.2	9.1	9.0	13.7	8.7	5.4	16.0	59.0	7.3	15.5	10.3	98.5	101.7	5.4	10.4	8.6	8.4	6.2	11.5	33.1	13.5	8.7	6.6	11.1	9.4	15.2	5.6	20.1	12.4	10.4	9.9	15.5	17.4	10.9
BCL2	"Bcl-2, PPP1R50"	ENSG00000171791	"BCL2 apoptosis regulator"	P10415	18	63123346-63320128	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Apoptosis		"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 271.6;Inhibitory neurons: 102.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	18	"B-cells: 5.4;T-cells: 8.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 44.2;HL-60: 43.7;Karpas-707: 72.9;U-266/70: 217.4"	"Low region specificity"	"Detected in all"							"CAB000003, HPA055295"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nuclear membrane"	Nucleoplasm	"CAB000003: AB_2064429, HPA055295: AB_2682776"	"unprognostic (1.11e-3)"	"prognostic favorable (5.13e-5)"	"unprognostic (5.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.93e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.51e-2)"	"prognostic favorable (1.29e-8)"	"unprognostic (6.67e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.47e-4)"	"unprognostic (2.63e-1)"	12.8	1.9	5.5	10.2	7.8	5.0	9.6	4.7	3.4	10.7	0.0	6.2	4.4	11.6	2.9	5.9	11.8	6.5	5.3	2.9	6.6	6.7	2.1	3.7	14.7	11.2	7.9	14.5	3.1	13.0	4.7	4.6	7.5	6.4	5.5	2.1	3.7	7.0	16.5	4.8	8.1	6.6	7.9	17.9	3.8	1.5	8.2	18.3	24.0	8.8	14.6	5.4	7.7	5.7	1.7	0.3	6.8	5.9	6.7	1.3	2.4	1.0	0.7	2.4	2.0	3.5	0.4	0.3	1.1	0.9	4.7	0.4	6.7	0.9	1.5	44.2	1.6	0.5	2.0	0.7	2.0	43.7	5.6	1.7	0.8	3.3	5.8	1.1	0.7	4.3	0.8	72.9	2.2	1.4	9.8	10.7	1.5	0.8	1.3	39.5	1.9	26.5	7.4	8.5	7.2	6.4	0.3	0.3	8.5	1.4	0.3	29.9	0.3	9.9	3.3	0.9	5.1	217.4	40.1	2.9	1.9	24.9	6.0	0.3	0.0	0.0	1.9	0.0	7.6	5.4	6.3	3.4	0.1	3.1	3.3	3.2	0.0	0.2	0.3	0.2	8.5	1.3	5.5	7.8	4.7	3.4	2.9	6.6	11.2	7.9	7.5	7.9	8.2	5.7	7.1	0.0	1.1	271.6	84.9	19.5	33.6	1.6	13.6	1.9	39.7	19.7	17.4	18.6	2.4	7.3	0.0	14.0	39.9	2.7	15.6	3.7	0.4	9.8	9.8	5.9	5.4	3.8	60.7	0.0	0.7	15.8	5.6	24.9	15.8	38.8	3.9	1.2	9.4	0.0	102.3	10.5	24.4	15.0	29.6	1.9	8.7	29.0	46.2	88.1	19.7	18.8	18.6	76.4	56.7	0.2	5.9	13.9	50.1	41.6	0.9	18.0	0.1	0.6	26.3	48.8	19.7	0.3	1.3	6.2	17.6	49.1	76.1	24.1	9.8	76.2
BMPR1B	"ALK6, CDw293"	ENSG00000138696	"Bone morphogenetic protein receptor type 1B"	O00238	4	94757955-95158448	"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Chondrogenesis	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.1;cervix: 24.7;prostate: 22.4"	"Cell type enriched"	"Detected in many"	7	"Astrocytes: 480.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 32.4;prostate cancer: 24.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 22.0;MCF7: 11.1;SH-SY5Y: 18.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (2.25e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.40e-3)"	"prognostic favorable (2.84e-4)"	"unprognostic (1.57e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.62e-3)"	"unprognostic (7.89e-4)"	"unprognostic (6.22e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.63e-2)"	0.7	4.6	13.4	0.3	15.4	0.1	1.0	13.5	15.0	24.7	2.1	0.9	0.1	4.4	2.4	0.2	12.5	2.6	0.8	12.5	16.0	7.8	0.8	1.7	0.0	19.3	20.1	6.2	1.1	0.1	1.9	0.7	17.5	22.4	0.2	8.1	1.0	14.2	3.0	0.8	0.1	0.6	15.3	0.9	2.4	3.7	15.6	6.4	0.5	1.1	0.0	0.2	0.5	12.1	0.0	22.0	5.6	0.0	2.3	4.8	0.2	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.2	1.0	0.0	1.3	3.6	8.4	0.1	0.0	4.9	0.0	1.4	0.0	0.6	0.5	0.1	2.7	9.0	2.8	6.2	0.4	0.1	0.0	0.0	0.0	7.1	11.1	0.6	0.1	2.1	0.1	3.2	0.2	3.4	0.1	4.3	0.1	0.2	18.8	0.3	3.2	3.2	0.8	1.7	0.0	0.0	4.0	3.8	0.2	4.3	0.0	0.0	0.0	1.5	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	13.4	15.4	13.5	15.0	12.5	16.0	19.3	20.1	17.5	15.3	15.6	12.1	0.0	6.4	0.0	480.6	0.0	2.7	1.3	13.1	1.2	0.4	3.8	1.0	3.4	2.8	33.4	60.7	0.0	0.0	0.0	0.0	1.9	3.0	1.4	28.5	1.4	1.1	18.4	0.0	51.0	0.4	0.3	1.5	0.0	20.8	0.0	38.6	2.9	0.0	0.1	0.0	2.5	0.0	8.2	0.0	1.2	1.4	3.1	0.4	28.4	22.5	0.0	38.5	0.0	10.1	2.8	0.7	0.0	3.8	0.0	28.5	0.0	0.2	15.7	1.6	0.0	1.7	2.9	1.2	10.6	0.4	2.3	0.0	0.5	4.4	0.0	1.6
C2orf72	LOC257407	ENSG00000204128	"Chromosome 2 open reading frame 72"	A6NCS6	2	231037523-231049719	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 14.6;liver: 18.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 163.2;Cholangiocytes: 47.1;Hepatocytes: 129.1;Oligodendrocyte precursor cells: 45.8;Paneth cells: 51.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 40.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.9;CACO-2: 2.2;EFO-21: 3.3;OE19: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044962	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Plasma membrane"		"HPA044962: AB_10960863"	"unprognostic (4.90e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.44e-3)"	"unprognostic (2.88e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.38e-1)"	"unprognostic (6.51e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (5.27e-4)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (2.78e-1)"	"unprognostic (7.23e-3)"	"unprognostic (2.70e-2)"	"unprognostic (5.19e-2)"	0.0	0.0	6.7	0.0	8.2	0.0	0.3	4.3	8.8	0.0	0.0	3.0	0.6	0.0	0.1	0.0	0.0	0.4	0.0	8.7	6.2	0.2	18.7	0.1	0.0	8.4	12.1	0.0	1.4	0.2	1.1	0.9	6.0	0.5	0.7	0.0	0.1	0.0	0.0	0.1	1.1	0.0	5.8	0.0	1.5	0.1	14.6	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.5	0.4	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	2.2	0.0	0.0	3.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	4.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	1.5	0.1	1.0	0.5	0.5	0.6	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	8.2	4.3	8.8	8.7	6.2	8.4	12.1	6.0	5.8	14.6	6.1	0.0	0.0	0.0	163.2	0.5	0.1	0.1	0.0	0.0	1.9	5.9	6.0	0.5	47.1	0.0	0.0	0.0	1.8	0.2	32.8	1.9	3.9	13.6	0.1	0.2	0.2	4.9	10.7	33.4	2.0	11.9	0.2	4.6	0.1	0.0	0.1	3.6	129.1	0.6	0.0	15.0	14.8	0.0	2.9	0.0	30.8	0.3	0.2	1.8	6.5	0.0	15.7	0.0	45.8	20.1	0.8	51.3	4.1	0.2	0.7	10.7	1.8	0.0	0.3	0.0	0.0	0.1	0.5	0.9	0.0	0.0	5.2	0.3	0.0	28.8	0.3
CABLES1	"FLJ35924, HsT2563"	ENSG00000134508	"Cdk5 and Abl enzyme substrate 1"	Q8TDN4	18	23134564-23260467	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 70.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 258.2;Glandular and luminal cells: 54.3;Oligodendrocyte precursor cells: 163.3"	"Cancer enriched"	"Detected in all"	5	"melanoma: 38.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"NK-cell: 1.2"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 154.3;U-266/70: 216.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073649			Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nuclear bodies"		"HPA073649: AB_2732233"	"unprognostic (1.27e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.56e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.01e-1)"	"prognostic favorable (4.71e-6)"	"unprognostic (1.00e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.80e-2)"	"unprognostic (7.81e-2)"	17.1	3.3	63.9	2.1	67.9	2.6	13.8	36.8	54.8	6.9	17.1	5.2	7.5	9.4	3.2	6.9	10.9	5.2	4.6	44.9	53.5	13.1	9.9	21.5	2.8	39.6	59.0	3.7	3.0	21.9	4.0	10.4	40.8	3.7	5.1	8.0	22.3	4.5	1.5	17.2	6.7	6.6	31.2	3.7	14.5	3.5	70.2	4.9	15.0	1.8	2.3	5.4	7.8	33.3	13.1	14.4	11.8	0.9	7.1	0.3	20.4	3.1	17.3	4.2	2.5	9.5	23.0	0.7	13.3	14.9	42.3	11.4	9.0	2.3	3.2	0.3	19.4	1.0	38.7	37.1	6.2	2.5	1.0	4.2	2.1	5.3	6.1	26.8	47.1	2.3	0.5	16.2	11.7	30.2	0.1	8.8	7.5	64.5	46.6	3.1	42.2	50.6	21.2	31.5	11.2	8.2	26.1	32.5	154.3	8.3	52.4	7.2	79.3	47.9	0.5	1.6	3.8	216.0	88.9	27.4	0.2	19.2	16.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.1	0.0	0.0	63.9	67.9	36.8	54.8	44.9	53.5	39.6	59.0	40.8	31.2	70.2	33.3	2.9	22.4	27.4	258.2	3.8	5.1	2.0	1.4	5.2	4.1	9.2	6.7	1.4	7.2	2.3	3.7	29.2	0.9	1.3	8.5	1.9	1.1	2.0	11.6	4.4	6.0	3.5	1.3	19.2	2.3	1.1	4.1	10.2	54.3	0.0	14.8	25.0	9.3	16.6	0.0	22.2	4.6	0.0	3.5	3.1	3.5	0.0	4.7	28.4	41.2	0.0	1.4	0.0	163.3	1.4	2.4	5.2	6.0	3.6	0.6	6.7	14.3	1.8	18.7	0.0	5.0	2.1	0.2	3.2	1.6	6.7	0.3	1.4	0.5	2.1	2.2
CACHD1	"KIAA1573, VWCD1"	ENSG00000158966	"Cache domain containing 1"	Q5VU97	1	64470129-64693058	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Astrocytes: 283.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 41.3;NTERA-2: 56.5;SuSa: 35.4;U-2197: 29.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017202	Uncertain		Uncertain	Nucleoplasm,Nucleoli		NA	NA		310000		"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nucleoli"		"HPA017202: AB_1852423"	"unprognostic (2.92e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.32e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.89e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.13e-1)"	11.1	13.1	17.5	2.0	18.7	0.1	11.8	6.4	11.3	11.9	22.8	2.9	1.5	10.8	9.1	3.7	14.4	4.5	4.0	14.9	12.9	6.3	1.8	9.0	1.9	12.0	18.1	22.6	7.3	6.9	9.1	10.2	10.9	8.2	2.7	6.4	8.2	7.6	2.9	7.7	3.5	9.6	8.6	4.5	6.7	2.3	18.9	5.1	6.4	5.4	1.6	6.0	10.6	5.7	0.3	1.7	41.3	6.1	16.1	5.6	0.0	5.9	7.8	10.0	9.7	24.8	0.2	0.0	16.8	9.7	8.0	3.1	23.4	5.0	10.4	4.6	12.2	8.9	2.9	0.0	0.0	3.8	0.1	5.0	3.4	1.2	6.2	6.0	5.7	6.0	0.0	0.0	0.0	0.7	0.8	0.0	56.5	0.3	4.2	5.2	4.2	0.0	0.0	1.3	2.1	23.5	12.7	0.0	5.2	35.4	1.7	0.5	3.7	1.0	7.3	29.1	5.3	0.0	0.0	0.0	1.0	0.7	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	17.5	18.7	6.4	11.3	14.9	12.9	12.0	18.1	10.9	8.6	18.9	5.7	25.2	6.4	49.9	283.7	0.1	17.3	7.5	6.1	6.8	15.5	8.3	7.0	1.3	0.0	11.5	3.7	0.0	0.0	0.2	0.1	0.0	2.3	9.5	14.0	8.1	20.2	0.0	0.0	19.4	2.7	0.1	11.1	5.6	16.9	2.5	26.0	4.2	1.3	0.2	0.0	6.9	0.2	4.1	0.3	6.1	4.1	14.3	0.8	1.8	24.4	0.2	6.4	0.0	57.8	1.8	1.2	0.1	3.0	0.0	2.0	0.5	4.2	10.2	1.3	6.6	25.2	6.4	0.5	0.8	2.9	14.8	0.0	0.9	0.8	0.5	5.1
CC2D2B	"bA248J23.4, bA690P14.3, C10orf130, C10orf131"	ENSG00000188649	"Coiled-coil and C2 domain containing 2B"	Q6DHV5	10	95907603-96033745	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"testis: 8.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 25.8;Early spermatids: 10.8;Microglial cells: 15.0;Oligodendrocyte precursor cells: 13.6;Oligodendrocytes: 7.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA044091, HPA072122"	Enhanced		Approved	"Nucleoli,Nucleoli rim"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoli, Nucleoli rim"		"HPA044091: AB_2732514, HPA072122: AB_2686489"	"unprognostic (6.38e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.63e-1)"	"unprognostic (8.18e-3)"	"unprognostic (2.11e-3)"	"unprognostic (9.11e-4)"	"unprognostic (1.93e-2)"	"unprognostic (4.34e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.41e-1)"	0.7	1.9	0.9	1.9	2.7	2.5	0.5	1.2	1.6	0.8	3.4	0.9	1.0	1.5	0.4	0.8	0.9	1.5	1.1	0.5	3.5	0.9	0.6	0.8	1.3	2.1	0.9	1.1	0.4	0.7	0.3	1.1	2.6	0.6	0.3	2.8	1.0	0.4	2.2	2.4	0.6	1.2	1.0	1.2	1.0	8.7	2.2	0.2	3.0	0.2	0.2	0.8	0.8	5.4	1.1	4.4	3.7	7.4	0.2	0.4	4.1	3.8	0.4	0.7	0.1	3.3	0.8	4.4	3.0	0.0	3.8	3.0	0.3	0.3	0.0	4.9	8.5	9.7	3.5	2.8	0.0	9.8	0.7	0.7	0.0	0.4	0.1	1.3	0.3	1.4	7.8	2.9	0.9	2.6	4.6	3.1	7.9	3.3	6.8	12.1	3.4	3.8	0.7	0.8	6.5	3.2	3.9	1.0	2.5	4.4	6.8	4.9	3.7	4.3	4.5	3.0	5.7	2.6	11.7	0.2	3.3	8.4	2.8	0.0	0.3	0.0	0.5	0.1	0.9	1.2	0.4	0.3	0.3	1.2	0.4	0.1	0.3	0.2	0.2	0.3	0.2	0.1	0.9	2.7	1.2	1.6	0.5	3.5	2.1	0.9	2.6	1.0	2.2	5.4	1.1	0.0	0.0	25.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.8	0.2	0.4	1.1	0.0	0.0	3.2	0.0	0.0	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	2.5	0.0	0.5	0.0	15.0	0.2	0.0	0.0	13.6	7.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0
CDH20	"Cdh7, CDH7L3"	ENSG00000101542	"Cadherin 20"	Q9HBT6	18	61333430-61555779	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 33.7;retina: 11.0;tongue: 24.1"	"Group enriched"	"Detected in some"	6	"Astrocytes: 1264.4;Oligodendrocyte precursor cells: 742.4;Oligodendrocytes: 1030.7"	"Cancer enriched"	"Detected in single"	15	"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	23	"basophil: 2.3"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 2.3"	"Cell line enhanced"	"Detected in some"		"AF22: 1.8;ASC diff: 5.7;HHSteC: 2.6;SH-SY5Y: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015490	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA015490: AB_1845900"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.11e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.93e-1)"	4.7	0.1	22.1	0.0	29.9	0.0	0.9	24.8	19.9	0.2	2.3	0.0	0.0	0.1	0.6	0.8	0.2	0.0	0.1	20.0	19.8	0.1	0.0	0.0	0.0	27.5	28.7	0.0	0.1	0.0	1.6	0.0	29.1	0.2	0.0	11.0	0.4	0.0	4.7	0.5	0.2	0.0	21.5	0.1	0.1	0.4	23.1	0.0	0.3	24.1	0.0	0.3	0.0	33.7	0.0	0.0	1.8	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	22.1	29.9	24.8	19.9	20.0	19.8	27.5	28.7	29.1	21.5	23.1	33.7	0.2	0.0	0.0	1264.4	0.1	0.0	0.0	0.0	0.0	26.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	2.6	0.1	0.2	0.2	0.0	0.0	146.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	98.7	0.1	0.0	0.3	0.0	2.7	0.0	0.1	0.0	41.2	0.0	11.1	0.0	742.4	1030.7	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	1.1	0.0	1.0	0.2	0.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1
CDH4		ENSG00000179242	"Cadherin 4"	P55283	20	61252261-61940617	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 11.0;lymphoid tissue: 3.7;ovary: 6.3;skeletal muscle: 3.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 157.0;Excitatory neurons: 54.4;Inhibitory neurons: 70.0;Oligodendrocyte precursor cells: 108.0;Skeletal myocytes: 28.7"	"Group enriched"	"Detected in many"	6	"glioma: 6.9;renal cancer: 3.4;thyroid cancer: 2.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 10.8;hTERT-HME1: 14.1;U-2 OS: 19.4;U-251 MG: 35.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015613			Supported	"Plasma membrane"		NA	NA		19000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 65: Brain - Ion transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"		"HPA015613: AB_2732414"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.39e-4)"	"unprognostic (2.16e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.72e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.78e-2)"	0.1	1.3	7.3	0.0	4.3	0.1	0.2	0.0	3.4	0.6	0.0	0.3	0.0	0.2	0.0	0.2	0.6	0.1	0.2	3.0	5.0	0.3	0.2	0.3	0.0	1.3	3.0	6.3	0.5	0.1	0.5	0.0	0.4	0.3	0.0	0.7	0.3	0.8	3.8	0.7	0.2	0.0	0.0	3.7	0.2	0.9	11.0	0.2	0.3	0.0	0.0	0.2	0.2	1.1	0.1	1.2	10.8	0.0	0.2	0.7	0.2	3.1	0.0	5.6	0.6	0.3	0.0	0.0	0.3	3.7	3.6	4.1	0.0	6.2	2.2	0.3	0.0	0.0	0.1	0.1	7.1	0.0	0.1	1.1	1.4	1.1	14.1	3.0	1.2	0.4	0.0	0.1	2.1	0.4	0.1	0.1	1.3	0.0	0.1	0.0	0.0	1.6	3.2	0.0	1.0	2.7	0.0	0.1	0.1	1.6	0.0	0.0	0.0	0.0	19.4	0.1	35.2	6.3	0.1	0.1	6.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	7.3	4.3	0.0	3.4	3.0	5.0	1.3	3.0	0.4	0.0	11.0	1.1	0.0	3.2	0.0	157.0	0.0	0.3	0.4	0.0	0.0	1.8	0.4	0.9	1.6	0.0	0.7	0.0	2.1	0.0	0.1	0.1	0.0	1.3	0.9	0.1	0.3	0.2	0.0	0.0	54.4	0.0	0.0	1.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	16.8	70.0	0.0	0.0	0.0	0.0	0.9	0.6	0.2	0.0	10.3	0.0	19.9	0.0	108.0	24.9	0.2	0.0	0.4	0.0	0.6	0.0	0.1	0.0	1.6	0.0	28.7	0.4	0.1	2.2	0.0	0.3	0.0	0.1	0.4	0.0	0.3
CHST10	HNK-1ST	ENSG00000115526	"Carbohydrate sulfotransferase 10"	O43529	2	100391860-100417668	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 33.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 16.0;Astrocytes: 21.5;Muller glia cells: 16.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012884, HPA051545"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		680000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol		"HPA012884: AB_1846710, HPA051545: AB_2681529"	"unprognostic (5.40e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.54e-2)"	"prognostic favorable (4.05e-4)"	"unprognostic (8.02e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.78e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.27e-1)"	4.3	6.7	26.5	4.2	28.2	3.2	5.1	24.3	33.6	7.1	18.8	6.3	2.3	11.5	13.3	4.2	9.7	5.5	11.0	27.2	23.2	4.3	1.2	8.1	4.4	24.6	26.4	12.7	5.6	9.6	11.5	8.2	23.2	8.0	2.4	9.4	6.1	5.2	6.0	2.2	3.6	12.0	24.8	5.0	4.4	6.1	28.6	5.7	10.0	8.3	5.4	5.5	3.7	25.1	0.2	14.6	28.4	14.6	8.5	11.9	14.2	16.7	11.8	22.4	14.3	0.3	8.5	20.4	14.1	10.1	39.6	0.0	20.2	2.2	14.3	29.1	21.2	10.5	8.3	23.1	10.1	21.5	26.5	8.8	2.7	10.6	2.0	10.7	17.8	19.5	31.0	0.1	9.7	4.8	19.1	16.8	42.0	0.2	17.7	13.6	17.6	0.2	6.2	6.4	30.5	24.9	1.2	0.1	23.3	20.0	7.8	29.0	16.4	15.5	24.5	11.7	15.7	0.0	0.1	21.2	19.0	18.7	18.6	0.0	0.0	0.0	1.3	0.0	0.4	0.8	0.2	1.0	0.2	0.6	0.3	0.7	0.0	0.0	0.0	1.1	0.0	0.5	26.5	28.2	24.3	33.6	27.2	23.2	24.6	26.4	23.2	24.8	28.6	25.1	2.8	16.0	3.1	21.5	4.4	0.9	1.1	0.3	0.6	9.7	2.4	2.0	6.3	1.5	4.4	1.8	0.0	5.4	2.3	0.0	3.9	3.5	1.5	2.7	6.7	4.9	1.8	3.0	10.7	2.9	10.5	5.0	0.0	6.2	0.0	6.5	0.4	0.0	6.2	6.7	7.5	0.0	0.0	0.8	1.1	0.4	2.1	1.3	0.0	6.5	3.2	16.7	1.0	12.5	5.9	2.2	0.0	5.3	2.3	1.5	0.0	1.1	0.7	4.8	0.0	3.7	3.5	1.5	5.1	0.3	0.6	1.4	3.4	8.5	0.1	0.2
CNGA4	"CNCA2, CNG5, CNGB2, OCNC2, OCNCb"	ENSG00000132259	"Cyclic nucleotide gated channel subunit alpha 4"	Q8IV77	11	6234765-6244479	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Olfaction, Sensory transduction, Transport"	"Ion channel, Ligand-gated ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 17.3;testis: 6.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 9.1;Early spermatids: 5.0;Endometrial ciliated cells: 2.7;Excitatory neurons: 3.0;Inhibitory neurons: 2.5;Late spermatids: 3.6;Oligodendrocytes: 3.1;Respiratory ciliated cells: 3.5"	"Cancer enriched"	"Detected in single"	6	"endometrial cancer: 2.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA074128			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"		"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Plasma membrane"		"HPA074128: "	"unprognostic (1.11e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.69e-3)"	"prognostic favorable (1.48e-4)"	"unprognostic (4.96e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.89e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.03e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.47e-2)"	"unprognostic (8.11e-2)"	"unprognostic (3.55e-3)"	0.1	0.2	1.2	0.2	1.3	0.4	0.2	1.3	1.2	0.7	0.7	0.2	0.3	0.6	0.2	0.2	17.3	0.2	0.1	1.4	1.4	0.4	0.2	1.4	0.2	2.8	3.8	0.4	0.4	0.0	0.7	0.0	2.5	0.2	0.1	1.1	0.1	0.5	0.0	0.3	0.2	0.1	1.8	0.3	0.2	6.1	1.2	0.3	0.2	0.0	0.2	0.2	0.2	1.9	0.0	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	1.3	1.2	1.4	1.4	2.8	3.8	2.5	1.8	1.2	1.9	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	2.7	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
COL5A3		ENSG00000080573	"Collagen type V alpha 3 chain"	P25940	19	9959561-10010504	"Cancer-related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"Astrocytes: 510.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 38.9;BJ: 23.6;BJ hTERT+: 26.2;BJ hTERT+ SV40 Large T+: 14.4;HSkMC: 28.2;WM-115: 26.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA041695, HPA048256"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		330000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"		"HPA041695: , HPA048256: AB_2680330"	"unprognostic (1.17e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.84e-3)"	"unprognostic (3.01e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (7.17e-8)"	"unprognostic (3.25e-2)"	"unprognostic (7.31e-3)"	"unprognostic (6.00e-2)"	"prognostic unfavorable (6.87e-5)"	47.4	5.0	33.2	9.9	33.2	0.1	32.3	30.6	45.9	44.9	43.6	19.3	3.7	27.3	1.9	9.0	22.8	4.1	33.5	33.3	26.4	7.9	13.4	14.2	3.2	35.2	30.2	6.3	5.2	3.0	3.5	32.8	32.3	16.6	2.0	21.1	7.3	8.9	15.3	21.7	11.7	10.3	31.0	1.7	9.9	4.7	30.2	4.5	12.7	6.0	3.9	12.6	26.4	28.4	0.0	0.0	0.5	0.0	12.4	38.9	0.0	23.6	26.2	14.4	5.7	0.0	0.0	0.0	0.2	4.4	0.3	2.3	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	28.2	0.6	5.2	5.5	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	6.6	0.1	0.0	0.0	0.0	11.6	5.5	0.5	0.0	0.0	0.0	0.0	1.5	0.0	26.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.2	33.2	30.6	45.9	33.3	26.4	35.2	30.2	32.3	31.0	30.2	28.4	13.7	0.0	0.0	510.3	0.0	4.2	0.1	0.2	2.2	65.1	0.3	0.9	6.4	0.0	0.1	0.0	6.2	0.1	0.3	1.3	0.0	0.2	6.9	0.4	12.0	8.1	0.0	0.0	15.6	0.0	0.2	17.5	0.5	0.4	0.0	0.0	3.9	22.9	0.6	3.3	3.4	0.0	0.0	0.0	3.2	2.1	17.4	0.4	14.2	36.5	0.1	2.6	0.0	73.9	2.5	0.3	0.1	8.2	0.0	0.3	0.2	0.1	0.9	28.3	92.1	8.5	58.0	0.3	0.3	3.2	7.1	0.1	1.9	0.9	0.0	0.3
CRB1	"LCA8, RP12"	ENSG00000134376	"Crumbs cell polarity complex component 1"	P82279	1	197268204-197478455	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Disease variant, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 21.3;retina: 74.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 469.5;Cone photoreceptor cells: 164.7;Inhibitory neurons: 130.1;Muller glia cells: 79.7;Oligodendrocyte precursor cells: 280.0;Oligodendrocytes: 105.6;Rod photoreceptor cells: 149.3"	"Cancer enriched"	"Detected in single"	12	"glioma: 2.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	28	"basophil: 7.7"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 7.7"	"Cell line enriched"	"Detected in some"	8	"HeLa: 12.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA061250, HPA063127"	Approved		Uncertain	Vesicles	"Secreted in brain"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Vesicles		"HPA061250: AB_2684458, HPA063127: AB_2684944"	"unprognostic (1.96e-1)"	"unprognostic (5.38e-3)"		"unprognostic (2.92e-3)"	"unprognostic (1.50e-2)"	"unprognostic (5.13e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.48e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.96e-1)"	0.1	0.1	15.7	0.0	17.6	0.4	0.1	19.8	20.5	0.0	9.6	0.1	0.0	0.0	0.1	0.1	0.4	0.0	0.2	15.8	14.2	0.1	0.0	0.1	0.1	18.7	18.4	0.7	0.4	0.0	2.2	0.0	17.5	0.0	0.0	74.7	0.0	0.0	0.7	0.0	0.0	0.0	18.9	0.0	0.2	2.9	16.1	0.0	0.2	0.5	0.0	0.0	0.0	21.3	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	15.7	17.6	19.8	20.5	15.8	14.2	18.7	18.4	17.5	18.9	16.1	21.3	0.0	0.0	0.0	469.5	0.0	0.3	0.2	0.3	0.0	15.0	0.2	0.1	1.1	0.0	0.2	0.0	164.7	0.0	0.0	0.0	0.0	0.0	1.9	0.2	0.0	0.7	0.0	11.6	53.2	0.0	0.0	0.2	0.0	0.0	0.0	6.4	0.0	0.0	0.0	1.7	130.1	0.0	2.0	0.0	0.5	1.6	1.8	0.0	0.0	24.4	0.0	79.7	0.0	280.0	105.6	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.9	149.3	0.0	0.2	0.1	1.8	0.3	0.0	0.3	0.0	0.1	0.2	0.0	0.0
CTNNA2	"CAP-R, CT114"	ENSG00000066032	"Catenin alpha 2"	P26232	2	79185231-80648861	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Differentiation"	"Developmental protein"	"Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 99.0;epididymis: 67.0;retina: 80.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 3673.8;Early spermatids: 560.8;Excitatory neurons: 1358.5;Inhibitory neurons: 1056.9;Oligodendrocyte precursor cells: 1304.4"	"Group enriched"	"Detected in some"	7	"endometrial cancer: 3.9;glioma: 11.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	96	"basophil: 55.3"	"Lineage enriched"	"Detected in single"	553	"granulocytes: 55.3"	"Cell line enhanced"	"Detected in some"		"AF22: 7.1;Karpas-707: 8.2;NTERA-2: 6.7;SCLC-21H: 3.8;SH-SY5Y: 10.7"	"Low region specificity"	"Detected in all"							CAB037175	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"			"CAB037175: AB_476883"	"unprognostic (9.15e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.31e-2)"	"unprognostic (4.04e-1)"	"unprognostic (3.17e-2)"	"unprognostic (5.62e-2)"	"unprognostic (7.96e-3)"	"unprognostic (8.76e-2)"	"unprognostic (2.27e-4)"	"unprognostic (7.80e-2)"	"unprognostic (8.44e-4)"	"unprognostic (1.73e-4)"	"unprognostic (2.83e-1)"	0.1	4.7	74.1	0.5	82.5	0.1	0.0	51.8	99.0	0.4	28.5	1.9	0.3	3.3	67.0	0.2	1.9	0.2	0.2	78.8	59.3	0.1	0.1	0.0	0.0	47.0	71.2	0.1	0.8	0.0	7.1	0.0	50.8	1.0	0.9	80.4	0.2	0.7	0.2	0.1	0.7	0.5	36.6	0.0	1.1	17.4	78.9	0.0	0.0	0.0	0.0	0.1	0.4	62.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	6.7	0.3	0.0	0.0	0.0	0.0	0.7	0.0	3.8	10.7	0.0	0.0	0.5	1.0	0.0	0.6	0.0	0.4	0.7	0.2	0.0	2.3	0.0	0.0	2.7	0.0	2.0	55.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	74.1	82.5	51.8	99.0	78.8	59.3	47.0	71.2	50.8	36.6	78.9	62.0	0.0	0.0	0.0	3673.8	0.0	0.0	0.0	0.0	0.0	17.2	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	560.8	12.9	7.0	0.5	0.0	0.0	1358.5	0.0	0.0	0.1	0.0	34.3	0.0	4.7	0.0	0.0	0.0	5.0	1056.9	0.0	0.0	0.0	0.0	144.4	2.5	0.5	0.0	187.4	0.0	112.1	0.0	1304.4	230.7	0.3	0.0	3.0	0.0	0.0	0.0	0.2	0.0	5.0	0.0	0.0	0.2	10.3	2.9	0.0	0.0	0.0	0.2	0.0	0.0	0.1
CTNND2	"GT24, NPRAP"	ENSG00000169862	"Catenin delta 2"	Q9UQB3	5	10971836-11904446	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway"	"Developmental protein"	"Autism, Autism spectrum disorder, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 93.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 2382.9;Excitatory neurons: 1253.9;Inhibitory neurons: 1124.0;Oligodendrocyte precursor cells: 1418.0;Oligodendrocytes: 433.8"	"Cancer enriched"	"Detected in many"	16	"glioma: 44.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 19.1;MCF7: 9.0;SK-BR-3: 5.3;U-266/84: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015077, CAB037339, HPA071124"	Enhanced		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 16: U-266 - Nucleosome"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Cell Junctions"	Cytosol	"CAB037339: , HPA015077: AB_2669150, HPA071124: "	"unprognostic (7.32e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.23e-1)"	"unprognostic (5.16e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.74e-2)"	"unprognostic (9.13e-2)"	"unprognostic (9.86e-2)"	"unprognostic (8.95e-3)"	"unprognostic (2.66e-1)"	"unprognostic (9.55e-4)"	"unprognostic (5.87e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.76e-2)"	0.2	0.7	79.2	0.2	79.3	0.0	0.9	49.7	75.7	0.1	15.2	1.1	0.1	0.1	0.3	0.1	0.2	2.6	3.8	84.6	56.7	0.0	0.5	0.7	0.1	93.8	72.6	0.5	15.8	0.0	9.0	0.3	71.5	0.9	0.3	7.0	0.8	0.2	0.1	0.7	0.5	0.1	77.7	3.9	0.6	2.6	83.7	0.2	0.2	0.1	0.0	0.1	0.2	76.1	0.0	0.2	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	9.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	5.3	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	3.4	0.0	17.5	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.2	79.3	49.7	75.7	84.6	56.7	93.8	72.6	71.5	77.7	83.7	76.1	0.1	0.0	0.0	2382.9	0.1	0.0	0.1	0.0	0.0	24.0	7.9	4.1	12.7	28.6	0.0	1.8	0.0	0.0	0.0	0.1	3.9	6.5	25.6	0.8	0.1	0.8	4.9	0.0	1253.9	6.1	0.2	0.5	0.0	0.9	0.0	0.0	0.0	0.2	0.1	8.4	1124.0	0.1	0.0	0.0	0.7	31.1	1.5	0.2	0.0	69.3	0.0	33.0	0.0	1418.0	433.8	2.2	0.0	0.0	0.0	2.8	0.0	0.4	0.0	3.6	0.0	3.3	0.3	4.6	5.9	0.0	0.0	0.0	0.1	0.5	0.3	0.1
DCLK2	"DCAMKL2, DCDC3, DCDC3B, DCK2, MGC45428"	ENSG00000170390	"Doublecortin like kinase 2"	Q8N568	4	150078445-150257438	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.0"	"Group enriched"	"Detected in many"	6	"Astrocytes: 501.1;Excitatory neurons: 189.8;Inhibitory neurons: 173.2;Oligodendrocyte precursor cells: 172.4"	"Cancer enriched"	"Detected in many"	17	"glioma: 53.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 23.6;BJ: 11.8;BJ hTERT+: 24.9;fHDF/TERT166: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015770	Enhanced	Approved				NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA015770: AB_1847509"	"unprognostic (7.37e-2)"	"unprognostic (1.56e-3)"	"unprognostic (9.30e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.06e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.90e-1)"	"unprognostic (7.38e-3)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.25e-4)"	"prognostic favorable (2.48e-4)"	"unprognostic (6.87e-2)"	"unprognostic (3.93e-3)"	"unprognostic (3.74e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.45e-2)"	1.7	2.8	45.8	0.9	42.0	0.5	1.4	34.6	43.6	2.0	7.7	5.6	1.4	2.7	2.0	1.5	1.9	2.5	12.2	59.0	41.2	2.3	0.6	2.1	0.4	41.2	46.6	2.9	2.2	0.6	8.3	1.5	38.4	2.7	2.0	18.4	0.8	2.0	1.2	1.0	2.2	4.7	46.6	1.2	2.3	2.8	42.7	0.2	2.6	1.4	0.3	2.6	1.3	46.8	1.2	4.2	23.6	3.7	0.0	1.1	0.4	11.8	24.9	3.5	0.9	0.1	0.0	0.0	0.4	11.0	3.6	0.1	3.5	0.0	4.4	5.1	2.1	0.0	7.0	0.0	5.0	0.7	0.7	0.6	0.0	2.2	0.2	2.2	1.2	0.6	0.0	0.1	2.5	0.2	0.4	0.0	0.5	0.3	1.6	0.0	2.8	1.0	0.1	1.0	9.2	9.1	4.7	3.4	1.0	2.0	0.0	0.1	2.1	3.3	1.3	2.2	1.3	1.1	0.0	0.1	3.1	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	45.8	42.0	34.6	43.6	59.0	41.2	41.2	46.6	38.4	46.6	42.7	46.8	10.7	0.0	0.0	501.1	0.6	0.5	0.1	0.0	0.6	26.2	2.8	2.2	10.5	1.5	0.7	3.7	16.7	0.0	0.0	0.8	0.0	0.4	0.1	0.4	4.6	7.6	3.0	0.0	189.8	0.7	0.0	3.4	1.1	0.5	4.5	5.7	7.5	0.0	1.6	35.3	173.2	0.3	0.0	0.6	3.4	0.3	1.8	0.7	5.4	43.1	0.2	31.2	0.0	172.4	37.6	0.1	0.4	3.8	0.3	0.6	0.0	0.4	0.1	9.6	13.1	5.6	9.2	0.1	2.0	0.1	0.6	0.3	0.9	6.6	1.4	0.2
DCP1B	FLJ31638	ENSG00000151065	"Decapping mRNA 1B"	Q8IZD4	12	1946053-2004535	"Predicted intracellular proteins, Predicted membrane proteins"	"Nonsense-mediated mRNA decay"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 36.2;Early spermatids: 55.2;Oligodendrocyte precursor cells: 37.7;Oligodendrocytes: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Lineage enriched"	"Detected in all"	5	"T-cells: 27.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039709	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Vesicles, Cytosol"		"HPA039709: AB_10672901"	"unprognostic (9.60e-2)"	"unprognostic (7.19e-3)"	"unprognostic (4.37e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.84e-2)"	"unprognostic (7.42e-2)"	9.2	16.4	3.4	3.4	3.4	1.6	8.8	3.0	3.6	15.0	3.9	26.2	3.0	21.9	5.8	6.6	13.8	4.0	4.5	3.2	3.6	7.9	10.0	7.9	4.8	2.9	3.0	13.1	9.0	5.5	13.6	3.7	2.9	14.4	5.0	5.0	7.7	6.7	10.5	8.1	10.2	9.2	2.9	9.2	11.9	20.7	3.5	6.7	9.4	5.1	4.6	18.2	10.9	3.1	0.1	3.8	6.9	5.3	8.5	10.7	11.5	4.7	9.2	5.8	7.1	0.6	6.0	9.4	1.6	6.9	5.0	0.0	4.6	5.0	5.1	15.8	5.0	3.9	3.0	5.6	11.3	5.6	4.5	8.1	8.1	5.2	4.5	12.0	9.6	7.2	2.5	3.7	7.1	4.5	7.8	4.6	15.0	3.4	1.4	4.6	3.3	1.7	6.8	0.0	1.0	5.0	4.0	3.3	3.4	15.4	3.4	5.1	5.7	2.8	10.0	6.4	4.9	3.1	2.5	6.5	6.6	3.8	7.1	5.3	2.9	0.3	10.0	4.2	12.5	5.1	10.3	9.8	5.4	4.9	7.8	10.2	0.5	5.9	5.0	2.6	27.3	5.5	3.4	3.4	3.0	3.6	3.2	3.6	2.9	3.0	2.9	2.9	3.5	3.1	4.9	6.4	4.6	36.2	6.4	0.9	4.1	7.5	5.2	6.4	4.0	5.0	2.5	1.5	5.7	7.3	10.4	6.5	5.1	4.0	13.7	7.3	55.2	6.6	8.7	5.8	2.4	3.0	24.3	4.2	4.8	7.6	8.2	2.8	5.7	12.2	3.3	5.9	5.7	6.7	28.9	4.6	14.2	3.5	0.9	19.8	5.6	3.7	1.8	17.8	6.5	4.1	2.1	37.7	35.3	4.9	5.8	9.4	5.8	3.0	8.1	7.2	5.2	7.0	0.0	3.7	7.1	23.6	10.2	4.5	2.4	2.9	8.6	10.3	5.1	2.9
DENND1A	"FAM31A, FLJ21129, KIAA1608"	ENSG00000119522	"DENN domain containing 1A"	Q8TEH3	9	123379654-123930152	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Astrocytes: 258.9;Excitatory neurons: 188.2;Inhibitory neurons: 175.8;Late spermatids: 88.5;Microglial cells: 178.0;Oligodendrocyte precursor cells: 165.4;Oligodendrocytes: 145.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"dendritic cells: 12.1;granulocytes: 20.4;monocytes: 21.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020481			Approved	Vesicles,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Vesicles, Cytosol"		"HPA020481: AB_2092106"	"unprognostic (1.35e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.19e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.48e-3)"	"unprognostic (5.63e-2)"	"prognostic favorable (4.11e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.66e-2)"	"unprognostic (4.31e-2)"	8.5	8.3	8.2	10.3	8.3	27.0	7.1	2.7	10.3	7.9	6.8	10.6	11.3	8.3	4.6	7.7	8.7	7.2	7.3	8.1	6.2	11.4	10.8	6.9	9.0	5.6	6.0	7.9	6.2	11.9	10.2	11.3	4.9	7.7	9.6	10.3	6.1	7.6	8.4	6.9	12.6	9.9	4.8	14.2	6.9	9.5	6.4	7.1	10.8	4.8	6.2	7.6	6.5	5.7	29.0	16.7	14.7	28.0	9.8	15.3	68.3	27.4	41.0	22.9	19.6	23.0	12.5	23.1	5.5	22.3	30.1	15.9	12.6	19.9	22.2	9.8	9.7	10.9	39.1	17.1	13.2	13.2	7.0	14.2	17.6	18.9	32.2	8.0	20.6	21.8	30.3	17.2	18.7	16.5	15.8	19.1	29.4	33.1	25.2	24.3	14.4	19.5	11.4	10.1	31.1	25.3	22.1	14.4	16.9	9.6	19.8	32.8	9.7	24.5	9.4	28.9	14.6	26.0	21.7	16.0	20.6	25.9	16.5	20.4	21.1	4.3	1.8	14.6	0.9	1.7	1.3	0.8	12.1	1.8	0.8	1.0	12.8	0.8	12.8	1.9	0.6	5.3	8.2	8.3	2.7	10.3	8.1	6.2	5.6	6.0	4.9	4.8	6.4	5.7	6.4	0.0	1.5	258.9	10.0	5.1	2.6	2.5	1.8	16.1	4.8	4.3	7.7	7.2	1.7	16.5	16.7	10.0	6.8	25.3	5.9	4.3	35.1	5.0	8.2	10.5	12.0	20.2	188.2	5.1	32.2	7.6	20.9	3.9	4.5	8.8	7.5	14.5	18.0	32.0	175.8	7.6	2.0	21.4	8.2	88.5	14.6	18.7	3.6	178.0	18.7	11.6	5.2	165.4	145.2	6.1	9.5	11.3	13.1	5.3	18.3	16.0	2.9	13.1	0.0	6.7	5.9	3.8	1.4	3.8	2.8	8.8	5.3	4.5	7.8	3.9
DNASE1L2	DNAS1L2	ENSG00000167968	"Deoxyribonuclease 1 like 2"	Q92874	16	2235816-2238711	"Predicted secreted proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 45.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 2.9;Excitatory neurons: 2.5;Inhibitory neurons: 2.6;Ionocytes: 4.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA044714			Uncertain	Mitochondria	"Secreted in other tissues"	NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 20: HeLa - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria		"HPA044714: AB_10962870"	"unprognostic (9.88e-2)"	"unprognostic (1.11e-3)"	"unprognostic (6.80e-4)"	"unprognostic (4.29e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.96e-3)"	"unprognostic (2.17e-2)"	"unprognostic (4.67e-4)"	"unprognostic (1.40e-4)"	"unprognostic (3.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.94e-4)"	0.9	1.1	4.8	0.4	5.2	0.5	1.2	7.3	8.4	1.8	2.0	1.0	0.5	1.1	0.2	0.9	1.2	0.3	0.9	4.2	4.5	4.6	1.7	0.9	0.4	6.1	4.5	2.0	1.9	0.1	4.7	0.7	6.4	2.3	0.1	1.1	0.8	0.1	0.7	45.8	1.0	0.1	3.7	2.6	1.0	1.5	4.9	0.6	6.0	0.1	0.8	0.9	1.6	7.6	1.4	2.9	1.2	1.3	1.0	0.5	5.0	0.5	0.3	1.1	0.6	3.2	3.0	1.9	1.5	0.1	0.4	0.5	0.4	0.2	0.1	3.8	2.8	0.8	5.6	0.7	0.1	0.9	3.0	0.6	1.0	0.8	0.2	1.1	0.2	2.1	2.7	2.8	0.4	3.4	2.7	5.6	1.2	0.4	1.9	5.0	1.4	2.7	0.6	0.6	2.5	1.3	0.7	1.1	2.1	0.3	4.5	2.0	0.1	2.4	3.1	1.4	1.0	6.8	3.5	1.8	0.8	1.8	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.8	5.2	7.3	8.4	4.2	4.5	6.1	4.5	6.4	3.7	4.9	7.6	0.2	0.0	0.6	2.9	0.1	0.1	0.1	0.4	0.0	0.7	0.7	0.5	0.7	1.5	0.1	0.0	0.0	0.1	0.2	0.5	0.0	0.1	0.1	0.2	1.0	0.3	0.0	0.0	2.5	0.0	0.1	0.1	1.1	0.4	0.0	0.6	0.4	0.4	0.1	1.7	2.6	0.1	4.1	0.0	0.0	0.1	0.6	0.1	0.0	1.0	0.1	0.9	0.0	1.0	1.8	0.0	0.1	0.0	0.5	0.2	0.8	0.1	0.1	1.8	0.0	0.0	0.2	0.1	0.5	0.0	0.1	0.0	0.2	0.3	0.3	0.1
DOCK7	"KIAA1771, ZIR2"	ENSG00000116641	"Dedicator of cytokinesis 7"	Q96N67	1	62454298-62688386	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Guanine-nucleotide releasing factor"	Epilepsy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 347.0;Inhibitory neurons: 103.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (2.07e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.51e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (4.90e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.74e-3)"	"unprognostic (1.18e-1)"	"unprognostic (8.16e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.99e-2)"	9.9	5.9	11.3	6.6	13.6	3.1	12.4	9.6	11.6	10.7	7.2	9.9	7.0	10.7	7.7	6.5	9.4	8.3	5.9	10.3	13.6	8.9	8.0	6.4	4.3	11.3	11.9	15.4	5.8	13.9	10.9	9.9	12.4	10.2	11.3	12.6	9.8	7.9	3.6	9.8	6.7	10.4	12.9	6.1	10.6	16.4	11.4	7.3	6.3	3.7	4.8	9.0	8.0	15.2	30.8	12.3	48.8	10.9	45.8	49.6	22.6	41.9	37.5	35.6	33.5	13.4	9.6	13.3	9.4	56.6	42.4	16.2	23.7	34.4	57.9	15.9	18.2	24.1	11.8	25.0	20.8	11.1	8.7	30.0	15.8	43.5	38.4	42.8	17.8	12.7	11.7	5.0	43.2	9.2	8.7	0.8	26.3	6.6	14.3	10.6	53.1	3.7	28.9	26.4	15.3	49.2	23.5	24.6	51.9	42.9	7.8	8.5	31.7	37.6	21.4	37.3	31.5	9.3	12.7	7.2	32.1	2.7	40.0	0.0	0.4	0.0	0.2	0.7	0.6	0.5	0.1	0.4	1.4	0.2	0.1	0.4	0.0	0.1	0.2	0.3	0.1	0.2	11.3	13.6	9.6	11.6	10.3	13.6	11.3	11.9	12.4	12.9	11.4	15.2	5.3	9.6	10.1	347.0	9.1	11.9	18.3	11.1	20.5	15.4	16.3	18.4	12.2	10.0	9.6	23.9	22.9	11.8	3.8	10.1	1.9	19.9	2.2	16.9	29.6	6.1	13.1	7.6	84.8	16.0	17.1	19.5	22.4	24.1	5.7	29.2	6.1	16.6	15.3	20.2	103.9	11.5	14.2	8.7	9.5	4.5	23.0	13.1	12.4	61.8	7.0	23.8	3.1	53.8	25.9	26.5	14.5	23.0	5.7	18.3	9.4	9.7	12.4	18.5	6.6	15.8	23.4	48.8	43.9	12.6	7.7	11.6	4.7	15.7	15.6	13.8
DPH6	"ATPBD4, MGC14798"	ENSG00000134146	"Diphthamine biosynthesis 6"	Q7L8W6	15	35217345-35546193	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 91.7;Oligodendrocytes: 101.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042976, HPA055496"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA042976: AB_10964890, HPA055496: AB_2682835"	"unprognostic (9.78e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.94e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.49e-3)"	"unprognostic (7.92e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.65e-6)"	"unprognostic (9.70e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.44e-2)"	8.6	7.5	3.7	4.9	4.7	5.4	10.8	4.6	5.0	6.8	3.6	6.7	6.1	7.9	10.7	9.6	8.1	6.0	10.2	3.6	4.7	10.4	8.1	5.3	5.3	4.6	4.4	9.7	14.3	8.7	5.9	8.1	4.8	5.8	7.0	8.9	6.7	6.1	10.8	9.7	6.6	6.4	4.3	6.3	6.8	5.9	3.9	7.0	10.8	6.9	7.4	8.0	7.1	5.7	16.9	8.9	14.7	12.5	2.6	11.7	14.3	6.2	10.8	14.7	7.6	11.9	15.5	5.2	14.8	5.7	17.9	19.0	17.2	17.9	17.5	4.1	10.7	19.6	9.9	18.9	15.3	10.6	12.1	9.9	22.2	5.9	28.5	9.0	14.4	11.0	21.8	20.6	13.6	6.6	13.0	9.8	13.0	25.4	8.1	16.0	13.7	7.2	12.9	21.0	10.7	10.4	11.6	12.8	10.7	8.5	44.6	14.4	4.4	14.2	13.8	14.4	10.0	18.2	31.3	13.4	12.3	17.7	13.9	0.0	6.7	0.3	6.0	6.7	7.7	8.9	8.1	8.4	6.7	6.3	10.3	9.3	0.3	14.7	6.2	5.8	5.8	4.5	3.7	4.7	4.6	5.0	3.6	4.7	4.6	4.4	4.8	4.3	3.9	5.7	15.9	16.0	7.5	91.7	18.7	31.0	20.0	19.8	24.5	29.2	12.0	16.6	15.8	18.6	17.2	9.2	39.6	26.7	9.3	7.5	13.7	16.3	2.2	10.7	13.7	10.0	5.4	16.8	28.0	24.1	23.5	12.0	21.4	13.3	3.8	21.1	5.7	7.4	17.5	18.5	47.0	7.4	14.2	10.3	12.9	3.3	14.0	9.8	16.0	44.0	14.3	15.0	11.3	71.9	101.5	18.7	7.1	6.8	6.9	8.9	13.4	19.9	7.6	24.2	0.0	18.9	14.0	9.8	14.0	21.2	23.2	22.6	9.9	21.9	10.5	13.4
DTNA	"D18S892E, DRP3, DTN, DTN-1, DTN-2, DTN-3"	ENSG00000134769	"Dystrobrevin alpha"	Q9Y4J8	18	34493290-34891844	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 461.9;choroid plexus: 120.6;heart muscle: 150.0;skeletal muscle: 166.9;tongue: 209.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1756.1;Excitatory neurons: 506.0;Inhibitory neurons: 650.9;Oligodendrocyte precursor cells: 491.6;Oligodendrocytes: 367.4"	"Cancer enriched"	"Detected in many"	9	"glioma: 28.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 37.7;NTERA-2: 42.0;SCLC-21H: 51.9;U-87 MG: 52.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015196, HPA071177"	Enhanced		Approved	"Nucleoplasm,Cell Junctions,Intermediate filaments"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Cell Junctions, Intermediate filaments"	Nucleoplasm	"CAB015196: AB_2261797, HPA071177: "	"unprognostic (1.57e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.13e-3)"	"unprognostic (7.82e-6)"	"unprognostic (5.03e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.73e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.35e-4)"	"unprognostic (6.89e-2)"	"prognostic favorable (2.64e-7)"	"unprognostic (6.08e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.27e-5)"	11.6	6.6	252.7	5.4	248.2	0.8	9.6	243.3	260.1	5.4	120.6	22.4	3.9	8.1	20.5	22.9	11.7	9.4	150.0	250.1	423.0	2.3	2.2	6.6	2.3	461.9	326.9	7.0	18.1	2.4	10.8	4.1	360.4	23.6	7.6	19.8	11.3	25.3	166.9	2.7	8.4	19.4	308.1	4.8	6.8	6.1	269.2	0.5	12.3	209.9	2.0	32.0	5.2	331.0	0.7	0.5	17.3	0.0	9.5	25.1	2.6	3.2	14.8	0.6	1.7	3.8	0.2	0.1	8.9	1.9	15.3	1.1	2.1	7.5	1.8	0.0	10.7	0.1	0.9	5.7	7.1	0.2	0.2	19.2	1.8	11.9	4.5	14.2	6.7	0.1	2.4	1.9	3.8	37.7	0.1	0.2	42.0	0.6	8.1	0.1	7.7	24.1	0.9	0.3	51.9	6.9	0.0	1.7	4.9	23.8	21.8	6.3	0.5	16.7	9.9	0.3	5.2	1.3	2.0	1.0	52.5	0.0	8.4	1.0	0.7	0.0	0.8	0.0	1.1	0.8	1.5	1.1	3.5	0.7	1.6	1.3	0.3	0.8	0.0	0.1	4.3	1.0	252.7	248.2	243.3	260.1	250.1	423.0	461.9	326.9	360.4	308.1	269.2	331.0	5.1	0.0	1.1	1756.1	0.1	1.5	0.1	0.8	0.0	18.3	22.2	12.3	134.3	27.1	1.4	0.0	6.2	0.1	0.4	0.0	5.9	12.6	3.1	7.0	2.6	6.4	0.0	0.0	506.0	25.1	0.1	5.7	0.0	0.4	0.0	2.3	0.0	0.2	9.0	1.7	650.9	0.1	4.1	4.0	21.5	3.7	5.9	8.0	5.4	105.9	0.9	34.0	0.0	491.6	367.4	8.0	0.0	0.4	0.0	1.8	0.1	2.0	7.1	3.8	13.1	22.7	17.3	0.9	4.8	0.2	1.0	0.0	0.2	0.3	0.2	0.2
ELP4	"C11orf19, PAXNEB"	ENSG00000109911	"Elongator acetyltransferase complex subunit 4"	Q96EB1	11	31509755-31790324	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation, tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 37.9"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 153.5;Excitatory neurons: 93.6;Inhibitory neurons: 90.2;Microglial cells: 91.8;Oligodendrocyte precursor cells: 129.2;Oligodendrocytes: 123.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038572, HPA038573"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA038572: AB_2676090, HPA038573: AB_2676091"	"unprognostic (7.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.73e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.38e-2)"	"unprognostic (3.63e-2)"	7.1	7.2	14.6	7.4	16.4	8.6	6.8	37.9	19.0	7.4	13.3	9.0	4.6	6.8	8.3	9.7	7.3	7.2	10.2	14.0	13.3	10.2	9.6	7.3	9.7	13.6	14.3	7.5	9.4	8.1	5.4	7.8	14.7	6.7	7.7	12.7	6.9	7.4	8.3	9.6	6.5	7.6	13.6	6.4	6.5	8.3	15.2	15.1	6.6	8.3	8.4	7.8	7.3	18.2	13.2	11.2	12.0	14.4	10.9	14.9	4.6	11.5	12.3	16.7	18.4	10.4	11.5	18.0	9.7	10.3	20.9	23.3	16.5	14.4	18.3	15.1	18.3	5.9	13.2	16.0	11.2	12.6	11.2	14.9	8.7	7.2	19.5	13.2	20.4	22.9	27.4	15.7	10.7	20.3	21.4	14.9	6.9	38.9	13.7	12.8	25.7	12.0	25.6	13.0	13.8	6.4	22.3	13.4	10.0	11.7	25.4	18.2	8.2	15.3	13.5	25.3	15.2	6.1	12.9	22.0	10.8	17.6	13.4	5.9	8.0	8.1	6.7	9.2	8.3	9.1	7.6	7.9	9.3	5.9	8.5	7.4	2.1	7.5	9.5	8.3	10.1	6.6	14.6	16.4	37.9	19.0	14.0	13.3	13.6	14.3	14.7	13.6	15.2	18.2	13.9	12.8	10.5	153.5	11.4	8.3	11.0	20.2	6.8	4.9	7.7	8.5	7.7	5.7	14.5	7.3	4.2	20.2	11.4	4.3	29.4	9.1	18.0	11.0	14.0	7.5	6.7	4.6	93.6	11.3	15.6	10.5	4.1	8.3	10.8	12.8	3.9	5.5	11.5	15.2	90.2	6.0	12.2	5.7	2.4	3.6	5.0	8.5	3.6	91.8	7.7	16.5	8.2	129.2	123.4	6.1	3.9	6.4	14.3	2.9	4.0	33.1	8.6	6.1	6.6	8.3	12.9	23.5	10.2	9.4	8.2	18.9	11.4	11.6	6.4	6.9
EPHB1	"EPHT2, Hek6"	ENSG00000154928	"EPH receptor B1"	P54762	3	134597801-135260467	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 198.8;dendritic cells: 53.7;Early spermatids: 42.2;Excitatory neurons: 47.9;Inhibitory neurons: 44.3;Late spermatids: 41.2;Oligodendrocyte precursor cells: 77.9"	"Cancer enriched"	"Detected in many"	6	"glioma: 7.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	33	"neutrophil: 24.0;plasmacytoid DC: 23.3"	"Group enriched"	"Detected in many"	33	"dendritic cells: 23.3;granulocytes: 24.0"	"Group enriched"	"Detected in some"	5	"HDLM-2: 63.9;HMC-1: 35.5;RPTEC TERT1: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067740	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Endoplasmic reticulum, Plasma membrane, Cytosol"		"HPA067740: AB_2685895"	"unprognostic (1.99e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.41e-6)"	"unprognostic (6.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.15e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.37e-3)"	"unprognostic (4.88e-4)"	1.0	0.6	4.7	0.8	18.7	0.7	3.2	40.6	12.8	1.8	0.0	3.2	1.4	2.2	0.9	1.9	1.3	1.7	0.3	7.0	5.1	1.3	1.6	0.3	1.9	5.0	14.4	0.7	0.3	0.2	1.0	0.2	5.5	1.7	0.5	4.2	2.2	2.7	4.9	4.8	0.7	0.7	0.9	1.9	0.6	10.8	12.0	0.7	7.0	10.3	1.7	1.5	1.0	4.2	0.0	0.0	8.4	0.1	0.2	0.0	0.0	6.6	0.1	0.3	0.1	0.1	0.0	1.1	1.6	3.4	0.6	0.1	5.5	0.0	1.2	63.9	0.8	4.8	0.0	0.0	0.0	0.0	35.5	0.1	0.0	0.1	0.0	0.3	0.2	0.5	0.0	0.3	4.7	0.2	0.0	0.3	2.4	1.2	0.1	0.0	0.9	0.2	16.5	0.0	1.1	0.2	0.0	0.1	0.0	1.1	0.1	0.7	0.5	1.1	3.4	0.7	7.9	0.1	0.0	0.2	0.3	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	23.3	0.0	0.2	4.7	18.7	40.6	12.8	7.0	5.1	5.0	14.4	5.5	0.9	12.0	4.2	1.9	0.0	0.0	198.8	1.0	3.7	0.0	0.0	0.0	1.9	0.8	12.3	1.6	0.0	0.0	0.0	10.4	0.0	53.7	0.0	0.0	0.8	42.2	0.1	0.5	2.8	0.0	0.0	47.9	0.4	0.1	0.4	0.0	0.1	0.0	3.3	0.4	7.0	0.4	0.0	44.3	0.0	0.0	0.0	0.8	41.2	0.6	0.8	1.8	8.4	0.1	16.9	0.0	77.9	5.6	0.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.5	0.0	3.3	0.8	0.5	1.6	0.0	5.8	0.0	0.2	3.0	0.3	0.2
ETNPPL	AGXT2L1	ENSG00000164089	"Ethanolamine-phosphate phospho-lyase"	Q8TBG4	4	108742048-108763054	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 155.6;liver: 191.1"	"Cell type enriched"	"Detected in some"	8	"Astrocytes: 219.4"	"Group enriched"	"Detected in some"	23	"glioma: 7.9;liver cancer: 21.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 5.7;Hep G2: 2.3;NTERA-2: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044546, HPA072938"	Supported		Approved	Nucleoplasm		Yes	NA				"Cluster 15: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA044546: AB_10962867, HPA072938: AB_2686560"	"unprognostic (5.20e-3)"	"unprognostic (1.33e-1)"		"unprognostic (3.93e-1)"	"prognostic favorable (9.52e-5)"		"unprognostic (5.93e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.32e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.48e-2)"	0.3	5.5	155.6	0.1	155.6	0.0	0.1	98.4	144.3	0.1	47.4	0.0	0.2	0.3	0.0	0.1	0.0	0.2	10.6	124.4	145.8	9.1	191.1	0.1	0.0	100.7	118.1	0.1	0.0	2.9	1.9	0.0	110.3	0.0	0.0	1.7	34.4	0.1	2.4	0.0	0.0	0.0	101.2	0.7	18.3	0.5	119.8	0.1	1.1	1.5	0.0	0.0	0.0	101.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	5.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.6	155.6	98.4	144.3	124.4	145.8	100.7	118.1	110.3	101.2	119.8	101.3	0.0	0.0	0.0	219.4	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	14.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.4	0.0	0.0	0.4	0.0	0.0	0.5	1.5	0.4	0.0	0.0	0.7	26.8	0.0	0.0	0.6	0.0	0.0	1.6	0.0	1.7	0.0	0.0	0.0	7.5	0.0	8.5	0.0	1.5	0.7	0.0	0.0	0.0	0.1	0.0	0.0	7.9	0.0	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1
EYA1	BOR	ENSG00000104313	"EYA transcriptional coactivator and phosphatase 1"	Q99502	8	71197433-71592025	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"	"Deafness, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 18.7;parathyroid gland: 23.7"	"Cell type enriched"	"Detected in some"	11	"Astrocytes: 214.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 27.6;RH-30: 21.3;RPMI-8226: 9.5;SH-SY5Y: 51.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 20.7"	HPA028917			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nuclear bodies"		"HPA028917: AB_2672826"	"unprognostic (3.74e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.72e-3)"	"unprognostic (5.95e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.91e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.22e-12)"	"unprognostic (1.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.81e-4)"	"unprognostic (1.25e-2)"	0.6	0.6	2.8	0.1	7.8	0.0	0.2	0.5	2.1	5.1	18.7	0.1	0.1	0.1	0.1	0.4	2.0	0.3	4.5	1.3	2.5	0.1	0.0	0.4	0.0	2.1	4.9	0.2	0.0	23.7	10.8	0.0	2.3	12.0	0.2	0.4	0.8	4.0	2.8	0.0	0.2	0.2	0.0	0.1	0.8	0.8	4.6	11.7	0.6	2.5	0.1	2.6	4.3	0.6	0.2	0.0	6.4	27.6	0.0	0.0	0.0	0.2	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.9	1.6	0.0	0.0	4.7	0.0	2.2	0.0	0.0	0.5	0.0	6.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	1.0	0.0	0.0	0.0	2.0	0.0	1.5	0.0	21.3	9.5	0.0	0.0	2.2	51.4	0.0	0.0	1.6	5.9	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	6.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	7.8	0.5	2.1	1.3	2.5	2.1	4.9	2.3	0.0	4.6	0.6	0.2	0.0	0.0	214.5	0.0	0.1	0.0	6.4	0.6	0.1	0.0	0.1	8.8	0.0	7.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	4.4	3.1	0.1	0.2	0.0	0.0	1.3	0.0	0.5	1.3	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	13.5	0.0	2.0	0.0	0.0	6.4	0.3	0.0	0.0	11.2	0.0	0.1	0.0	18.6	0.6	0.0	0.0	0.4	0.0	0.1	0.0	0.3	10.5	0.2	0.0	0.2	0.5	0.8	1.0	1.1	0.1	0.5	0.0	1.4	0.0	0.1
EYA2	EAB1	ENSG00000064655	"EYA transcriptional coactivator and phosphatase 2"	O00167	20	46894624-47188844	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 55.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 153.8;Basal prostatic cells: 47.5;Basal respiratory cells: 50.4;Endometrial ciliated cells: 43.7;Glandular and luminal cells: 53.8;Oligodendrocyte precursor cells: 48.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 69.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 40.1;SCLC-21H: 58.3;U-266/70: 110.9;U-266/84: 139.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027024, HPA059291"	Uncertain		Supported	Cytosol		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol		"HPA027024: AB_1848334, HPA059291: AB_2683967"	"unprognostic (1.08e-1)"	"unprognostic (5.71e-3)"	"unprognostic (4.03e-1)"	"prognostic favorable (4.30e-5)"	"unprognostic (3.32e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.56e-1)"	12.0	1.5	12.3	2.4	14.1	0.0	11.0	15.6	12.3	55.6	11.2	9.3	0.3	17.2	3.7	34.2	34.0	1.8	5.0	10.7	11.8	4.7	2.1	2.2	0.8	14.6	14.4	0.7	1.9	9.4	5.3	6.3	13.7	23.6	3.1	1.2	31.2	9.3	2.5	5.3	1.1	1.8	11.8	0.6	8.9	5.6	13.4	18.8	14.6	3.4	6.6	4.9	16.5	11.0	0.2	4.4	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.7	2.5	1.9	0.3	40.1	0.0	0.0	8.1	0.0	0.1	0.0	0.0	0.1	0.3	2.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	7.7	0.1	0.0	0.6	0.1	0.0	0.1	0.8	0.5	0.0	0.0	58.3	0.0	0.0	24.8	0.0	3.0	5.3	0.2	0.0	0.0	4.5	0.3	8.8	110.9	139.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	14.1	15.6	12.3	10.7	11.8	14.6	14.4	13.7	11.8	13.4	11.0	0.4	0.0	0.0	153.8	0.9	0.6	47.5	50.4	14.8	0.4	7.8	7.6	0.5	2.8	33.0	0.0	6.2	27.7	0.0	2.5	0.0	0.9	0.2	43.7	3.9	0.6	1.2	0.0	1.5	0.0	3.0	4.8	9.2	53.8	1.3	9.8	0.4	3.3	7.4	0.0	5.1	0.6	34.6	0.0	0.4	0.3	0.0	1.1	3.6	13.1	2.6	0.0	0.0	48.7	1.0	1.1	1.7	0.7	3.4	10.9	0.0	6.3	22.2	0.4	0.0	0.3	2.8	0.2	7.4	16.0	0.3	10.8	0.6	4.2	3.6	34.6
FAM171A1	"APCN, C10orf38, FLJ12884"	ENSG00000148468	"Family with sequence similarity 171 member A1"	Q5VUB5	10	15211643-15371289	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 86.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 263.8;Cholangiocytes: 98.7;Excitatory neurons: 166.9;Oligodendrocytes: 214.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 1.7;MAIT T-cell: 4.4;memory CD4 T-cell: 2.5;memory CD8 T-cell: 2.2;naive CD4 T-cell: 4.7;naive CD8 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	19	"T-cells: 4.7"	"Cell line enhanced"	"Detected in many"		"TIME: 105.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051345	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		130000	"Cluster 32: T-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"	Nucleoplasm	"HPA051345: AB_2681449"	"unprognostic (3.60e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.11e-2)"	"unprognostic (9.84e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.87e-1)"	"prognostic favorable (2.71e-5)"	"unprognostic (3.08e-1)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (4.90e-6)"	"unprognostic (3.28e-2)"	11.0	5.0	60.1	7.5	73.2	0.5	8.8	69.8	56.4	11.8	22.7	21.6	19.1	12.8	6.4	6.4	15.6	12.9	10.6	68.5	49.5	31.9	15.4	7.4	6.0	79.6	64.8	14.2	22.4	10.9	3.7	4.1	75.6	11.2	17.6	2.6	14.1	11.9	7.6	4.2	13.0	12.3	59.3	12.4	13.3	3.5	68.7	3.9	6.9	6.1	6.6	9.0	6.3	86.7	0.0	16.2	33.3	12.6	13.2	24.9	0.4	19.5	3.9	10.2	8.8	3.0	19.2	0.1	21.5	53.4	22.7	1.4	24.0	0.2	11.5	5.9	33.4	46.7	5.2	48.1	14.3	0.0	36.0	19.7	4.9	27.8	4.0	36.8	51.4	6.8	17.5	0.2	32.8	1.4	7.7	0.1	30.4	9.3	7.8	30.4	17.0	5.1	12.7	0.0	22.4	27.6	10.9	0.2	0.1	35.0	0.2	0.6	105.6	13.9	53.6	50.4	20.8	6.3	2.1	0.1	30.3	0.0	10.8	0.0	0.0	0.0	1.7	0.0	4.4	0.0	2.5	2.2	0.0	0.0	4.7	2.4	0.0	0.2	0.0	0.0	0.5	0.9	60.1	73.2	69.8	56.4	68.5	49.5	79.6	64.8	75.6	59.3	68.7	86.7	11.1	0.0	0.0	263.8	1.0	1.3	4.0	3.1	8.0	4.0	7.6	5.7	6.8	98.7	1.7	14.7	0.0	0.1	0.2	25.4	3.9	21.1	0.7	5.9	12.5	43.7	21.0	6.5	166.9	12.2	0.2	12.3	35.7	14.6	1.3	14.4	49.2	24.7	0.4	6.7	76.6	23.7	4.1	2.8	1.7	1.1	5.3	0.3	1.8	33.7	0.7	1.5	0.0	44.2	214.4	17.5	16.1	5.7	5.2	16.5	7.3	4.5	2.4	1.1	0.0	7.5	5.9	2.3	5.7	8.0	1.8	0.1	2.0	11.4	38.8	3.6
FAM181B	"LOC220382, MGC33846"	ENSG00000182103	"Family with sequence similarity 181 member B"	A6NEQ2	11	82729940-82733864	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 26.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 56.2;Endometrial ciliated cells: 24.1;Muller glia cells: 18.4;Oligodendrocyte precursor cells: 22.1;Oligodendrocytes: 19.0"	"Cancer enriched"	"Detected in many"	19	"glioma: 29.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RT4: 2.4;SH-SY5Y: 1.2;U-2 OS: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066861	Enhanced		Approved	"Nuclear membrane,Mitochondria"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 15: RT4 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria	"Nuclear membrane"	"HPA066861: AB_2685738"	"unprognostic (2.84e-4)"	"unprognostic (3.47e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (8.07e-4)"	"unprognostic (6.71e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.50e-2)"	"unprognostic (6.27e-4)"	"unprognostic (2.52e-3)"	"unprognostic (6.81e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.20e-3)"	"unprognostic (7.20e-2)"	0.5	0.6	18.0	0.2	20.3	0.1	0.4	19.8	14.3	1.3	5.9	1.4	0.2	0.7	0.1	0.3	1.0	0.0	1.7	14.5	14.7	0.7	0.0	0.0	0.0	26.9	20.8	0.8	0.5	0.1	1.2	0.0	16.3	0.6	0.0	0.6	0.8	0.5	0.2	0.3	0.4	0.1	23.9	0.0	0.4	0.2	19.9	0.0	0.8	0.1	0.2	1.1	0.7	23.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	2.4	0.3	1.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	20.3	19.8	14.3	14.5	14.7	26.9	20.8	16.3	23.9	19.9	23.6	0.7	0.0	0.0	56.2	0.0	0.3	0.2	0.1	0.0	0.8	1.0	3.6	2.9	0.0	0.1	5.5	0.0	0.0	0.0	0.0	3.9	0.1	0.0	24.1	1.8	1.3	0.0	0.0	0.4	0.0	0.0	1.2	0.0	2.4	0.0	0.6	0.0	0.0	0.1	0.0	0.6	1.5	0.0	0.0	0.3	0.4	0.6	0.2	1.8	1.9	0.0	18.4	0.0	22.1	19.0	0.0	0.0	0.4	0.0	0.2	0.1	0.4	0.1	1.1	0.0	1.6	7.0	0.1	1.6	0.3	0.0	0.0	0.1	2.2	0.2	0.1
FAM189A2	"C9orf61, X123"	ENSG00000135063	"Family with sequence similarity 189 member A2"	Q15884	9	69324567-69392558	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 48.3;thyroid gland: 58.2"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 1: 157.0;Astrocytes: 256.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 22.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.2;NTERA-2: 5.1;RPTEC TERT1: 1.8;RT4: 2.3;SK-MEL-30: 5.0;SuSa: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029411, HPA057207"	Approved					NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA029411: AB_10602338, HPA057207: AB_2683369"	"unprognostic (2.04e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.16e-6)"	"unprognostic (2.24e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.71e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (1.75e-5)"	"unprognostic (3.42e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.14e-1)"	6.0	4.7	12.8	0.4	15.0	0.0	13.7	15.8	11.2	26.0	9.2	7.1	1.2	6.8	1.7	5.2	6.8	1.6	13.3	12.2	15.7	4.7	0.2	22.3	0.6	20.1	16.7	24.6	7.3	6.0	7.6	1.5	17.1	11.1	1.1	4.4	6.2	3.4	48.3	12.4	4.0	4.9	16.3	0.4	13.7	1.3	19.8	5.6	58.2	9.0	0.9	7.9	4.6	15.1	0.0	0.0	0.2	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.8	0.7	0.7	0.0	0.0	0.6	1.6	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	5.1	0.3	0.0	0.0	0.1	0.0	1.8	2.3	0.0	0.0	0.0	0.0	5.0	1.9	0.1	0.0	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	15.0	15.8	11.2	12.2	15.7	20.1	16.7	17.1	16.3	19.8	15.1	12.1	157.0	23.3	256.3	0.4	3.3	4.9	1.9	7.4	2.1	18.4	39.6	14.6	0.0	26.9	1.8	0.0	1.2	0.4	1.5	0.0	0.9	0.1	19.9	2.8	8.0	0.0	0.0	0.7	0.6	0.1	1.7	11.7	33.0	0.0	2.0	2.2	0.0	0.3	0.0	3.9	0.4	0.0	0.3	1.3	0.0	0.0	0.4	19.6	20.6	0.0	35.1	0.0	7.1	2.1	3.5	1.2	0.0	0.2	3.7	0.2	0.2	2.3	1.0	0.0	3.8	3.8	0.1	0.6	1.9	2.4	0.3	1.0	0.7	0.7	1.8
FGD6	"FLJ11183, ZFYVE24"	ENSG00000180263	"FYVE, RhoGEF and PH domain containing 6"	Q6ZV73	12	95076749-95217482	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 109.0;Microglial cells: 90.9;Pancreatic endocrine cells: 78.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 23.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007974	Approved		Approved	Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 31: Skin - Epidermis development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 64: Astrocytes - Nervous system maintenance"	Vesicles		"HPA007974: AB_1848520"	"unprognostic (1.28e-2)"	"unprognostic (2.67e-3)"	"unprognostic (6.06e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.70e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (4.62e-5)"	"prognostic unfavorable (9.83e-4)"	"prognostic unfavorable (5.46e-6)"	"unprognostic (1.01e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.92e-1)"	1.8	3.3	3.3	5.1	5.3	1.5	2.9	0.3	5.2	3.3	4.0	4.5	1.3	3.4	1.2	3.3	1.9	4.9	3.6	3.2	0.4	3.3	3.1	5.2	5.5	2.0	1.7	4.5	3.4	1.2	1.1	4.3	0.3	3.3	4.2	2.2	2.2	4.0	1.6	7.8	3.5	3.5	1.8	3.3	1.8	3.0	2.9	2.5	5.2	1.3	9.7	3.3	3.5	1.6	22.5	20.1	18.2	2.0	1.9	1.8	9.5	3.1	4.4	1.1	1.8	7.7	15.0	23.8	5.1	2.0	1.3	8.9	3.3	18.7	2.6	2.5	2.0	1.1	3.2	3.8	2.5	2.5	0.2	7.5	8.4	2.2	22.1	7.3	11.9	3.2	5.1	0.4	0.6	1.2	2.0	0.5	7.5	2.8	6.9	5.5	3.6	1.9	12.8	7.1	3.0	4.9	9.0	4.6	0.4	9.1	2.1	0.2	16.4	0.7	2.0	0.9	2.4	2.2	5.3	6.7	0.9	1.6	1.4	0.2	1.6	0.0	0.0	2.5	0.0	0.5	0.0	0.0	0.9	1.4	0.1	0.0	0.1	0.1	2.0	0.0	0.0	0.6	3.3	5.3	0.3	5.2	3.2	0.4	2.0	1.7	0.3	1.8	2.9	1.6	12.4	16.0	17.0	109.0	3.9	48.6	21.9	18.6	29.0	3.8	11.0	10.5	22.2	10.0	14.0	9.2	4.2	4.5	1.5	26.5	0.0	22.6	1.7	10.9	17.3	22.3	12.5	1.7	23.9	21.9	8.8	7.3	6.6	22.1	1.3	10.6	16.4	5.2	11.7	1.7	22.4	15.5	10.2	16.1	11.8	3.1	12.5	11.0	1.8	90.9	12.6	1.9	1.0	4.0	4.1	78.1	17.0	10.5	3.5	19.3	14.9	5.2	12.0	9.7	0.0	3.5	6.1	4.8	16.0	28.3	24.9	43.8	1.7	4.9	5.5	30.7
FGFR3	"ACH, CD333, CEK2, JTK4"	ENSG00000068078	"Fibroblast growth factor receptor 3"	P22607	4	1793293-1808872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Deafness, Disease variant, Dwarfism, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 148.3;esophagus: 139.7;skin 1: 271.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 410.4;Basal keratinocytes: 103.8;Cholangiocytes: 91.5;Suprabasal keratinocytes: 88.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 48.2;HaCaT: 34.9;Hep G2: 80.6;NTERA-2: 36.1;RT4: 64.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004231, HPA067204"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted - unknown location"	NA	NA		2500000		"Cluster 27: Brain & Skin - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Endoplasmic reticulum"		"CAB004231: AB_627596, HPA067204: AB_2685804"	"unprognostic (1.34e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (5.90e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.22e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.97e-1)"	1.6	1.6	118.0	1.5	140.6	1.4	5.5	115.6	104.0	23.7	37.4	12.2	19.5	1.5	2.8	139.7	2.2	7.9	4.8	100.8	107.6	39.3	40.7	7.4	0.4	144.7	129.2	0.5	76.4	0.2	16.1	9.3	109.8	13.8	5.2	0.2	20.2	15.0	1.3	271.5	14.7	0.4	108.9	4.0	7.8	17.6	148.3	1.7	1.5	0.9	11.1	23.1	60.9	81.2	0.0	3.8	19.5	5.6	0.0	0.3	22.1	2.4	0.3	0.8	0.4	48.2	1.0	0.0	17.8	0.7	0.7	34.9	5.5	0.3	0.3	0.2	19.3	14.2	3.9	80.6	0.1	0.0	0.6	0.0	10.9	0.2	0.1	0.1	0.1	2.3	16.7	0.1	0.0	23.9	0.8	0.5	36.1	19.5	0.1	1.2	1.0	0.3	2.8	64.1	5.7	1.6	1.9	4.0	0.0	22.2	20.4	2.5	1.0	0.0	2.1	0.5	1.6	0.1	0.0	0.0	0.2	1.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	118.0	140.6	115.6	104.0	100.8	107.6	144.7	129.2	109.8	108.9	148.3	81.2	2.2	0.0	32.5	410.4	1.1	103.8	4.1	29.8	23.9	0.0	4.8	1.5	3.1	91.5	37.6	14.7	0.0	0.5	1.6	36.1	0.0	5.0	7.9	3.0	1.7	3.4	4.2	0.0	0.5	0.7	12.0	3.2	3.6	4.0	0.0	0.1	16.1	30.4	0.6	0.0	1.3	20.7	4.1	1.2	6.5	1.3	0.6	0.6	12.4	14.0	0.6	0.1	0.0	34.2	2.2	0.4	18.0	0.4	0.0	4.2	21.2	9.9	9.8	0.6	0.0	0.7	2.9	0.4	25.9	55.0	88.7	0.8	0.7	0.1	17.0	12.8
FRS2	"FRS2A, FRS2alpha, SNT-1, SNT1"	ENSG00000166225	"Fibroblast growth factor receptor substrate 2"	Q8WU20	12	69470349-69579793	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 104.5;Oligodendrocyte precursor cells: 76.9;Oligodendrocytes: 89.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038323, HPA073385"			Uncertain	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane, Cell Junctions"		"HPA038323: , HPA073385: "	"unprognostic (9.15e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.50e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.97e-2)"	"unprognostic (2.34e-2)"	"unprognostic (5.70e-3)"	"unprognostic (3.80e-2)"	"unprognostic (8.22e-2)"	"unprognostic (6.66e-2)"	9.9	8.1	13.4	5.4	18.1	27.0	13.2	22.4	16.2	11.9	9.2	8.4	6.0	12.3	13.6	8.6	9.5	11.5	7.8	13.7	15.8	8.2	11.9	8.5	6.1	15.6	13.2	14.9	6.0	12.2	4.7	10.8	15.2	8.0	8.5	10.2	7.8	7.1	7.2	8.3	7.6	11.8	19.2	6.1	7.6	9.2	13.4	9.4	12.8	8.8	7.3	7.9	6.9	27.1	15.1	12.4	21.9	9.7	12.2	13.6	38.9	16.5	17.8	14.8	11.8	25.1	6.4	6.8	10.2	21.5	7.7	13.2	11.6	17.7	18.6	11.7	9.2	12.2	9.9	7.9	11.1	10.6	8.8	13.0	20.4	17.9	13.1	17.8	7.3	7.8	8.7	15.2	12.8	19.3	8.6	4.0	24.4	7.9	9.7	7.5	18.8	5.6	11.3	36.5	10.6	20.6	25.4	10.7	15.5	27.1	31.0	5.9	13.1	11.7	13.0	15.3	13.0	13.2	22.4	6.3	8.5	5.9	10.7	0.5	4.2	2.2	2.6	3.8	2.8	2.8	2.6	2.2	2.9	6.0	5.0	2.9	4.3	2.7	7.4	2.6	1.6	2.0	13.4	18.1	22.4	16.2	13.7	15.8	15.6	13.2	15.2	19.2	13.4	27.1	12.8	6.4	12.7	104.5	13.3	20.3	8.6	9.3	30.7	11.9	29.1	20.6	23.2	5.7	15.0	11.0	16.7	7.9	8.7	6.9	3.9	7.8	5.9	16.3	27.5	10.1	10.2	8.6	64.8	7.2	11.6	20.8	13.7	25.0	13.4	13.0	9.3	15.3	6.9	6.7	68.1	9.4	4.1	10.7	11.8	9.9	19.0	9.9	7.2	43.1	11.6	18.2	6.2	76.9	89.5	12.3	6.0	13.2	11.4	13.1	7.4	7.3	11.0	11.4	6.6	18.5	21.9	11.5	11.7	19.6	12.6	6.3	10.3	18.2	8.0	12.5
FUT9	Fuc-TIX	ENSG00000172461	"Fucosyltransferase 9"	Q9Y231	6	96015974-96215612	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 18.9;stomach 1: 23.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 776.4;Excitatory neurons: 333.5;Inhibitory neurons: 238.2;Oligodendrocyte precursor cells: 168.9;Oligodendrocytes: 224.7"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 2.9;OE19: 2.8;RT4: 6.5;SCLC-21H: 6.3;SK-BR-3: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070923			Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"		Yes	No				"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	"Microtubules, Cytokinetic bridge, Cytosol"	"HPA070923: AB_2686323"	"unprognostic (1.60e-1)"	"unprognostic (2.48e-1)"		"unprognostic (5.99e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.40e-1)"		"unprognostic (2.97e-1)"		"unprognostic (1.35e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.43e-3)"	"unprognostic (5.60e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.03e-2)"	0.0	0.4	10.5	0.0	12.6	0.0	0.6	14.5	11.7	0.0	0.0	0.1	2.1	0.2	0.0	0.0	0.2	0.0	0.0	11.8	13.6	0.2	0.0	0.0	0.0	3.4	18.9	0.0	4.8	0.0	0.4	0.4	3.2	0.2	0.0	0.5	0.0	0.2	0.1	0.1	0.0	0.0	5.5	0.0	23.2	0.0	15.3	0.0	0.1	0.0	0.0	0.9	0.0	6.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	1.4	2.8	0.0	0.0	0.0	0.0	0.0	6.5	6.3	0.1	0.0	3.6	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	12.6	14.5	11.7	11.8	13.6	3.4	18.9	3.2	5.5	15.3	6.4	0.0	0.0	0.0	776.4	0.2	0.0	0.6	0.0	0.0	4.2	1.4	1.7	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.5	0.1	1.3	0.0	0.0	333.5	2.0	0.0	0.1	56.1	1.4	0.0	0.4	0.0	0.0	0.1	0.0	238.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.2	0.0	168.9	224.7	0.5	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.2
GABBR1	"GPRC3A, hGB1a"	ENSG00000204681	"Gamma-aminobutyric acid type B receptor subunit 1"	Q9UBS5	6	29555629-29633976	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 150.5;Excitatory neurons: 58.7;Inhibitory neurons: 68.1;Oligodendrocyte precursor cells: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 6.3;HEL: 6.4;U-2 OS: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050483, HPA058459"	Uncertain		Approved	Centrosome	"Intracellular and membrane"	NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	Centrosome		"HPA050483: AB_2681140, HPA058459: "	"unprognostic (1.01e-1)"	"unprognostic (2.07e-3)"	"unprognostic (3.22e-3)"	"unprognostic (2.93e-3)"	"unprognostic (3.37e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.95e-4)"	"unprognostic (5.44e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (2.54e-5)"	"unprognostic (1.23e-3)"	"prognostic unfavorable (3.77e-10)"	"unprognostic (3.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.55e-2)"	20.4	18.0	10.2	2.4	10.9	2.8	20.7	6.4	9.6	45.3	0.0	33.6	0.2	42.8	0.0	14.5	39.0	0.9	28.4	3.9	0.0	16.9	4.7	20.6	2.0	0.3	2.0	40.7	10.4	1.1	30.8	1.3	0.0	34.3	0.5	0.5	16.3	4.2	6.1	19.2	20.2	1.4	0.0	39.0	18.5	7.9	6.1	0.2	22.8	0.0	1.2	25.3	31.6	0.0	2.4	0.0	1.5	6.3	0.7	1.6	1.6	1.6	0.7	1.4	0.4	1.9	0.1	1.1	1.5	0.0	0.3	2.0	0.7	0.0	0.0	5.9	2.6	6.4	3.7	0.0	0.9	0.2	3.1	0.0	0.0	1.2	0.0	1.8	0.8	3.3	5.5	0.0	0.2	1.5	0.6	0.1	0.4	0.0	0.9	2.9	0.6	0.1	0.2	0.0	0.4	1.0	0.4	0.0	2.6	0.4	1.2	0.9	3.6	2.5	6.2	0.2	3.1	5.4	0.6	0.0	1.4	2.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	10.2	10.9	6.4	9.6	3.9	0.0	0.3	2.0	0.0	0.0	6.1	0.0	16.8	12.8	20.2	150.5	10.6	11.9	6.2	4.7	10.2	30.6	13.4	17.7	13.9	1.5	10.7	3.7	0.0	0.3	5.7	0.8	0.0	1.4	4.7	1.3	30.6	17.0	7.2	5.7	58.7	0.9	0.2	16.0	1.5	1.9	7.6	14.6	22.5	0.3	1.1	23.5	68.1	4.7	2.0	5.9	18.3	3.1	15.2	14.4	0.0	19.7	11.0	9.8	0.0	72.4	16.3	1.7	1.6	25.6	0.7	7.6	0.1	1.0	1.1	17.3	13.1	12.5	18.8	1.2	2.7	5.3	11.1	0.5	5.9	6.7	1.5	2.8
GABRB1		ENSG00000163288	"Gamma-aminobutyric acid type A receptor subunit beta1"	P18505	4	46993723-47426447	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 26.3"	"Group enriched"	"Detected in some"	15	"Astrocytes: 926.2;Excitatory neurons: 440.3;Inhibitory neurons: 507.4;Oligodendrocyte precursor cells: 266.9"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"REH: 7.1;U-87 MG: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 14: REH - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (3.11e-2)"		"unprognostic (7.56e-3)"		"unprognostic (5.10e-2)"	"unprognostic (1.83e-1)"			"unprognostic (1.11e-1)"		"unprognostic (4.98e-3)"		"unprognostic (8.16e-3)"	"unprognostic (6.22e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.34e-1)"		0.0	0.2	19.1	0.0	24.8	0.0	0.0	0.3	26.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.2	3.6	26.2	24.6	0.3	0.0	0.0	0.0	0.5	7.4	0.0	0.0	0.3	1.5	0.1	0.6	0.0	0.1	2.4	0.1	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	26.1	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	24.8	0.3	26.3	26.2	24.6	0.5	7.4	0.6	1.1	26.1	2.3	0.0	0.0	0.0	926.2	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.3	0.1	1.2	0.0	440.3	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	507.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.7	0.1	32.9	0.0	266.9	16.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.1	0.3	1.9	0.0	0.0	0.1	0.0	0.0	0.3	0.0
GABRG1		ENSG00000163285	"Gamma-aminobutyric acid type A receptor subunit gamma1"	Q8N1C3	4	46035769-46124054	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 44.7"	"Cell type enriched"	"Detected in some"	8	"Astrocytes: 135.5"	"Cancer enriched"	"Detected in single"	8	"glioma: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/70: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035622, HPA058102"	Approved		Supported	"Plasma membrane"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"		"HPA035622: AB_10603669, HPA058102: "	"unprognostic (2.50e-1)"				"unprognostic (2.20e-1)"		"unprognostic (6.06e-2)"			"unprognostic (1.46e-2)"	"unprognostic (7.39e-4)"		"unprognostic (1.23e-1)"		"unprognostic (1.28e-1)"	"unprognostic (1.99e-1)"		0.1	0.1	21.6	0.0	20.6	0.0	0.0	19.0	27.3	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	19.4	31.7	0.0	0.0	0.0	0.0	24.8	38.0	1.2	0.0	0.0	0.6	0.0	23.9	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	21.1	0.1	0.0	0.2	44.7	0.0	0.1	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	20.6	19.0	27.3	19.4	31.7	24.8	38.0	23.9	21.1	44.7	23.1	0.3	0.0	0.0	135.5	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	11.2	0.0	15.4	0.0	2.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	6.6	0.0	1.8	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0
GFAP	FLJ45472	ENSG00000131095	"Glial fibrillary acidic protein"	P14136	17	44903159-44916937	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 13076.3"	"Cell type enriched"	"Detected in some"	7	"Astrocytes: 381.9"	"Cancer enriched"	"Detected in some"	368	"glioma: 2468.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 6.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.2;NK-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000039, HPA056030, HPA063513"	Enhanced	Supported	Supported	"Intermediate filaments"		No	No		170000000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Intermediate filaments"		"CAB000039: AB_10013382, HPA056030: AB_2683015, HPA063513: AB_2685027"	"unprognostic (1.79e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.12e-5)"	"unprognostic (4.08e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.53e-2)"	"unprognostic (6.57e-3)"	"unprognostic (7.35e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.75e-5)"	"unprognostic (1.49e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.64e-1)"	1.9	1.8	5096.2	2.2	5407.4	14.1	3.5	5902.8	4887.4	1.9	2342.2	1.4	0.4	0.9	1.5	3.7	2.2	1.6	8.2	5059.3	9869.7	2.1	1.7	1.3	1.9	13076.3	9001.4	2.1	1.5	1.6	33.9	0.7	9204.1	1.3	1.0	117.7	1.9	1.0	2.1	2.6	0.7	0.9	10040.2	1.5	1.5	1.4	8068.5	0.4	1.7	0.3	1.1	1.4	0.9	10496.9	1.0	0.7	1.2	2.3	0.0	0.4	0.2	1.0	1.2	1.5	1.2	1.3	1.5	2.2	1.9	0.5	0.9	2.7	1.4	0.4	1.8	3.0	1.1	1.4	2.1	0.9	0.0	0.2	2.2	0.1	0.8	1.0	0.0	1.7	0.0	2.3	0.7	5.3	0.8	1.3	1.9	2.6	1.6	0.1	3.3	0.7	0.7	1.2	0.7	0.6	1.6	1.8	0.1	1.7	0.2	1.0	1.2	1.2	0.7	1.2	0.9	1.1	2.0	0.7	1.6	1.6	6.1	2.0	2.7	1.5	0.8	0.3	0.3	0.6	0.2	0.2	0.2	0.4	0.1	0.5	0.3	0.4	6.2	1.7	0.5	0.5	0.2	0.2	5096.2	5407.4	5902.8	4887.4	5059.3	9869.7	13076.3	9001.4	9204.1	10040.2	8068.5	10496.9	0.0	0.0	0.0	381.9	0.1	0.0	0.1	0.0	0.0	0.8	1.3	0.6	5.2	0.0	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.8	0.0	0.0	0.5	0.2	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	3.7	0.0	53.5	0.0	10.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4.4	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1
GLI3	"ACLS, GCPS, PAP-A, PAPA, PAPA1, PAPB, PHS, PPDIV"	ENSG00000106571	"GLI family zinc finger 3"	P10071	7	41960949-42264100	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	8	"Astrocytes: 301.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 47.1;WM-115: 34.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005534	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	"Nucleoli, Vesicles"	"HPA005534: AB_1078973"	"unprognostic (2.53e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.35e-3)"	"unprognostic (2.24e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.48e-5)"	"unprognostic (9.13e-3)"	"unprognostic (5.41e-2)"	"unprognostic (3.21e-3)"	"unprognostic (7.00e-2)"	6.1	1.9	9.2	3.6	8.8	0.1	8.9	1.0	5.4	7.2	0.0	11.6	1.2	11.8	2.7	3.7	8.2	3.8	1.6	6.3	5.5	1.7	0.3	3.4	0.9	1.7	10.4	13.2	0.7	0.5	1.1	11.9	3.0	5.5	2.9	1.8	2.8	8.2	1.1	8.3	3.4	10.7	0.5	1.1	2.6	1.7	14.4	3.0	4.6	2.3	1.7	4.8	7.3	2.3	0.0	0.0	47.1	0.4	16.9	23.6	3.5	3.1	9.0	9.3	12.8	0.0	0.0	0.0	1.7	22.1	22.7	10.1	8.7	8.9	10.8	0.0	7.0	0.0	6.0	0.0	9.0	0.0	0.1	21.0	12.9	10.6	6.8	5.7	10.6	5.4	0.0	0.2	5.6	5.6	0.4	0.0	20.9	0.0	21.2	12.4	0.1	1.4	0.2	6.4	1.5	0.0	6.3	7.0	4.1	23.8	8.0	0.1	11.3	13.6	18.8	16.0	6.0	0.1	0.0	0.0	7.3	0.2	34.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	8.8	1.0	5.4	6.3	5.5	1.7	10.4	3.0	0.5	14.4	2.3	2.9	0.0	7.7	301.3	0.2	23.5	7.2	8.5	31.9	1.6	20.5	27.1	1.8	0.0	2.3	1.8	0.0	21.1	0.5	0.0	0.0	0.0	16.6	2.4	12.6	3.4	0.0	0.0	0.8	0.0	13.6	25.9	0.0	4.6	1.3	10.5	3.9	0.0	3.3	0.0	3.6	0.1	6.1	0.3	6.3	5.4	19.3	0.4	8.8	22.5	0.0	13.6	0.0	8.5	0.7	0.1	0.0	3.4	1.2	6.6	0.0	3.8	1.5	1.1	13.1	17.0	12.1	0.3	2.2	7.9	15.5	34.2	0.7	5.2	0.1	5.0
GLIS3	"MGC33662, ZNF515"	ENSG00000107249	"GLIS family zinc finger 3"	Q8NEA6	9	3824127-4348392	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Congenital hypothyroidism, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.2;choroid plexus: 20.5"	"Cell type enriched"	"Detected in many"	7	"Astrocytes: 649.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 21.5;HSkMC: 29.5;RPTEC TERT1: 20.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056426	Approved		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA056426: AB_2683128"	"unprognostic (6.24e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.63e-3)"	"unprognostic (4.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.14e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.91e-3)"	"unprognostic (6.88e-3)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.35e-2)"	4.3	1.6	5.1	2.1	5.5	0.2	1.9	4.9	4.6	7.8	20.5	2.0	0.7	3.3	2.8	0.5	8.7	6.5	2.9	5.4	10.8	7.8	3.3	3.8	1.1	24.2	18.0	6.6	9.7	2.4	2.4	1.4	11.4	3.3	2.1	1.3	3.1	8.2	1.3	0.8	1.5	2.1	13.7	2.0	1.8	2.8	6.5	0.2	18.6	0.8	0.7	4.0	2.4	13.2	1.0	8.5	2.5	0.0	3.7	9.5	0.4	5.9	21.5	3.1	4.4	1.3	3.4	0.0	4.3	5.5	9.6	0.0	2.0	0.0	6.7	2.5	1.2	0.0	0.4	0.0	11.0	0.9	0.0	29.5	0.0	9.8	1.1	5.8	0.4	0.1	0.0	0.2	2.9	0.4	0.0	1.5	0.2	0.0	0.8	0.0	5.2	0.0	20.8	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.0	0.0	5.5	3.4	0.9	3.2	13.3	0.0	0.0	0.0	8.1	0.0	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	5.1	5.5	4.9	4.6	5.4	10.8	24.2	18.0	11.4	13.7	6.5	13.2	8.1	9.6	24.0	649.7	1.0	1.9	9.3	17.1	0.6	1.0	4.6	1.3	1.6	75.8	34.5	69.9	0.0	3.2	0.3	3.7	0.0	51.0	5.2	79.6	17.5	11.2	43.7	0.0	18.3	22.6	3.2	21.9	4.1	82.3	1.3	1.6	6.8	8.3	2.4	0.0	54.2	1.6	12.2	0.8	4.0	2.4	13.7	3.4	3.6	86.2	2.2	15.6	0.0	26.7	4.1	49.1	3.9	11.3	0.0	16.5	2.4	16.4	35.7	0.4	0.0	34.4	19.0	1.3	7.4	0.6	1.3	4.2	1.2	8.8	6.6	6.1
GNA14		ENSG00000156049	"G protein subunit alpha 14"	O95837	9	77423079-77648322	"Predicted intracellular proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 219.1;Early spermatids: 50.2;Hepatic stellate cells: 61.4;Late spermatids: 38.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	95	"basophil: 27.3"	"Lineage enriched"	"Detected in single"	95	"granulocytes: 27.3"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.3;HUVEC TERT2: 1.6;PC-3: 3.2;THP-1: 1.6;U-2197: 2.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA048886	Approved					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA048886: AB_2680544"	"unprognostic (7.80e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.53e-4)"	"unprognostic (2.48e-6)"	"unprognostic (6.35e-3)"	"unprognostic (3.34e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.75e-3)"	"unprognostic (2.03e-1)"	3.4	2.2	7.3	4.0	6.5	0.0	2.4	2.7	8.4	3.6	11.8	5.8	1.7	15.6	5.2	4.8	3.6	4.9	4.1	9.2	4.5	11.7	6.0	8.8	3.3	9.7	5.0	6.0	1.4	1.4	3.1	7.0	7.0	6.8	6.1	0.1	8.0	13.7	0.6	0.9	3.0	13.8	8.1	7.3	3.3	2.1	5.6	0.7	17.6	0.6	2.1	7.6	4.8	13.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.3	1.0	0.3	0.0	0.6	0.0	0.9	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.9	0.4	3.2	0.0	0.0	0.0	0.0	1.2	0.1	0.1	0.8	0.4	0.0	1.2	0.3	1.6	0.4	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	27.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	7.3	6.5	2.7	8.4	9.2	4.5	9.7	5.0	7.0	8.1	5.6	13.9	2.3	0.0	1.1	219.1	0.2	0.6	2.0	0.2	0.0	0.0	1.0	0.4	0.8	0.0	6.5	0.0	0.0	0.1	0.0	2.6	0.0	0.7	50.2	1.7	4.9	12.8	3.0	2.7	15.8	1.0	0.1	4.2	0.0	1.8	4.5	0.1	61.4	1.2	0.3	0.0	4.4	13.7	2.0	2.5	1.1	38.8	3.7	0.2	1.8	15.9	0.0	0.0	0.0	7.1	12.4	0.1	2.7	1.9	0.0	1.0	0.5	7.1	20.8	0.0	0.0	19.4	0.9	0.4	0.7	0.3	0.6	0.1	0.2	0.5	2.9	4.9
GNAQ	"G-ALPHA-q, GAQ"	ENSG00000156052	"G protein subunit alpha q"	P50148	9	77716097-78031811	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		Transducer	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 556.6;Excitatory neurons: 405.6;Microglial cells: 394.4;Oligodendrocyte precursor cells: 338.3;Oligodendrocytes: 495.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 27.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 27.0"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"CAB010036, HPA048886"	Uncertain		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA		800000	"Cluster 38: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nuclear speckles"	"Plasma membrane, Cytosol"	"CAB010036: AB_631536, HPA048886: AB_2680544"	"unprognostic (2.10e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.83e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.11e-7)"	"unprognostic (1.90e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.01e-1)"	23.5	21.3	37.2	18.8	42.2	43.8	20.1	35.8	51.3	21.1	19.3	30.3	14.5	23.7	18.7	23.2	16.9	20.1	8.6	51.0	38.5	20.9	22.0	31.1	9.9	40.5	42.7	22.4	14.6	16.3	12.5	21.7	39.9	21.2	27.2	10.4	16.8	25.7	10.5	8.9	16.8	27.4	42.4	11.3	27.9	11.5	45.5	19.7	23.1	11.8	9.1	23.5	13.8	48.5	30.6	34.1	29.8	32.0	34.9	35.5	42.8	40.7	29.7	16.6	20.6	10.5	24.1	0.1	32.0	35.5	24.5	48.5	22.5	23.4	20.6	1.1	12.5	83.0	29.0	21.4	31.4	51.8	30.0	24.3	28.0	33.9	32.5	34.3	42.7	70.3	14.8	0.2	29.5	38.5	58.8	31.0	24.0	46.5	4.7	22.0	36.5	0.3	37.8	64.5	33.1	49.6	29.3	23.3	30.5	27.5	22.2	18.3	55.0	29.2	1.9	41.9	24.0	0.2	0.1	0.3	20.3	28.9	32.0	27.0	2.5	5.7	0.8	2.2	1.7	0.9	2.0	1.1	2.8	0.9	2.1	1.7	8.9	3.6	4.5	3.2	2.2	1.5	37.2	42.2	35.8	51.3	51.0	38.5	40.5	42.7	39.9	42.4	45.5	48.5	117.7	176.3	97.5	556.6	4.8	47.3	38.4	42.7	39.3	34.0	75.6	54.5	6.0	58.6	48.3	77.3	16.7	47.4	33.4	137.0	7.9	36.2	18.9	57.5	64.2	107.3	92.3	58.0	405.6	39.7	53.2	51.7	70.8	76.0	50.7	40.2	98.6	64.0	53.7	82.4	242.0	92.5	30.5	139.5	173.9	11.1	39.4	128.8	48.0	394.4	114.6	40.5	8.2	338.3	495.2	54.2	60.7	52.3	6.2	70.5	52.9	45.4	67.0	5.0	26.3	62.3	40.8	5.6	13.2	46.3	21.6	29.0	25.0	45.2	75.4	70.1
GPC5		ENSG00000179399	"Glypican 5"	P78333	13	91398621-92873682	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 23.1;kidney: 7.3;testis: 6.1"	"Cell type enriched"	"Detected in some"	20	"Astrocytes: 3868.1"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"CACO-2: 49.9;HeLa: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040152, HPA044081"	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Cytosol	"HPA040152: AB_2676863, HPA044081: AB_2678801"	"unprognostic (4.99e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.93e-5)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (4.46e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.49e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.21e-5)"	"unprognostic (2.19e-2)"	"unprognostic (1.82e-6)"	"unprognostic (3.03e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.69e-3)"	0.1	1.6	10.3	0.3	18.1	0.1	0.0	6.7	9.6	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.1	0.5	1.1	8.4	12.1	7.3	1.3	3.2	0.2	18.2	13.4	0.4	0.1	0.0	1.7	0.4	20.5	0.1	0.5	0.5	0.1	0.4	0.0	0.1	0.1	0.1	5.7	0.0	0.1	6.1	23.1	0.1	1.1	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.9	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.0	27.4	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.3	0.6	0.0	1.7	0.0	0.8	0.0	0.2	0.0	0.0	1.0	0.1	0.1	0.1	0.0	0.0	3.4	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.0	0.0	10.3	18.1	6.7	9.6	8.4	12.1	18.2	13.4	20.5	5.7	23.1	4.9	0.0	0.0	2.7	3868.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.3	0.0	0.0	0.1	0.0	0.1	64.6	0.0	1.6	0.0	0.0	0.1	0.0	0.0	116.6	0.0	0.0	0.4	0.0	0.1	0.0	7.9	0.0	0.0	0.1	0.0	190.6	0.1	0.0	0.0	0.4	1.0	0.3	0.1	0.0	118.0	0.6	0.0	0.0	127.2	20.9	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.7	0.8	0.3	0.1	0.0	0.0	0.1	0.1	0.5	0.0	0.1
GPM6A	GPM6	ENSG00000150625	"Glycoprotein M6A"	P51674	4	175632934-176002664	"Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"brain: 577.8;choroid plexus: 249.3;retina: 147.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 3712.4;Excitatory neurons: 833.0;Inhibitory neurons: 581.3;Muller glia cells: 459.6;Oligodendrocyte precursor cells: 1341.6"	"Cancer enriched"	"Detected in many"	107	"glioma: 110.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"memory B-cell: 34.8;naive B-cell: 16.6"	"Lineage enriched"	"Detected in many"	12	"B-cells: 34.8"	"Group enriched"	"Detected in some"	10	"AF22: 49.9;Daudi: 43.0;HAP1: 17.4;U-251 MG: 50.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017338	Supported					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA017338: AB_1849933"	"unprognostic (1.36e-4)"	"unprognostic (3.35e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.34e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.82e-5)"	"unprognostic (2.24e-1)"	"unprognostic (9.13e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.69e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.60e-3)"	3.8	4.2	366.9	1.4	455.6	0.5	2.5	422.6	577.8	6.8	249.3	25.4	1.9	7.7	2.9	1.9	7.5	4.4	2.8	469.8	268.7	7.1	13.4	20.1	2.6	225.0	265.4	12.3	1.8	0.7	7.7	0.3	222.4	5.7	6.0	147.3	0.9	6.9	0.6	0.8	3.4	11.1	257.9	15.8	1.1	1.5	281.9	0.3	11.9	0.6	1.3	2.6	2.9	336.4	0.3	0.7	49.9	0.5	0.0	0.0	0.2	0.1	0.5	0.2	0.4	1.1	0.7	43.0	0.2	0.2	1.8	0.9	17.4	1.5	0.1	0.2	4.0	0.5	3.7	1.4	0.1	0.4	0.7	0.1	0.0	0.1	0.2	2.0	0.0	0.1	0.4	1.7	0.0	1.2	1.6	0.6	1.2	0.0	0.6	0.2	0.2	0.3	0.1	2.1	0.5	0.4	0.2	0.9	0.2	0.3	0.6	0.1	0.2	0.9	0.6	0.6	50.8	1.6	0.1	2.6	1.8	0.4	1.1	0.8	0.1	0.1	0.1	0.1	0.1	34.8	0.1	0.0	0.2	16.6	0.1	0.1	0.4	0.1	0.2	2.9	0.1	0.8	366.9	455.6	422.6	577.8	469.8	268.7	225.0	265.4	222.4	257.9	281.9	336.4	0.6	96.1	8.7	3712.4	9.6	1.8	5.3	0.0	0.0	220.3	0.2	0.1	0.7	1.5	0.6	0.0	14.6	0.0	0.0	0.1	1.9	0.0	11.7	0.4	0.1	29.0	0.0	5.3	833.0	0.2	0.2	2.4	0.0	0.2	0.0	0.2	116.0	2.1	0.3	124.5	581.3	0.0	0.0	4.4	0.4	3.6	3.4	1.6	0.0	208.0	0.0	459.6	0.0	1341.6	37.3	0.0	0.0	1.5	0.1	9.0	0.0	3.4	0.0	30.5	0.0	15.3	3.3	0.5	0.4	0.2	0.9	0.1	1.2	3.0	0.0	6.5
GRAMD1C	DKFZp434C0328	ENSG00000178075	"GRAM domain containing 1C"	Q8IYS0	3	113828182-113947174	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 181.8;Early spermatids: 97.1;Late spermatids: 80.5;Oligodendrocyte precursor cells: 82.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"memory B-cell: 2.7;naive B-cell: 2.9;neutrophil: 2.1"	"Group enriched"	"Detected in many"	13	"B-cells: 2.9;granulocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 13.5;HUVEC TERT2: 10.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA012316	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane, Cytosol"		"HPA012316: AB_1849949"	"unprognostic (2.73e-3)"	"unprognostic (6.16e-3)"	"unprognostic (3.27e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.50e-2)"	"unprognostic (9.81e-3)"	"unprognostic (1.43e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.49e-2)"	"prognostic favorable (4.22e-15)"	"unprognostic (8.48e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.09e-2)"	1.4	1.9	13.0	1.7	12.0	0.1	8.8	11.9	15.3	3.1	9.0	5.0	7.6	2.2	2.0	5.5	10.7	2.6	0.7	11.6	12.1	24.0	27.7	4.9	2.0	13.9	15.4	0.8	12.7	10.6	8.1	6.1	11.8	2.6	3.9	14.3	12.0	2.1	0.8	12.1	16.7	0.7	12.3	1.3	9.0	16.8	14.5	1.1	3.9	3.2	3.9	2.0	3.7	10.0	1.6	0.0	4.0	3.0	0.7	1.8	5.2	3.5	3.1	0.7	2.1	0.0	13.5	0.4	1.0	2.0	1.4	1.3	0.7	1.5	1.8	1.9	0.6	0.3	0.1	0.0	1.4	0.2	0.0	3.0	1.0	0.6	0.1	7.1	10.2	4.5	0.0	0.1	1.1	0.4	1.6	0.2	0.3	1.4	0.5	0.0	0.8	2.4	4.2	1.9	0.8	1.1	1.0	5.2	3.4	1.6	3.6	0.0	2.2	1.5	2.8	0.0	0.3	2.2	1.3	1.9	2.2	0.1	1.8	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.1	0.2	0.0	2.9	0.1	0.1	2.1	0.1	0.0	0.0	0.0	0.0	13.0	12.0	11.9	15.3	11.6	12.1	13.9	15.4	11.8	12.3	14.5	10.0	4.5	12.8	10.5	181.8	15.6	1.0	6.9	3.0	5.2	0.2	9.9	7.0	0.9	15.7	7.1	14.7	37.5	17.5	0.3	10.1	31.3	4.4	97.1	33.3	8.5	4.7	4.9	2.7	29.7	2.7	3.7	1.5	6.6	51.9	0.0	1.4	5.7	17.0	1.5	11.8	4.3	5.5	4.1	0.3	0.8	80.5	2.8	0.9	1.8	9.4	0.1	13.4	0.0	82.4	1.7	2.3	9.3	1.5	6.3	2.8	34.3	14.0	27.9	19.7	0.0	1.2	1.7	28.2	6.7	6.8	4.7	42.4	1.9	5.0	5.3	7.0
GRIFIN		ENSG00000275572	"Galectin-related inter-fiber protein"	A4D1Z8	7	2474844-2476894	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"brain: 1.5"	"Cell type enhanced"	"Detected in single"		"Astrocytes: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"									NA	NA				"Cluster 27: Brain & Skin - Unknown function"		"Cluster 64: Astrocytes - Nervous system maintenance"								"unprognostic (1.18e-2)"			"unprognostic (2.98e-2)"		"unprognostic (1.36e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.68e-2)"	"unprognostic (4.31e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.73e-1)"			0.3	0.1	0.4	0.0	0.3	0.2	0.0	1.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.1	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	1.0	0.3	0.7	0.5	0.9	0.9	0.6	0.4	1.5	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GRIN2C	"GluN2C, NMDAR2C"	ENSG00000161509	"Glutamate ionotropic receptor NMDA type subunit 2C"	Q14957	17	74842023-74861504	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 58.7;heart muscle: 18.6;thyroid gland: 16.6"	"Cell type enriched"	"Detected in some"	6	"Astrocytes: 138.7"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.3;RPMI-8226: 2.3;SCLC-21H: 2.8"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	14	"cerebellum: 43.2"							NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (7.21e-3)"	"unprognostic (4.68e-2)"	"unprognostic (9.38e-3)"	"unprognostic (2.24e-5)"	"unprognostic (3.42e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.14e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.14e-1)"	0.7	2.4	27.3	0.2	29.5	0.6	0.2	58.7	27.6	0.4	8.9	0.6	0.2	0.2	0.1	0.2	0.2	0.2	18.6	23.2	18.0	0.3	0.1	0.1	0.1	33.8	19.7	0.3	0.2	0.1	0.6	1.8	36.7	0.2	0.1	3.3	10.5	0.2	0.4	0.2	0.4	0.2	14.5	0.2	0.3	3.8	24.9	0.0	16.6	0.2	0.0	0.3	0.3	22.0	0.0	0.2	0.2	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.8	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.2	0.1	0.2	0.2	0.0	0.4	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.1	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.2	0.5	2.3	0.0	0.1	2.8	0.2	1.2	0.1	0.4	0.4	0.4	0.0	0.1	0.2	1.1	0.2	0.1	0.6	0.0	0.1	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	27.3	29.5	58.7	27.6	23.2	18.0	33.8	19.7	36.7	14.5	24.9	22.0	0.5	0.0	0.0	138.7	0.0	0.1	0.1	0.0	0.0	6.9	0.2	0.0	16.6	1.5	0.2	1.8	0.0	0.2	0.7	0.0	0.0	0.1	1.1	0.7	0.4	0.4	0.0	0.0	0.4	0.2	0.2	0.9	0.0	3.4	0.0	21.5	0.7	0.1	12.5	1.7	1.3	0.4	0.0	0.6	0.3	6.5	0.0	0.5	1.8	11.2	0.1	20.7	2.1	4.5	0.5	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	2.4	0.0	0.9	2.8	5.8	3.4	0.0	0.0	0.7	0.6	8.5	0.1	0.1
HEPACAM	"FLJ25530, GLIALCAM"	ENSG00000165478	"Hepatic and glial cell adhesion molecule"	Q14CZ8	11	124919205-124936412	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Cell cycle, Growth arrest, Growth regulation"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 222.6;choroid plexus: 79.7"	"Group enriched"	"Detected in some"	9	"Astrocytes: 184.8;Oligodendrocyte precursor cells: 72.9;Oligodendrocytes: 163.2"	"Cancer enriched"	"Detected in some"	12	"glioma: 29.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	30	"Hep G2: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017613, CAB025486"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Vesicles		"CAB025486: , HPA017613: AB_1850595"	"unprognostic (3.22e-3)"	"unprognostic (1.06e-2)"		"unprognostic (1.64e-1)"	"unprognostic (6.41e-2)"		"unprognostic (1.47e-1)"		"unprognostic (9.16e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.06e-6)"	"unprognostic (2.62e-1)"	"unprognostic (3.21e-1)"			15.6	0.3	172.8	0.2	203.3	0.0	2.5	170.4	162.1	0.2	79.7	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.2	163.2	156.1	0.1	16.2	0.0	0.2	222.6	182.8	0.0	0.0	0.0	0.8	0.0	183.6	0.2	0.2	1.8	0.2	0.5	0.1	0.0	0.2	0.1	205.7	0.0	0.1	0.2	182.0	0.0	0.0	0.3	0.6	0.0	0.1	212.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	25.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.2	0.2	0.1	0.1	0.2	172.8	203.3	170.4	162.1	163.2	156.1	222.6	182.8	183.6	205.7	182.0	212.2	0.1	0.0	0.0	184.8	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	11.2	0.0	0.0	2.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.6	0.0	15.5	0.0	72.9	163.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
HEPN1		ENSG00000221932	"Hepatocellular carcinoma, down-regulated 1"	Q6WQI6	11	124919244-124920677	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"adipose tissue: 11.4;brain: 37.3;liver: 20.9"	"Group enriched"	"Detected in some"	23	"Astrocytes: 94.3;Muller glia cells: 29.1;Oligodendrocyte precursor cells: 49.3;Oligodendrocytes: 114.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	287	"Hep G2: 55.5"									"HPA043768, HPA063054"	Uncertain		Approved	"Golgi apparatus"		Yes	NA				"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Golgi apparatus"		"HPA043768: AB_2678662, HPA063054: AB_2684932"																		11.4	0.2	6.1	0.1	23.1	0.0	8.3	0.3	9.4	0.4	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.0	0.6	5.0	6.1	0.2	20.9	0.1	0.1	37.3	10.3	0.1	0.2	0.0	2.4	0.0	13.5	0.8	0.0	2.2	0.4	0.0	0.2	0.3	0.7	0.0	5.1	0.1	0.5	0.5	19.0	0.0	0.2	0.0	0.0	0.2	0.5	17.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	23.1	0.3	9.4	5.0	6.1	37.3	10.3	13.5	5.1	19.0	17.9	0.2	0.0	0.0	94.3	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	3.1	0.0	0.0	1.1	0.0	0.0	0.0	0.6	0.5	0.6	0.0	0.0	1.9	0.0	29.1	0.0	49.3	114.6	0.0	0.0	1.2	0.0	0.1	0.0	2.2	0.0	1.9	0.0	0.1	0.1	1.8	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0
HHIPL1	KIAA1822	ENSG00000182218	"HHIP like 1"	Q96JK4	14	99645129-99680569	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 33.3;Bipolar cells: 10.5;Excitatory neurons: 8.3;Inhibitory neurons: 12.2;Muller glia cells: 13.1;Oligodendrocyte precursor cells: 13.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.1;fHDF/TERT166: 5.6;SiHa: 3.7;THP-1: 3.9"	"Low region specificity"	"Detected in many"												"Secreted in other tissues"	NA	NA		120000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (6.16e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.75e-2)"	"unprognostic (4.70e-3)"	"unprognostic (6.68e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.35e-3)"	"unprognostic (8.49e-6)"	"unprognostic (2.52e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.70e-2)"	"unprognostic (7.12e-6)"	1.6	0.3	7.0	1.1	8.7	0.1	0.8	4.1	8.4	1.5	3.0	2.0	0.5	2.5	0.4	0.8	1.3	1.2	1.6	7.2	4.6	0.7	0.6	0.7	1.0	4.9	4.7	1.0	0.2	0.3	0.9	0.6	4.5	1.7	0.3	2.1	0.8	0.9	0.3	0.5	0.9	1.8	4.0	0.9	0.8	0.4	6.3	0.1	0.5	0.4	0.6	1.3	1.1	4.2	0.0	0.2	0.4	0.1	0.1	0.0	1.7	1.6	0.4	0.3	0.1	0.1	0.5	0.1	3.1	5.6	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	1.7	0.0	0.0	0.9	0.1	1.2	0.2	0.1	1.4	0.1	0.0	0.1	0.9	0.2	0.0	0.2	1.2	0.0	0.0	0.5	0.0	0.2	0.0	0.1	0.1	0.6	3.7	0.0	0.0	0.6	0.0	3.9	1.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.0	8.7	4.1	8.4	7.2	4.6	4.9	4.7	4.5	4.0	6.3	4.2	1.6	0.0	0.0	33.3	0.1	0.0	0.0	0.0	0.0	10.5	0.3	0.8	3.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	2.0	1.7	0.0	0.0	8.3	0.0	0.1	2.6	0.0	0.0	0.0	0.9	0.7	0.3	1.9	0.0	12.2	0.0	0.0	2.1	0.7	0.2	0.3	0.3	3.6	6.5	0.0	13.1	0.0	13.0	6.2	0.0	1.4	1.9	0.0	0.1	0.1	0.0	0.0	1.7	0.0	0.9	0.9	0.3	0.4	0.0	0.0	0.1	0.0	0.7	0.0	0.1
HPSE2	"HPA2, HPR2, UFS"	ENSG00000172987	"Heparanase 2 (inactive)"	Q8WWQ2	10	98457077-99235862	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.6;cervix: 36.7;vagina: 27.6"	"Cell type enriched"	"Detected in some"	9	"Astrocytes: 900.7"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 4.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"BJ hTERT+: 10.2;HEL: 20.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA044603	Uncertain				"Secreted to extracellular matrix"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 36: HEL - Hemostasis"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA044603: AB_10794051"	"unprognostic (2.44e-1)"	"unprognostic (4.28e-3)"	"unprognostic (4.83e-3)"	"unprognostic (6.00e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.82e-2)"	"unprognostic (4.03e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.86e-4)"	"unprognostic (5.79e-2)"	"unprognostic (2.51e-1)"	"unprognostic (9.39e-3)"	"unprognostic (6.13e-3)"	2.0	0.0	9.9	2.0	20.9	0.0	5.2	15.4	7.6	36.7	3.6	2.9	2.7	4.5	0.0	14.3	1.8	1.4	0.1	5.8	21.1	3.5	0.0	2.2	0.0	23.2	29.6	0.2	0.0	0.0	0.3	1.5	21.5	11.1	3.0	0.0	2.4	4.2	0.3	3.2	5.2	1.7	16.5	0.0	4.6	2.7	28.5	0.1	0.1	3.0	0.4	18.3	27.6	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	10.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	20.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.9	20.9	15.4	7.6	5.8	21.1	23.2	29.6	21.5	16.5	28.5	11.9	0.3	0.0	0.0	900.7	0.0	0.0	4.8	0.0	0.0	0.0	0.2	0.8	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.3	0.4	24.8	0.3	0.0	0.0	6.4	0.0	0.0	4.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	97.3	0.2	0.0	0.0	0.0	48.6	0.3	0.0	0.0	40.3	0.0	0.0	0.0	16.6	4.6	0.0	0.0	0.4	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.9	1.9	11.5	2.1	0.0	0.1	0.0	0.2	0.8	0.0	0.7
ITPKB	"IP3-3KB, IP3KB"	ENSG00000143772	"Inositol-trisphosphate 3-kinase B"	P27987	1	226631690-226739323	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 211.8;choroid plexus: 123.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 70.5;Astrocytes: 225.3;Microglial cells: 58.1;Oligodendrocytes: 110.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 44.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 47.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030273, HPA072923"	Enhanced		Approved	Nucleoplasm		NA	NA		39000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA030273: AB_10601127, HPA072923: AB_2686558"	"unprognostic (4.54e-2)"	"unprognostic (3.85e-2)"	"unprognostic (8.41e-3)"	"unprognostic (9.37e-3)"	"unprognostic (1.53e-1)"	"prognostic favorable (1.72e-5)"	"unprognostic (1.24e-1)"	"prognostic favorable (6.65e-4)"	"unprognostic (2.29e-1)"	"unprognostic (9.57e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.90e-2)"	"unprognostic (7.46e-2)"	"unprognostic (6.54e-3)"	"unprognostic (7.87e-2)"	29.6	4.5	148.6	15.6	205.6	19.0	19.6	152.0	104.8	28.0	123.3	45.3	6.6	48.8	17.0	14.0	27.0	10.0	16.2	109.0	149.5	15.1	3.2	22.5	29.0	211.8	188.0	9.5	5.8	7.1	6.8	15.9	169.1	14.5	6.7	0.6	30.2	22.7	12.4	19.4	24.9	31.7	154.6	23.5	21.2	3.7	207.6	33.2	8.3	12.3	20.3	38.6	15.6	133.7	4.7	5.0	7.9	9.1	6.1	3.9	2.1	1.2	5.5	2.5	5.7	0.7	5.8	21.6	7.4	1.2	0.5	6.8	10.1	4.1	1.2	3.0	6.9	9.6	5.5	0.0	2.3	8.8	16.4	4.4	5.9	2.8	2.5	6.9	17.2	10.8	0.1	2.9	0.3	4.5	16.7	12.1	17.3	3.5	8.0	6.4	14.2	4.8	18.2	7.5	4.6	6.0	3.8	2.8	47.2	7.7	11.7	10.1	12.0	3.2	2.4	2.9	7.6	0.2	8.0	25.8	0.8	8.0	12.1	0.9	0.9	5.4	2.6	1.3	2.3	1.2	3.2	2.7	0.6	1.8	4.7	3.5	3.4	2.1	2.5	0.5	1.9	2.0	148.6	205.6	152.0	104.8	109.0	149.5	211.8	188.0	169.1	154.6	207.6	133.7	70.5	0.0	7.4	225.3	16.0	12.2	4.8	3.1	7.4	0.3	7.0	5.3	8.5	1.5	4.5	7.3	0.0	0.6	28.9	1.2	3.9	2.2	2.8	4.7	6.8	42.2	4.2	5.2	2.4	2.4	2.3	8.9	3.6	4.5	10.1	21.8	27.8	1.0	19.8	0.0	6.9	2.8	2.0	16.0	38.0	22.9	7.2	14.4	19.6	58.1	10.2	1.2	28.8	10.6	110.6	2.7	3.7	9.4	11.8	5.1	2.0	0.6	2.6	0.1	0.0	5.9	16.3	0.9	4.7	5.3	10.1	0.4	35.2	3.7	3.1	2.7
KCNN3	"hSK3, KCa2.3, SKCA3"	ENSG00000143603	"Potassium calcium-activated channel subfamily N member 3"	Q9UGI6	1	154697455-154870281	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 33.1"	"Group enriched"	"Detected in many"	4	"Astrocytes: 168.8;Skeletal myocytes: 121.5"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.7;memory B-cell: 2.6"	"Group enriched"	"Detected in many"	11	"B-cells: 2.6;granulocytes: 4.7;monocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 39.3;HMC-1: 26.1;Karpas-707: 65.5;RPMI-8226: 18.7;U-266/70: 62.3;U-698: 21.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA057127	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA057127: AB_2683345"	"unprognostic (2.09e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.22e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.43e-2)"	"unprognostic (9.51e-2)"	"unprognostic (4.07e-3)"	"unprognostic (4.89e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (1.71e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.80e-2)"	0.9	1.1	24.9	3.9	24.2	0.3	0.7	15.1	12.8	2.7	0.0	7.4	3.0	4.9	0.6	1.7	5.7	1.5	2.1	16.9	18.5	2.1	0.2	1.5	3.5	14.4	33.1	0.8	0.3	1.1	1.2	0.0	16.5	1.6	2.4	0.3	1.3	1.2	6.1	0.3	2.2	6.0	12.9	3.5	2.4	0.5	25.7	1.0	1.9	5.3	5.5	3.1	1.6	11.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	39.3	3.1	0.0	0.1	0.1	0.9	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	26.1	0.5	0.0	0.3	0.0	0.1	0.8	0.1	0.0	65.5	0.6	0.1	0.2	0.0	0.8	0.0	2.5	0.0	16.2	18.7	0.0	0.0	0.8	0.4	0.0	0.1	0.0	0.2	0.0	0.0	1.2	1.1	0.0	0.0	0.0	62.3	8.8	21.4	0.6	0.0	6.2	4.7	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	24.9	24.2	15.1	12.8	16.9	18.5	14.4	33.1	16.5	12.9	25.7	11.0	8.7	12.8	2.7	168.8	3.9	1.3	0.6	0.7	0.6	0.5	0.1	0.0	3.4	0.0	2.1	0.0	2.1	0.1	0.0	0.0	3.9	0.2	3.4	26.6	0.6	25.9	4.2	0.0	18.2	0.2	0.0	16.3	0.0	5.8	0.0	2.0	13.9	0.3	0.4	0.0	13.6	0.0	4.1	0.0	3.0	7.7	0.3	0.9	0.0	11.2	0.0	2.2	0.0	12.1	5.0	0.0	2.2	0.0	30.9	0.5	0.0	0.3	18.3	0.4	0.0	121.5	1.3	0.7	0.2	0.8	1.7	0.0	0.5	22.5	0.0	0.7
KIAA1755	RP5-1054A22.3	ENSG00000149633	KIAA1755	Q5JYT7	20	38210503-38260772	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 105.0"	"Group enriched"	"Detected in some"	4	"Astrocytes: 63.3;Microglial cells: 67.5;Oligodendrocytes: 135.6"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 75.6;ASC diff: 11.3;ASC TERT1: 16.9;WM-115: 19.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051064	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoli	"Golgi apparatus, Vesicles"	"HPA051064: AB_2681331"	"unprognostic (3.98e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.01e-3)"	"unprognostic (1.77e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.42e-8)"	"unprognostic (1.41e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.53e-3)"	5.6	2.1	18.4	6.0	87.7	0.5	3.4	39.2	42.2	13.1	0.0	9.0	2.4	14.6	6.4	5.1	8.7	16.2	11.4	29.0	64.1	4.1	1.2	2.5	5.0	59.2	62.3	13.6	0.9	0.1	2.2	0.1	54.7	6.6	4.2	0.5	5.8	7.3	0.6	1.4	4.2	14.7	18.3	2.7	3.6	2.6	75.3	8.3	2.0	1.7	4.7	5.2	4.8	105.0	3.0	0.3	75.6	0.1	11.3	16.9	0.0	7.6	4.3	0.0	0.0	0.3	2.2	0.0	0.3	2.4	2.5	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.3	0.0	2.2	1.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	2.0	0.1	0.0	0.0	0.4	0.0	1.1	0.4	1.4	0.0	0.0	0.0	0.2	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	87.7	39.2	42.2	29.0	64.1	59.2	62.3	54.7	18.3	75.3	105.0	0.1	0.0	0.0	63.3	0.0	0.3	0.0	0.0	0.0	0.0	0.8	1.8	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.5	0.1	2.5	0.2	0.0	0.0	0.8	0.0	0.0	4.4	0.0	0.6	0.0	0.0	0.4	1.1	0.1	0.0	0.5	0.0	0.0	0.0	0.5	1.9	3.7	0.2	1.8	67.5	0.0	0.0	0.0	19.6	135.6	0.6	0.0	7.5	0.0	0.0	0.0	4.1	0.0	0.0	0.0	1.1	1.2	0.3	0.3	0.2	0.3	0.0	0.0	0.4	0.0	0.0
KIF24	"bA571F15.4, C9orf48, FLJ10933, FLJ43884"	ENSG00000186638	"Kinesin family member 24"	Q5T7B8	9	34252381-34311371	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 11.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 32.3;Early spermatids: 28.9;Late spermatids: 41.6;Spermatocytes: 14.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	19	"basophil: 2.8"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 2.8"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA020643	Uncertain					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA020643: AB_2131749"	"unprognostic (2.68e-1)"	"prognostic favorable (1.33e-4)"	"unprognostic (9.44e-2)"	"unprognostic (3.82e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.40e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.40e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.50e-1)"	0.2	0.6	0.7	0.9	1.0	2.1	0.7	0.6	0.7	0.6	4.4	0.9	0.6	0.6	1.4	0.9	3.2	0.4	0.5	0.8	0.8	0.9	0.3	0.6	1.3	1.9	2.3	0.4	0.5	1.5	1.0	0.6	1.3	0.4	1.0	0.4	0.3	0.5	0.7	0.9	0.6	0.7	1.5	0.3	0.6	11.1	0.8	3.9	1.2	0.6	1.6	0.3	0.4	0.8	9.8	6.4	7.5	6.2	0.6	1.0	2.8	5.3	3.4	7.0	8.4	3.1	3.0	7.6	1.6	2.5	4.5	4.5	7.6	4.6	7.2	4.9	3.3	3.5	10.7	1.9	0.2	7.2	5.3	0.4	0.9	9.1	3.8	1.3	3.2	5.3	3.6	6.0	3.9	4.0	8.7	6.7	3.0	4.5	3.8	8.0	4.6	2.1	2.9	2.5	3.5	3.4	6.5	3.3	0.9	2.9	3.6	3.5	2.6	6.5	7.1	5.1	6.5	1.7	2.9	4.1	4.4	3.5	8.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	1.0	0.6	0.7	0.8	0.8	1.9	2.3	1.3	1.5	0.8	0.8	0.3	0.0	1.1	32.3	0.7	0.4	0.2	0.7	0.6	0.3	0.7	1.1	0.9	1.5	1.6	1.8	0.0	0.6	0.3	0.7	0.0	0.4	28.9	8.2	0.8	0.4	0.0	3.0	7.2	0.2	1.0	0.7	2.0	0.8	0.0	1.5	0.0	0.0	0.7	0.0	3.5	0.8	2.0	0.3	0.3	41.6	0.9	0.4	0.0	3.7	0.1	0.2	0.0	10.1	9.2	0.2	0.0	1.9	2.1	0.1	0.3	0.4	11.0	0.4	0.0	0.5	0.4	14.5	6.9	1.0	0.9	0.3	0.3	0.8	0.7	0.1
KNDC1	"bB439H18.3, C10orf23, FLJ25027, KIAA1768, RASGEF2, v-KIND, Very-KIND"	ENSG00000171798	"Kinase non-catalytic C-lobe domain containing 1"	Q76NI1	10	133160219-133226412	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.0;pituitary gland: 27.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 93.4;Excitatory neurons: 41.9;Inhibitory neurons: 36.3;Respiratory ciliated cells: 25.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.6;EFO-21: 1.2;MCF7: 1.1;NTERA-2: 1.4;RPMI-8226: 2.1;SuSa: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039624, HPA056143"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane, Cytosol"	Vesicles	"HPA039624: AB_10671045, HPA056143: "	"unprognostic (2.32e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.35e-4)"	"unprognostic (1.59e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.76e-1)"	"unprognostic (5.61e-2)"	"unprognostic (2.75e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.80e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.41e-2)"	1.5	13.7	31.1	0.1	17.9	0.0	0.2	8.4	44.0	2.3	0.0	0.3	0.0	2.8	0.7	0.2	9.0	0.2	0.3	19.8	9.1	0.8	6.5	2.8	0.0	17.3	13.3	8.5	0.5	0.4	27.5	0.4	10.3	1.1	0.0	0.9	0.6	0.9	0.0	0.2	0.2	0.4	3.0	0.5	0.3	1.8	22.7	0.0	2.5	0.0	0.0	0.2	0.9	13.1	0.2	0.3	0.2	1.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.6	0.2	0.0	1.2	0.1	0.5	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	1.4	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	31.1	17.9	8.4	44.0	19.8	9.1	17.3	13.3	10.3	3.0	22.7	13.1	0.0	0.0	9.0	93.4	0.2	0.0	0.1	0.4	0.0	1.6	0.2	0.0	2.4	1.5	4.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	14.2	1.5	0.2	3.0	0.0	41.9	0.0	0.1	1.4	0.0	0.3	0.0	1.5	0.4	4.6	0.2	1.7	36.3	0.0	0.0	1.0	0.4	1.0	3.7	1.2	0.0	5.6	0.3	4.5	0.0	6.6	2.1	0.0	0.0	1.2	0.0	0.1	0.0	0.0	25.9	1.0	0.0	0.1	0.5	0.0	1.7	0.0	0.3	0.1	0.4	1.2	0.0	0.0
LCNL1	FLJ45224	ENSG00000214402	"Lipocalin like 1"	Q6ZST4	9	136981904-136986410	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 3.4;testis: 1.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 71.2;dendritic cells: 24.9;Leydig cells: 53.4;Muller glia cells: 30.2;Peritubular cells: 127.5"	"Cancer enhanced"	"Detected in some"		"glioma: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"									NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (1.39e-1)"	"unprognostic (4.60e-3)"	"unprognostic (1.08e-3)"	"unprognostic (5.14e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.03e-5)"	"unprognostic (6.46e-2)"	"unprognostic (6.67e-2)"	"unprognostic (7.79e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.34e-9)"	"unprognostic (4.31e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.93e-1)"	0.0	0.1	0.9	0.0	1.0	0.0	0.0	0.9	3.4	0.5	0.8	0.0	0.0	0.3	0.2	0.0	0.4	0.0	0.7	0.8	1.0	0.4	0.0	0.1	0.1	1.1	0.9	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.8	0.3	0.0	1.6	1.1	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	1.0	0.9	3.4	0.8	1.0	1.1	0.9	1.1	0.8	1.1	1.1	0.0	0.0	0.0	71.2	0.0	0.1	0.0	0.0	0.0	8.3	0.1	0.1	2.0	0.0	0.0	0.0	0.0	0.1	24.9	0.0	0.0	0.0	2.0	0.3	3.9	1.5	0.0	0.0	2.6	0.0	0.7	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	14.2	0.0	0.0	0.0	0.0	6.0	53.4	0.1	0.0	7.5	0.0	30.2	5.2	3.5	11.9	0.0	0.0	127.5	0.3	0.0	0.0	0.0	0.0	2.0	0.0	1.8	0.2	0.4	0.8	0.0	0.0	0.1	0.4	0.0	0.0	0.1
LGI1	"EPITEMPIN, EPT, ETL1, IB1099"	ENSG00000108231	"Leucine rich glioma inactivated 1"	O95970	10	93757840-93806272	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 39.7;choroid plexus: 44.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 242.9;Excitatory neurons: 57.1;Inhibitory neurons: 74.7;Oligodendrocyte precursor cells: 28.6"	"Group enriched"	"Detected in some"	7	"glioma: 1.8;testis cancer: 0.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.4;CACO-2: 2.0;NTERA-2: 6.1;SuSa: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in brain"	NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (1.26e-1)"			"unprognostic (4.68e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.20e-2)"		"unprognostic (1.28e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.07e-3)"	"unprognostic (8.71e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.93e-2)"	"unprognostic (4.65e-1)"	0.5	1.8	26.8	0.1	31.5	0.0	0.2	23.8	39.7	0.1	44.7	4.0	0.5	0.1	0.0	4.3	0.1	1.0	0.5	29.2	22.6	0.0	2.7	0.0	0.0	29.9	24.2	0.0	0.2	0.0	7.6	0.0	32.9	0.7	2.6	0.4	0.1	0.5	5.9	0.3	1.5	0.6	23.7	0.0	1.8	0.4	26.7	0.0	0.2	3.6	0.1	0.9	0.3	25.2	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	3.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.8	31.5	23.8	39.7	29.2	22.6	29.9	24.2	32.9	23.7	26.7	25.2	0.2	0.0	0.0	242.9	0.0	0.3	0.4	0.0	0.0	0.5	0.4	0.1	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.4	0.0	0.0	57.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	6.0	0.0	0.0	74.7	0.0	0.0	0.0	0.4	1.6	1.5	0.0	0.0	10.3	0.0	0.1	0.0	28.6	3.9	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.5	0.6	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.2
LHFPL1		ENSG00000182508	"LHFPL tetraspan subfamily member 1"	Q86WI0	X	112630648-112680054	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 11.2;salivary gland: 2.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 4.6;Inhibitory neurons: 1.1;Ionocytes: 2.0;Microglial cells: 1.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 2.6;SuSa: 3.8"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in single"	4	"olfactory bulb: 3.3"	HPA003029	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA003029: AB_1079248"	"unprognostic (2.23e-2)"	"unprognostic (2.78e-3)"		"unprognostic (2.49e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.31e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.41e-3)"	"unprognostic (5.19e-5)"	"unprognostic (1.33e-1)"	"unprognostic (7.63e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.92e-1)"	0.0	0.1	4.1	0.1	5.3	0.0	0.6	0.5	2.5	0.4	0.0	0.0	0.0	0.1	0.2	0.1	0.4	0.0	0.7	2.2	6.1	0.1	0.0	0.0	0.1	1.2	11.2	0.3	0.0	0.1	1.3	0.1	4.6	0.3	0.1	0.1	2.9	0.8	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	7.3	0.9	0.5	0.7	0.1	0.1	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.8	0.0	0.0	0.6	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	2.6	3.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	4.1	5.3	0.5	2.5	2.2	6.1	1.2	11.2	4.6	0.1	7.3	0.8	0.0	0.0	0.0	4.6	0.0	0.0	0.4	0.4	0.0	0.0	0.4	0.4	0.9	0.0	0.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.1	0.1	0.0	0.1
LINC00634		ENSG00000205704	"Long intergenic non-protein coding RNA 634"		22	41952174-41958933	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	9	"brain: 33.2;choroid plexus: 10.7"	"Group enriched"	"Detected in some"	35	"Astrocytes: 5.2;Excitatory neurons: 4.0;Inhibitory neurons: 3.6;Oligodendrocyte precursor cells: 3.5;Oligodendrocytes: 1.6"	"Cancer enriched"	"Detected in single"	13	"glioma: 5.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 2.9;SCLC-21H: 2.7"									HPA029815			Approved	"Nuclear speckles,Cytosol"		NA	NA					"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nuclear speckles"	Cytosol	"HPA029815: AB_10601803"	"unprognostic (1.42e-1)"	"unprognostic (8.80e-4)"	"unprognostic (3.93e-4)"	"unprognostic (9.78e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.72e-4)"	"unprognostic (6.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.11e-6)"	"unprognostic (5.40e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.17e-1)"	0.0	2.1	27.4	0.0	25.9	0.1	0.0	16.3	33.2	0.0	10.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	30.2	22.6	0.0	0.0	0.0	0.0	19.0	23.6	0.0	0.0	0.0		0.0	17.9	0.1	0.0	2.4	0.0	0.3	0.0	0.0	0.0	0.0	15.6	0.0	0.2	1.0	30.1	0.0	0.0	0.0	0.1	0.0		21.9	0.3	0.0	1.3	1.3	0.0	0.7	0.8	0.0	0.0	0.2	0.3	0.4	1.0	2.4	0.1	0.0	0.9	0.2	0.0	0.0	0.0	0.9	2.1	0.1	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.6	0.6	0.0	0.0	2.5	0.1	1.5	0.0	0.6	1.0	1.4	0.3	0.3	2.0	2.9	0.5	0.1	0.0	0.1	2.7	1.8	0.1	0.1	0.3	0.2	0.3	0.0	0.0	0.2	1.1	0.0	0.3	0.8	1.7	2.4	0.0	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.4	25.9	16.3	33.2	30.2	22.6	19.0	23.6	17.9	15.6	30.1	21.9	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LINGO1	"FLJ14594, LERN1, LRRN6A"	ENSG00000169783	"Leucine rich repeat and Ig domain containing 1"	Q96FE5	15	77613027-77820900	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.1"	"Group enriched"	"Detected in many"	4	"Astrocytes: 271.0;Excitatory neurons: 271.6;Horizontal cells: 132.9;Inhibitory neurons: 220.5;Microglial cells: 167.7;Oligodendrocyte precursor cells: 240.8;Oligodendrocytes: 324.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"amygdala: 37.4;basal ganglia: 43.9;cerebral cortex: 56.1;hippocampal formation: 49.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 23.9;AN3-CA: 20.1;HAP1: 30.2;HEK 293: 21.0;MCF7: 13.5;NTERA-2: 56.9;SuSa: 21.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074653	Enhanced		Supported	"Plasma membrane"		NA	NA		25000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"		"HPA074653: AB_2686706"	"unprognostic (1.06e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (3.23e-7)"	"unprognostic (2.07e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.59e-2)"	3.9	1.1	37.4	1.2	43.9	0.0	3.5	0.0	56.1	4.6	0.0	2.2	1.5	4.5	2.2	0.9	2.7	2.1	11.8	49.1	0.0	4.2	0.8	1.0	0.7	0.0	0.0	2.3	2.5	4.1	1.9	6.7	0.0	1.6	0.8	16.2	3.2	2.0	0.8	2.8	1.7	4.6	0.0	3.3	1.4	5.3	0.2	0.3	2.2	1.4	0.3	2.3	2.9	4.6	0.0	2.1	23.9	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.4	0.0	0.4	0.1	30.2	0.0	0.0	0.0	21.0	0.0	0.0	0.4	0.3	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	13.5	0.0	0.0	56.9	1.3	0.0	0.0	0.0	0.5	0.0	0.0	4.2	1.2	0.1	2.4	4.9	21.6	0.3	0.4	2.1	0.0	5.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.4	43.9	0.0	56.1	49.1	0.0	0.0	0.0	0.0	0.0	0.2	4.6	2.1	0.0	0.0	271.0	0.0	0.3	0.1	0.0	0.0	21.8	0.7	0.3	7.3	1.5	0.0	0.0	2.1	0.1	0.0	1.8	0.0	0.3	8.6	0.8	3.7	2.3	0.0	0.0	271.6	0.2	0.2	1.8	0.0	0.2	0.0	14.9	4.2	0.0	0.3	132.9	220.5	0.3	0.0	0.0	0.0	16.5	0.3	0.1	3.6	167.7	0.0	51.1	0.0	240.8	324.2	0.2	7.7	0.4	0.0	0.0	0.0	0.0	0.0	19.5	26.3	0.0	21.9	0.2	3.1	0.0	0.1	0.3	0.1	0.5	0.2	0.0
LRIG1	"DKFZP586O1624, LIG-1, LIG1"	ENSG00000144749	"Leucine rich repeats and immunoglobulin like domains 1"	Q96JA1	3	66378797-66501263	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 144.4"	"Cell type enriched"	"Detected in many"	5	"Astrocytes: 331.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 79.7;hTEC/SVTERT24-B: 55.2;U-698: 59.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011846	Approved		Approved	Cytosol		NA	NA		78000	"Cluster 35: T-regs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol		"HPA011846: AB_2668545"	"unprognostic (6.41e-2)"	"unprognostic (4.18e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.58e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.32e-1)"	"prognostic favorable (3.01e-5)"	"unprognostic (5.12e-1)"	"unprognostic (7.86e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (1.50e-4)"	31.0	1.8	33.1	17.0	29.2	4.0	27.2	15.1	21.0	29.9	0.0	38.6	16.8	21.9	3.0	13.5	26.7	20.9	37.0	21.4	26.7	3.6	11.2	17.6	7.9	29.4	39.2	17.1	144.4	5.2	6.5	4.7	17.2	24.8	14.7	5.0	19.2	7.2	37.2	11.7	13.4	30.5	14.3	3.9	36.5	12.5	51.0	3.5	16.2	32.9	9.6	5.9	5.2	17.7	1.4	1.3	27.6	0.5	7.6	4.8	2.8	4.9	26.6	4.6	14.0	23.6	0.3	79.7	13.1	2.2	6.1	0.0	5.5	10.0	10.1	0.0	16.8	0.0	4.1	2.0	1.8	0.7	16.7	6.0	5.4	55.2	9.0	18.8	24.3	0.3	0.3	0.0	1.0	3.6	0.0	0.1	22.8	2.3	0.0	14.1	8.7	3.7	5.1	0.0	3.9	1.0	4.6	4.1	0.2	4.6	25.6	6.7	8.2	13.9	6.3	27.9	12.9	6.2	3.2	59.5	24.3	0.0	5.0	0.0	0.0	0.3	0.1	0.0	0.6	0.1	0.4	0.4	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	1.1	0.1	33.1	29.2	15.1	21.0	21.4	26.7	29.4	39.2	17.2	14.3	51.0	17.7	12.5	38.5	50.2	331.1	4.3	11.3	7.8	8.0	14.2	2.1	51.9	35.8	32.0	11.5	25.0	0.0	8.4	0.2	5.8	9.6	1.9	5.6	1.6	29.1	9.7	9.2	26.5	0.0	10.6	17.1	0.1	17.1	19.9	58.8	1.3	14.9	6.4	20.7	2.0	8.4	15.6	26.2	12.2	1.9	7.7	2.1	11.5	2.4	10.6	57.1	1.7	39.8	0.0	37.7	58.3	6.0	10.2	17.3	8.7	15.6	5.7	1.2	33.7	6.8	0.0	65.5	19.9	1.6	20.0	8.9	11.5	0.1	15.2	2.1	22.8	5.0
LRP2BP	DKFZp761O0113	ENSG00000109771	"LRP2 binding protein"	Q9P2M1	4	185363872-185395924	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 28.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 57.5;Cone photoreceptor cells: 33.3;Early spermatids: 62.1;Inhibitory neurons: 34.2;Late spermatids: 42.3;Oligodendrocyte precursor cells: 40.2;Oligodendrocytes: 34.9;Rod photoreceptor cells: 34.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-266/70: 5.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036664, HPA036665"	Approved					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA036664: AB_10672361, HPA036665: AB_10673660"	"unprognostic (2.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.64e-3)"	"unprognostic (3.15e-5)"	"unprognostic (2.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.53e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.84e-2)"	"unprognostic (4.35e-4)"	"unprognostic (2.17e-2)"	"unprognostic (9.76e-3)"	"unprognostic (2.15e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.54e-4)"	1.7	2.1	6.7	0.7	6.9	0.4	1.6	15.0	7.9	2.7	9.8	3.6	0.3	1.8	2.3	1.0	6.9	0.9	3.6	6.5	7.5	4.8	1.6	4.4	0.7	11.4	10.0	8.5	3.2	0.2	17.4	0.6	8.7	3.7	0.4	28.9	1.5	0.5	3.0	1.5	1.9	0.3	9.8	2.7	1.7	10.7	8.1	0.2	3.5	0.7	0.1	2.1	1.7	10.8	0.5	0.4	0.5	1.1	0.3	0.1	1.0	1.5	0.4	0.0	0.3	0.5	0.5	1.8	0.1	0.1	0.5	0.3	0.3	0.2	0.2	1.7	0.9	0.4	1.5	1.6	0.2	0.3	0.5	0.3	0.2	0.7	0.2	1.5	0.4	1.3	0.6	1.4	0.4	0.1	0.6	1.2	0.6	0.0	0.2	0.3	0.3	0.4	0.4	0.3	1.2	0.8	0.3	0.4	1.0	0.7	0.4	0.1	1.4	0.8	0.6	0.2	0.8	5.3	0.5	0.3	1.3	0.3	0.6	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.2	0.2	0.0	0.5	0.3	0.2	0.1	0.1	0.1	0.5	0.2	0.0	6.7	6.9	15.0	7.9	6.5	7.5	11.4	10.0	8.7	9.8	8.1	10.8	3.1	9.6	2.6	57.5	3.5	2.4	4.1	1.3	2.8	28.8	3.0	2.4	5.5	0.0	1.8	0.0	33.3	1.2	3.3	1.7	0.0	1.5	62.1	17.6	3.1	3.2	7.8	0.0	28.0	0.9	2.5	2.1	2.6	4.4	0.0	1.9	1.4	0.3	0.5	26.9	34.2	2.4	4.1	1.2	1.4	42.3	2.8	1.9	5.4	3.7	0.8	10.4	0.0	40.2	34.9	1.0	0.2	3.8	2.5	4.3	2.6	1.6	14.1	34.0	0.0	5.4	2.8	8.4	1.9	0.8	3.1	1.6	3.1	2.1	1.0	2.1
LRRC3B	LRP15	ENSG00000179796	"Leucine rich repeat containing 3B"	Q96PB8	3	26622806-26717537	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 28.0;choroid plexus: 8.7;skeletal muscle: 9.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 256.9;Early spermatids: 115.3;Inhibitory neurons: 50.0;Oligodendrocyte precursor cells: 38.2"	"Group enriched"	"Detected in some"	9	"endometrial cancer: 0.7;glioma: 2.6;ovarian cancer: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.5;SuSa: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA015568	Approved					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA015568: AB_1853282"	"unprognostic (1.22e-2)"			"unprognostic (2.94e-1)"	"unprognostic (1.87e-1)"		"unprognostic (7.42e-2)"	"unprognostic (8.82e-4)"		"unprognostic (2.84e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.91e-4)"	"unprognostic (3.31e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.82e-1)"	0.3	0.1	18.7	0.0	21.2	0.0	0.4	28.0	24.4	0.3	8.7	0.5	0.0	0.7	0.0	0.4	0.4	0.0	0.3	23.1	16.2	0.1	0.1	0.0	0.0	17.9	18.4	1.5	0.0	0.0	1.5	0.0	17.6	0.1	0.5	1.1	0.4	0.1	9.5	0.1	0.2	0.4	20.7	0.1	0.5	7.2	18.9	0.7	0.1	0.2	0.0	4.8	0.2	16.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	21.2	28.0	24.4	23.1	16.2	17.9	18.4	17.6	20.7	18.9	16.1	0.8	0.0	0.0	256.9	0.0	0.1	0.0	0.0	0.0	1.6	1.2	4.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	115.3	0.2	3.2	0.3	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.6	0.0	0.0	0.0	50.0	0.0	0.0	0.0	0.0	11.6	0.6	0.1	0.0	9.4	0.0	0.8	0.0	38.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4.6	0.0	1.6	0.6	0.0	0.1	0.0	0.1	0.1	0.0	0.1
LRRC3C		ENSG00000204913	"Leucine rich repeat containing 3C"	A6NJW4	17	39941474-39944734	"Predicted membrane proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Astrocytes: 11.4;Microglial cells: 3.7;Oligodendrocytes: 9.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071271	Uncertain					NA	NA						"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA071271: AB_2686378"	"unprognostic (1.59e-1)"			"unprognostic (6.57e-2)"	"unprognostic (6.17e-2)"		"unprognostic (2.81e-1)"	"unprognostic (3.16e-4)"		"unprognostic (9.20e-2)"		"unprognostic (4.27e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.90e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	3.7	0.0	0.0	0.0	2.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
LSAMP	"IGLON3, LAMP"	ENSG00000185565	"Limbic system associated membrane protein"	Q13449	3	115802363-117139389	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 73.9;retina: 41.3"	"Group enriched"	"Detected in many"	9	"Astrocytes: 3381.0;Excitatory neurons: 1001.8;Inhibitory neurons: 2137.4;Oligodendrocyte precursor cells: 2480.6;Oligodendrocytes: 933.9"	"Cancer enhanced"	"Detected in many"		"glioma: 13.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 11.0;SH-SY5Y: 22.5;WM-115: 55.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054051, HPA076122"			Enhanced	Cytosol		NA	NA		150000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 58: Brain - Synaptic function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol		"HPA054051: AB_2682358, HPA076122: AB_2686779"	"unprognostic (4.18e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.97e-3)"	"unprognostic (6.03e-2)"	"unprognostic (9.63e-2)"	"unprognostic (4.15e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.70e-2)"	"unprognostic (5.71e-2)"	"unprognostic (6.82e-3)"	"unprognostic (1.26e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.23e-5)"	"unprognostic (1.31e-2)"	3.1	15.7	47.8	5.6	45.4	1.0	1.7	22.6	73.9	21.8	0.0	9.9	2.0	5.0	3.1	3.9	3.1	13.5	2.3	64.2	36.3	2.6	0.8	10.6	4.9	37.5	32.2	5.5	14.4	8.9	3.8	1.0	37.8	26.1	3.8	41.3	1.2	7.3	0.2	5.1	2.6	3.8	28.5	1.9	3.8	4.6	56.4	1.2	5.0	0.2	6.7	6.5	4.8	31.9	0.2	3.2	11.0	0.3	1.1	3.4	1.1	1.0	0.5	0.4	1.1	0.2	0.7	0.8	0.2	6.0	0.3	0.2	0.2	0.1	0.5	0.5	0.1	0.3	1.0	0.3	0.2	0.8	0.5	2.8	0.0	1.3	0.1	0.2	0.1	1.3	0.4	1.2	0.0	0.3	1.3	0.8	4.1	0.1	0.9	0.2	0.2	0.2	2.8	1.1	2.4	22.5	0.0	0.2	3.5	4.5	0.3	0.8	0.0	2.0	1.5	2.7	0.6	1.3	1.2	0.3	0.4	0.3	55.9	0.9	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.3	0.2	0.1	0.4	0.0	0.1	0.1	0.1	0.0	47.8	45.4	22.6	73.9	64.2	36.3	37.5	32.2	37.8	28.5	56.4	31.9	0.5	0.0	1.1	3381.0	0.6	7.6	0.3	0.0	0.0	54.2	1.2	0.4	25.5	4.3	0.6	0.0	2.1	0.2	0.0	0.0	0.0	0.0	22.5	0.9	26.5	5.8	0.0	0.0	1001.8	3.6	0.0	25.0	2.6	1.1	0.0	20.1	4.2	0.0	0.3	220.4	2137.4	0.0	0.0	0.0	3.2	22.2	126.2	1.9	56.9	111.5	0.0	126.9	0.0	2480.6	933.9	0.4	0.0	91.7	1.0	18.3	0.0	0.2	0.0	11.3	0.0	0.1	4.0	0.9	0.5	0.6	5.1	0.0	0.4	4.9	0.0	0.6
MEGF10	"KIAA1780, SR-F3"	ENSG00000145794	"Multiple EGF like domains 10"	Q96KG7	5	127290796-127465737	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Myogenesis, Phagocytosis"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 52.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 218.4;Oligodendrocyte precursor cells: 97.5;Oligodendrocytes: 381.7;Skeletal myocytes: 62.9"	"Cancer enhanced"	"Detected in some"		"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 31.6;RH-30: 38.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		73000000		"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (7.02e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.26e-3)"	"unprognostic (8.91e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.76e-4)"	"unprognostic (5.28e-3)"	"unprognostic (2.59e-1)"	"unprognostic (9.36e-4)"	"unprognostic (1.17e-1)"	0.2	1.7	18.0	0.1	34.9	0.0	0.7	29.4	19.9	0.3	0.0	0.8	0.1	0.7	0.4	0.1	0.1	0.0	0.4	15.6	18.2	0.0	0.4	0.0	0.0	26.6	26.8	0.1	0.0	0.0	1.7	0.1	29.4	0.7	0.2	8.0	1.9	1.1	3.0	0.3	0.2	0.3	21.2	0.1	0.1	0.4	23.8	0.6	0.1	4.8	0.2	0.0	0.1	52.6	0.0	0.0	31.6	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	6.8	0.0	0.2	0.2	0.0	0.0	0.0	2.5	0.0	0.0	0.0	3.4	0.0	0.0	0.0	38.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.7	0.0	0.1	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	34.9	29.4	19.9	15.6	18.2	26.6	26.8	29.4	21.2	23.8	52.6	0.0	0.0	0.0	218.4	0.0	0.0	0.1	0.0	0.0	2.0	0.7	1.5	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	6.5	1.3	0.2	0.0	0.0	4.5	0.0	0.0	0.4	0.0	15.4	0.0	0.7	0.0	0.2	0.0	8.4	3.5	0.0	0.0	0.3	0.0	1.0	0.0	0.1	0.0	29.0	0.0	38.9	1.0	97.5	381.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	2.0	0.0	62.9	0.2	0.4	0.7	0.0	0.1	0.0	0.1	5.1	0.0	0.1
MEIKIN		ENSG00000239642	"Meiotic kinetochore factor"	A0A087WXM9	5	131806990-131945698	"Metabolic proteins, Predicted intracellular proteins"	"Chromosome partition, Meiosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 3.0;testis: 7.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 179.6;Excitatory neurons: 46.6;Inhibitory neurons: 54.4;Microglial cells: 27.2;Oligodendrocyte precursor cells: 35.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-2 OS: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (3.21e-1)"				"unprognostic (2.30e-1)"			"unprognostic (2.64e-2)"		"unprognostic (5.27e-2)"	"unprognostic (4.31e-1)"		"unprognostic (4.64e-6)"	"unprognostic (2.38e-1)"		"unprognostic (3.81e-1)"		0.1	0.0	1.5	0.1	1.5	0.0	0.0	1.8	3.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.4	0.1	0.1	0.1	0.0	1.5	1.4	0.0	0.0	0.1	0.0	0.3	1.4	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.2	0.0	1.3	0.2	0.0	7.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.1	0.1	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.5	1.5	1.8	3.0	1.6	1.4	1.5	1.4	1.4	1.3	1.5	1.7	0.0	0.0	0.0	179.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	46.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	54.4	0.0	0.0	0.0	0.0	0.5	0.0	1.9	0.0	27.2	2.2	0.0	0.0	35.2	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MID1	"FXY, OS, RNF59, TRIM18"	ENSG00000101871	"Midline 1"	O15344	X	10445310-10833654	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 129.3;Basal squamous epithelial cells: 82.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 156.1;AF22: 132.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002878, HPA003715"	Approved		Uncertain	"Golgi apparatus,Centriolar satellite,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Centriolar satellite"	"Golgi apparatus, Cytosol"	"HPA002878: , HPA003715: AB_1079384"	"unprognostic (1.99e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.61e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.25e-3)"	"unprognostic (9.89e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.12e-3)"	"unprognostic (5.88e-2)"	5.9	2.5	6.9	5.0	7.7	1.7	5.3	17.2	5.0	7.0	6.5	17.3	5.7	8.9	4.9	7.0	6.4	6.8	9.3	7.0	4.9	7.3	4.2	6.5	2.2	3.6	10.4	4.4	3.5	2.8	4.2	6.2	4.9	10.4	10.6	12.3	4.9	12.9	0.7	2.9	5.8	12.3	2.1	1.0	3.8	3.6	8.2	2.3	4.2	2.2	3.1	11.7	6.2	4.4	33.2	156.1	132.5	16.7	8.1	9.2	14.6	16.2	17.8	19.7	20.7	31.0	9.7	10.6	6.5	21.9	58.4	22.5	11.0	15.1	23.0	1.3	11.0	2.7	24.3	1.1	2.8	0.3	1.2	12.1	7.0	16.1	15.8	20.4	23.1	5.1	2.1	3.2	9.6	8.0	5.3	0.5	32.7	5.1	10.0	3.9	28.9	0.4	18.7	36.2	7.1	3.5	7.4	23.5	10.1	42.7	19.2	0.2	13.7	7.2	1.0	34.1	17.0	2.8	1.2	0.4	13.5	0.3	31.3	0.5	0.1	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.0	0.1	0.7	0.0	0.1	0.4	0.0	0.1	6.9	7.7	17.2	5.0	7.0	4.9	3.6	10.4	4.9	2.1	8.2	4.4	16.5	35.3	20.7	129.3	0.7	21.4	31.5	24.7	82.6	10.7	8.5	13.2	4.8	8.6	19.6	23.9	18.8	9.1	1.3	22.6	1.9	13.4	2.2	39.8	8.9	25.4	12.1	2.7	15.5	8.7	26.9	16.2	10.7	38.5	1.3	13.4	69.9	4.0	1.5	69.0	44.3	9.0	2.0	2.5	5.8	7.9	30.1	1.2	3.6	23.4	0.0	37.0	0.0	66.4	59.2	7.3	17.2	41.3	0.2	8.2	11.3	1.5	19.3	2.9	6.6	3.7	3.3	0.3	2.4	36.1	10.1	20.0	0.8	9.7	20.0	49.2
MLC1	"KIAA0027, LVM, MLC, VL"	ENSG00000100427	"Modulator of VRAC current 1"	Q15049	22	50059391-50085426	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 262.7;choroid plexus: 145.6"	"Cell type enriched"	"Detected in some"	6	"Astrocytes: 115.6"	"Cancer enriched"	"Detected in some"	69	"glioma: 122.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 20.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HL-60: 228.2;NB-4: 219.8;THP-1: 401.5;U-266/70: 131.6;U-266/84: 120.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003040	Enhanced		Supported	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol		"HPA003040: AB_1079387"	"unprognostic (2.68e-2)"	"unprognostic (5.46e-6)"	"unprognostic (5.41e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.42e-3)"	"unprognostic (9.54e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.51e-3)"	"unprognostic (8.39e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.92e-1)"	0.3	0.1	239.3	0.7	235.7	36.4	0.1	212.7	261.8	3.0	145.6	0.1	0.4	0.3	1.0	0.1	1.8	1.0	0.6	225.8	234.5	0.1	0.4	1.6	0.3	262.7	243.1	0.3	0.1	0.0	1.1	2.3	221.8	4.8	0.0	4.1	0.1	1.4	0.1	1.0	0.1	0.2	231.9	2.2	0.2	3.8	231.5	0.5	0.1	0.0	0.5	0.4	11.9	217.2	0.4	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	68.1	0.0	0.0	0.1	228.2	68.4	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	1.8	219.8	0.3	0.0	0.1	24.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	401.5	0.0	0.0	0.2	0.1	0.3	131.6	120.2	0.4	0.3	35.7	2.2	0.0	1.1	0.0	3.9	6.8	0.1	0.1	0.3	1.6	0.9	0.0	0.1	1.8	0.1	20.2	9.2	0.2	0.1	4.0	239.3	235.7	212.7	261.8	225.8	234.5	262.7	243.1	221.8	231.9	231.5	217.2	0.0	0.0	0.5	115.6	0.3	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.1	17.2	0.0	0.0	0.0	1.1	0.1	0.4	0.1	0.0	7.8	0.4	0.0	0.1	2.4	0.0	0.1	1.3	4.4	0.4	0.0	3.5	0.0	0.5	0.0	0.0	0.3	0.0	0.7	0.0	0.6	1.8	7.5	0.6	16.3	18.6	0.5	0.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.3	2.7	0.1	0.0	0.0
MMD2	PAQR10	ENSG00000136297	"Monocyte to macrophage differentiation associated 2"	Q8IY49	7	4905989-4959213	"Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 27.4;retina: 6.1;testis: 7.1"	"Group enriched"	"Detected in some"	14	"Astrocytes: 253.4;Oligodendrocyte precursor cells: 121.2"	"Cancer enriched"	"Detected in single"	59	"glioma: 3.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 64: Astrocytes - Nervous system maintenance"								"unprognostic (2.32e-1)"							"unprognostic (1.53e-2)"		"unprognostic (5.03e-2)"	"unprognostic (2.03e-1)"			0.0	0.2	23.8	0.0	25.9	0.0	0.0	8.5	19.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	26.6	0.0	0.0	0.0	0.0	25.6	22.3	0.1	0.0	0.0	3.2	0.0	18.2	0.0	0.0	6.1	0.1	0.1	0.0	0.0	0.1	0.0	14.3	0.0	0.0	7.1	27.4	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	25.9	8.5	19.4	22.0	26.6	25.6	22.3	18.2	14.3	27.4	15.9	0.0	0.0	0.0	253.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	13.1	0.0	2.6	0.0	121.2	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MT3	GIF	ENSG00000087250	"Metallothionein 3"	P25713	16	56589074-56591088	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	57	"brain: 6445.7;choroid plexus: 3969.5"	"Cell type enriched"	"Detected in many"	5	"Astrocytes: 228.8"	"Cancer enriched"	"Detected in many"	58	"glioma: 392.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"naive CD8 T-cell: 5.0"	"Lineage enriched"	"Detected in single"	51	"T-cells: 5.0"	"Cell line enhanced"	"Detected in some"		"JURKAT: 3.4;RPMI-8226: 6.2;SCLC-21H: 11.0;U-87 MG: 18.3"					"Low region specificity"	"Detected in all"			"HPA004011, CAB017779"	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 64: Astrocytes - Nervous system maintenance"			"CAB017779: , HPA004011: AB_1854158"	"unprognostic (6.63e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.34e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.49e-3)"	"unprognostic (2.45e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.26e-2)"	4.2	91.7	4616.8	0.9	4744.4	0.1	2.8	4634.5	6445.7	6.0	3969.5	15.7	0.2	0.5	0.0	3.0	3.7	0.4	12.2	4519.6	4483.6	7.6	2.2	1.6	0.7	4417.7	4500.0	4.7	1.9	2.2	40.3	1.5	4413.7	7.1	2.5	63.3	44.0	0.6	4.3	3.7	4.8	0.3	4335.2	0.9	6.5	10.1	4826.7	1.9	2.1	5.6	12.8	3.8	9.6	4588.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	3.4	0.0	1.5	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.0	0.0	6.2	0.0	0.0	11.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	1.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.4	0.0	0.0	1.2	5.0	0.0	0.0	0.0	0.0	0.0	0.5	4616.8	4744.4	4634.5	6445.7	4519.6	4483.6	4417.7	4500.0	4413.7	4335.2	4826.7	4588.2	0.4	0.0	0.5	228.8	0.0	0.3	0.1	10.7	0.0	0.0	0.0	0.5	29.6	0.0	4.0	0.0	0.0	0.0	0.0	9.9	45.0	1.7	8.0	8.3	0.1	0.5	10.3	0.0	14.3	0.0	0.1	2.9	0.0	1.8	0.0	3.9	0.7	0.2	0.3	0.0	10.0	12.3	4.1	0.0	0.0	9.7	1.2	0.3	0.0	16.9	0.0	0.0	1.0	43.7	28.2	0.0	3.2	0.4	0.0	0.3	0.3	0.7	18.4	0.0	0.0	3.8	0.7	4.0	2.5	0.0	0.0	0.0	1.5	20.4	8.3	0.1
MTMR10	FLJ20313	ENSG00000166912	"Myotubularin related protein 10"	Q9NXD2	15	30938941-30991628	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 86.2;Oligodendrocytes: 149.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 13.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006081	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA006081: AB_2667508"	"unprognostic (1.60e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.31e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (7.77e-12)"	"unprognostic (9.92e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.01e-1)"	18.6	9.5	29.3	10.7	46.9	18.7	10.3	49.4	33.3	11.2	24.8	9.9	12.8	9.4	9.4	20.9	7.5	9.6	12.7	28.0	36.3	30.6	24.2	13.6	12.0	57.6	48.5	11.5	12.4	21.3	1.9	25.9	56.5	11.0	10.3	12.1	14.9	11.4	29.4	11.2	11.6	10.0	45.3	15.1	13.0	8.5	40.8	16.7	14.2	24.0	10.6	10.1	5.4	63.3	8.1	9.0	8.2	5.2	17.7	9.6	7.2	11.9	23.9	9.4	9.4	5.9	3.5	3.9	15.5	15.5	9.1	11.5	6.5	7.0	8.9	12.5	2.1	5.5	6.2	10.4	10.3	8.9	12.2	13.2	5.4	6.1	6.7	10.8	23.7	10.9	4.9	9.2	8.9	2.3	9.3	5.6	4.7	9.7	4.3	6.7	6.7	19.5	35.6	12.7	3.0	7.8	5.4	6.3	2.4	10.4	4.2	16.4	10.9	10.6	8.0	5.6	6.8	9.4	7.8	9.0	6.7	4.7	13.4	3.7	3.2	3.1	0.7	4.0	0.8	1.9	0.8	0.6	3.1	2.8	1.2	1.2	13.5	1.4	7.4	3.7	1.2	1.7	29.3	46.9	49.4	33.3	28.0	36.3	57.6	48.5	56.5	45.3	40.8	63.3	15.8	25.6	15.2	86.2	11.3	8.9	4.3	3.3	8.0	0.0	6.7	4.6	24.1	10.0	7.0	33.1	0.0	19.3	12.9	12.7	1.9	3.4	13.6	10.1	9.6	16.8	6.0	5.2	15.4	3.8	3.1	8.6	13.3	19.7	17.1	9.4	11.4	33.9	11.8	0.0	13.6	7.7	2.0	24.9	16.2	24.9	10.5	19.0	8.8	55.3	13.8	0.0	3.1	25.6	149.3	5.6	9.2	7.5	8.0	6.7	14.4	18.6	4.7	0.0	0.0	10.6	8.9	11.1	8.9	33.6	11.1	38.4	6.8	6.7	8.2	8.7
MTMR3	"FYVE-DSP1, KIAA0371, ZFYVE10"	ENSG00000100330	"Myotubularin related protein 3"	Q13615	22	29883169-30030868	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 81.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 111.3;Inhibitory neurons: 78.3;Microglial cells: 90.9;Oligodendrocyte precursor cells: 96.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034515, HPA034516, HPA061399"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Cytosol	"HPA034515: AB_10669726, HPA034516: AB_10669727, HPA061399: "	"unprognostic (4.39e-3)"	"unprognostic (7.84e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.51e-3)"	"unprognostic (2.25e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.42e-1)"	"unprognostic (4.39e-1)"	"unprognostic (8.33e-4)"	"unprognostic (1.28e-1)"	"unprognostic (5.35e-4)"	"unprognostic (7.96e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.49e-1)"	"unprognostic (8.38e-2)"	17.8	18.4	18.5	13.0	19.4	81.6	17.0	21.2	18.6	18.9	17.0	15.5	11.1	16.0	12.8	22.4	16.4	12.5	13.9	20.8	19.3	11.7	10.8	20.7	11.5	19.2	19.8	20.4	16.5	18.3	17.0	15.0	17.3	16.0	12.7	21.2	17.2	11.3	36.7	25.5	14.5	14.8	18.6	21.7	15.7	26.2	21.6	16.2	17.2	30.0	13.9	15.1	19.4	16.6	13.4	11.7	17.0	18.3	16.7	12.1	12.8	12.2	17.4	15.7	18.2	10.0	7.9	10.2	7.6	22.1	12.4	16.0	18.5	14.3	16.6	21.0	15.4	18.6	10.6	10.1	15.3	15.9	45.0	12.8	22.9	14.9	26.9	14.7	15.3	10.7	11.6	17.5	10.3	16.2	10.7	11.1	6.5	13.7	7.5	12.5	23.3	10.4	14.1	24.3	19.2	13.1	22.1	19.7	11.7	14.1	11.2	15.3	16.8	25.3	16.7	5.5	8.3	14.7	11.1	9.3	11.0	7.5	11.8	8.3	7.4	11.2	3.2	4.9	4.0	2.3	2.5	3.4	4.1	2.4	3.1	2.7	17.8	4.1	5.4	1.5	2.9	4.3	18.5	19.4	21.2	18.6	20.8	19.3	19.2	19.8	17.3	18.6	21.6	16.6	15.9	3.2	14.8	111.3	13.3	16.7	9.8	11.5	14.8	0.0	13.7	11.0	4.2	10.0	17.7	12.9	0.0	13.6	10.4	21.5	1.9	9.5	14.0	16.8	14.9	10.6	12.5	21.0	61.2	8.8	7.0	12.6	31.6	24.5	7.6	14.7	13.9	10.1	10.9	0.0	78.3	9.2	46.8	20.6	11.7	16.7	13.7	20.8	14.2	90.9	22.3	0.0	12.3	96.5	73.2	12.3	11.1	11.3	13.0	14.6	12.2	7.3	16.4	0.0	6.6	15.3	11.0	26.8	28.0	18.1	13.8	13.7	13.0	8.9	11.5	21.2
MTNR1B		ENSG00000134640	"Melatonin receptor 1B"	P49286	11	92969651-92985066	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 3.1;placenta: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"GAMG: 4.9;SuSa: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA074024	Supported					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA074024: "					"unprognostic (3.61e-1)"												"unprognostic (1.43e-1)"	0.0	0.0	2.2	0.0	2.8	0.0	0.0	0.7	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.2	0.0	0.0	0.0	0.0	3.0	2.8	0.0	0.0	0.0	0.0	1.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.8	0.7	1.1	2.3	1.2	3.0	2.8	3.1	2.1	1.2	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
NAT8L	"FLJ37478, Hcml3, Shati"	ENSG00000185818	"N-acetyltransferase 8 like"	Q8N9F0	4	2059327-2069089	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adipose tissue: 43.5;brain: 99.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 126.7;Excitatory neurons: 46.0;Horizontal cells: 80.8;Inhibitory neurons: 37.6;Muller glia cells: 25.0"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 6.2;glioma: 17.2;melanoma: 14.6;ovarian cancer: 8.0;thyroid cancer: 7.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 20.8;SCLC-21H: 25.8;SK-MEL-30: 21.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040677			Approved	Mitochondria		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria		"HPA040677: AB_2732486"	"unprognostic (1.32e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.02e-3)"	"prognostic unfavorable (1.01e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.63e-4)"	"unprognostic (6.58e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.78e-3)"	"unprognostic (7.24e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.35e-2)"	43.5	0.7	56.1	0.1	46.4	0.0	1.6	42.9	99.0	0.0	0.6	0.2	0.1	0.3	1.3	0.1	0.9	0.1	0.8	45.8	29.0	5.3	0.0	0.0	0.2	52.3	46.4	0.2	2.3	0.9	1.8	0.1	57.5	1.0	0.1	3.7	2.3	1.6	5.7	1.0	0.2	0.2	33.0	0.3	0.4	9.0	88.8	0.2	0.3	2.5	0.0	0.0	0.0	38.9	0.1	9.2	4.9	10.0	0.9	0.0	5.7	0.2	0.0	0.2	0.0	4.1	0.3	0.0	1.9	0.0	1.5	0.1	11.1	0.0	0.1	0.0	13.2	0.1	2.1	6.6	1.5	14.5	6.9	0.0	0.2	0.0	0.0	1.8	0.0	3.4	11.5	0.0	0.4	6.2	0.2	20.8	14.1	0.0	4.1	0.7	2.3	0.4	0.2	0.5	25.8	8.6	6.6	0.0	21.4	0.8	0.7	8.3	0.0	0.0	3.3	0.1	5.6	0.0	0.0	0.2	0.0	6.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	56.1	46.4	42.9	99.0	45.8	29.0	52.3	46.4	57.5	33.0	88.8	38.9	0.5	0.0	0.0	126.7	0.0	0.3	0.0	0.0	0.0	14.5	1.4	2.2	2.6	0.0	0.0	1.8	6.2	0.0	5.4	0.0	0.0	4.6	1.1	1.7	0.1	0.4	1.8	0.0	46.0	0.6	0.1	0.2	0.0	1.0	0.0	21.9	0.0	0.0	0.8	80.8	37.6	0.0	0.0	0.0	0.3	3.8	0.0	0.7	10.6	17.8	0.0	25.0	0.0	23.1	15.7	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.0	0.8	0.5	1.5	0.0	0.1	0.0	0.0	0.1	0.0	0.1
NCAN	CSPG3	ENSG00000130287	Neurocan	O14594	19	19211958-19252233	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	63	"brain: 73.6"	"Cell type enriched"	"Detected in some"	6	"Astrocytes: 195.5"	"Cancer enriched"	"Detected in some"	57	"glioma: 71.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.0;SCLC-21H: 2.3;SH-SY5Y: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036814	Enhanced				"Secreted in brain"	NA	NA		790000		"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA036814: AB_10673666"	"unprognostic (1.02e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.58e-3)"	"unprognostic (4.38e-2)"	"unprognostic (9.09e-6)"	"unprognostic (1.10e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.58e-2)"	0.0	0.1	52.8	0.0	53.1	0.0	0.0	15.2	73.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.6	44.2	0.0	0.0	0.0	0.0	33.3	32.3	0.0	0.0	0.0	0.3	0.0	38.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.0	0.9	61.5	0.1	0.0	0.0	0.0	0.0	0.0	49.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.8	53.1	15.2	73.6	55.6	44.2	33.3	32.3	38.1	21.5	61.5	49.4	0.0	0.0	0.0	195.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.1	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	15.5	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	8.4	0.0	0.5	0.0	29.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.4	0.0	0.1	0.0	0.0	0.3	0.0	0.0
NEO1	"HsT17534, IGDCC2, NGN, NTN1R2"	ENSG00000067141	"Neogenin 1"	Q92859	15	73051710-73305205	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 231.8;Excitatory neurons: 124.5;Oligodendrocyte precursor cells: 120.1;Oligodendrocytes: 439.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009320, HPA027804, HPA027805, HPA027806"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA		390000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Plasma membrane"	"Golgi apparatus"	"CAB009320: AB_2150998, HPA027804: AB_10600771, HPA027805: AB_10601755, HPA027806: AB_10601006"	"unprognostic (1.90e-1)"	"unprognostic (2.38e-2)"	"unprognostic (7.60e-3)"	"unprognostic (3.76e-2)"	"unprognostic (5.44e-1)"	"unprognostic (3.83e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.51e-2)"	"unprognostic (8.05e-2)"	"prognostic favorable (4.39e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.75e-1)"	9.6	7.4	28.9	8.9	43.8	1.5	16.7	38.1	31.4	18.2	10.7	46.0	27.3	19.6	9.9	11.5	21.9	19.6	7.8	29.4	29.2	23.4	8.7	15.9	3.9	34.6	38.0	24.8	17.2	41.8	6.7	1.7	35.6	33.0	55.1	19.5	18.3	36.0	30.9	37.5	26.5	23.3	28.7	5.3	22.9	13.5	36.6	7.2	18.2	24.8	6.2	10.5	9.6	60.0	8.9	42.9	50.1	33.2	29.6	8.6	12.5	3.3	4.1	8.2	1.7	6.4	42.8	2.5	4.9	9.4	30.8	1.9	35.3	19.5	3.5	15.8	26.0	29.0	0.5	6.0	8.6	0.8	0.9	21.3	35.4	1.6	16.2	9.5	0.0	22.3	0.2	53.9	2.0	26.8	10.5	0.7	47.9	6.7	3.6	23.9	26.8	5.8	15.8	23.7	22.7	32.1	40.2	17.6	20.7	39.9	18.6	5.3	0.1	38.0	19.9	12.5	9.3	22.8	45.2	6.2	8.2	8.3	10.9	0.0	0.0	0.1	0.4	0.0	0.7	0.0	0.2	0.3	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.1	28.9	43.8	38.1	31.4	29.4	29.2	34.6	38.0	35.6	28.7	36.6	60.0	3.1	9.6	10.4	231.8	2.3	14.1	8.2	20.7	13.6	15.7	14.2	18.2	6.9	21.5	11.4	22.0	14.6	0.5	4.8	55.6	1.9	11.6	3.3	14.4	13.4	3.4	60.1	3.0	124.5	6.4	0.8	14.6	20.9	24.6	0.0	11.8	5.7	8.9	0.9	10.1	72.8	51.2	10.2	1.2	2.7	7.1	31.7	1.2	10.6	62.8	0.1	12.5	2.1	120.1	439.4	9.9	40.0	62.8	2.6	11.5	39.6	15.5	12.7	21.9	6.6	22.2	10.2	11.8	20.3	14.7	25.4	0.3	6.0	3.1	60.5	7.2
NHSL1	"bA43P8.1, C6orf63, KIAA1357"	ENSG00000135540	"NHS like 1"	Q5SYE7	6	138422043-138692571	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 23.2"	"Cell type enriched"	"Detected in many"	4	"Astrocytes: 502.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.6;non-classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Hep G2: 46.2;TIME: 64.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029966, HPA029967"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nuclear membrane"	Nucleoplasm	"HPA029966: AB_10601972, HPA029967: AB_2673271"	"unprognostic (1.85e-1)"	"unprognostic (9.71e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.34e-2)"	"unprognostic (5.21e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.19e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.55e-2)"	"unprognostic (4.06e-2)"	4.1	1.2	15.7	2.4	14.1	0.3	2.5	9.7	8.5	2.4	16.6	13.2	15.8	1.2	4.6	10.4	1.0	3.0	15.7	14.6	11.2	5.8	14.8	12.8	1.0	16.2	15.9	0.5	3.3	2.1	1.1	4.3	10.7	0.8	11.4	2.6	3.5	0.5	0.5	11.4	23.2	3.2	9.2	2.6	7.8	0.4	14.4	0.6	1.4	0.8	2.1	2.7	4.5	5.6	5.5	4.7	32.8	13.8	9.4	11.4	12.2	4.8	2.3	1.7	1.6	6.2	3.1	0.0	6.0	4.1	3.1	12.3	20.0	12.5	0.9	0.4	13.4	3.4	2.2	46.2	13.8	12.4	2.3	16.7	7.0	0.9	14.1	1.8	23.3	1.9	0.0	1.8	7.2	10.7	1.3	1.0	13.1	3.1	8.8	14.1	3.4	1.0	11.2	13.7	12.4	0.0	5.1	10.3	33.4	21.5	3.3	3.9	64.3	4.6	4.5	4.6	13.3	1.2	2.7	0.0	0.4	5.0	25.5	0.4	1.2	0.2	0.0	1.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.2	15.7	14.1	9.7	8.5	14.6	11.2	16.2	15.9	10.7	9.2	14.4	5.6	6.2	60.9	66.9	502.1	0.5	42.8	3.1	6.6	4.0	0.6	4.1	6.0	22.7	15.7	9.9	29.5	29.2	14.2	0.1	84.1	9.8	3.7	1.1	19.0	1.8	9.3	20.3	2.7	3.3	3.6	3.5	15.6	16.8	16.9	8.8	1.5	26.4	38.1	4.5	37.0	2.9	32.3	6.1	9.4	7.1	0.4	0.6	7.5	21.4	104.0	0.6	15.4	0.0	79.9	2.3	3.9	43.0	0.0	0.1	5.4	87.3	15.8	22.0	1.4	6.6	2.3	4.7	0.0	1.1	7.7	49.2	43.4	1.8	0.8	45.4	10.5
NKAIN3	"FAM77D, FLJ39630, NKAIN3-IT1"	ENSG00000185942	"Sodium/potassium transporting ATPase interacting 3"	Q8N8D7	8	62248591-63014000	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	9	"brain: 18.9"	"Group enriched"	"Detected in some"	6	"Astrocytes: 1258.6;Oligodendrocyte precursor cells: 811.8"	"Cancer enriched"	"Detected in single"	5	"glioma: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.2;SCLC-21H: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA018833	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA018833: AB_2669943"	"unprognostic (1.28e-1)"		"unprognostic (2.92e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.83e-1)"			"unprognostic (3.56e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.81e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.26e-1)"		"unprognostic (3.22e-2)"	"unprognostic (3.15e-2)"		"unprognostic (1.58e-1)"	0.2	1.7	18.9	0.3	11.8	0.9	0.3	0.8	9.9	0.6	0.0	0.4	0.3	0.4	0.7	0.2	0.2	0.3	0.3	16.1	10.6	0.4	2.0	0.2	0.3	3.7	11.2	0.4	0.3	0.7	0.0	0.2	2.2	0.3	0.4	1.7	1.2	0.4	0.6	0.7	0.4	0.2	1.4	0.4	0.3	0.4	16.1	0.1	0.2	0.1	0.1	0.2	0.0	4.8	0.4	0.6	2.2	0.3	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.6	0.5	0.3	0.2	0.2	0.2	0.5	0.1	0.1	0.4	0.1	0.9	1.2	0.3	0.1	0.5	0.4	0.1	0.1	0.1	0.1	0.2	0.0	0.3	0.5	1.3	0.1	0.2	0.3	0.5	0.8	0.4	1.1	1.9	0.3	0.2	0.0	0.6	3.7	0.3	0.3	0.4	0.2	0.6	0.3	0.4	0.4	0.5	0.5	0.4	0.3	0.6	0.5	0.2	0.6	0.4	1.2	0.9	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.3	0.1	0.2	0.5	0.2	0.2	0.2	0.1	0.0	18.9	11.8	0.8	9.9	16.1	10.6	3.7	11.2	2.2	1.4	16.1	4.8	0.0	0.0	0.0	1258.6	0.0	0.4	0.1	0.0	0.0	10.4	1.3	1.5	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.8	0.2	6.3	0.0	0.0	0.0	35.7	0.7	0.1	0.8	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	168.5	0.0	0.0	0.0	0.0	4.2	0.3	0.0	1.8	21.5	0.0	0.0	0.0	811.8	3.8	0.6	0.0	0.0	0.0	0.6	0.0	2.3	0.0	0.2	0.0	7.6	0.1	0.0	0.4	0.3	0.0	0.1	0.0	0.2	0.0	0.2
NLRP13	"CLR19.7, NALP13, NOD14, PAN13"	ENSG00000173572	"NLR family pyrin domain containing 13"	Q86W25	19	55891699-55932336	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA060459	Uncertain					NA	NA						"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA060459: AB_2684284"												"unprognostic (2.16e-1)"			"unprognostic (4.66e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPFF	FMRFAL	ENSG00000139574	"Neuropeptide FF-amide peptide precursor"	O15130	12	53506690-53507638	"Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	84	"epididymis: 820.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 11.1;Excitatory neurons: 1.3;Inhibitory neurons: 1.2;Microglial cells: 1.9;Oligodendrocytes: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HHSteC: 13.3"	"Region enriched"	"Detected in some"	7	"pons and medulla: 11.4"	"Region enriched"	"Detected in all"	7	"cerebellum: 50.8"						"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 64: Astrocytes - Nervous system maintenance"																					0.2	0.4	1.4	0.0	1.4	0.0	0.1	1.4	9.7	0.2	1.4	0.1	0.8	0.0	820.5	0.1	0.1	0.1	0.2	1.4	2.1	0.1	0.1	0.3	0.0	3.4	3.2	0.2	0.1	0.0	0.1	0.0	1.6	0.1	0.0	0.2	0.3	0.3	0.0	0.1	0.1	0.0	3.1	0.1	0.1	0.1	1.8	0.1	0.1	0.0	0.0	0.1	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.5	0.2	0.6	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.1	1.6	0.3	0.0	0.6	0.2	0.0	0.2	0.2	0.4	1.5	0.0	0.0	0.2	0.0	0.5	0.1	1.7	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.4	1.4	9.7	1.4	2.1	3.4	3.2	1.6	3.1	1.8	1.6	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0
NRBP2	DKFZp434P086	ENSG00000185189	"Nuclear receptor binding protein 2"	Q9NSY0	8	143833583-143840973	"Enzymes, Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 134.2;Oligodendrocytes: 120.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020944, HPA029051, HPA029052"	Approved		Approved	Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol		"CAB020944: , HPA029051: AB_2672886, HPA029052: AB_10602714"	"unprognostic (1.84e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.00e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (2.01e-5)"	"unprognostic (3.86e-2)"	"unprognostic (3.98e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.04e-1)"	18.8	9.6	21.4	6.4	35.9	1.6	18.4	35.6	28.7	15.1	12.6	28.2	7.6	17.3	7.4	9.5	17.6	10.3	15.1	24.9	25.8	18.1	32.3	16.6	4.5	49.6	35.7	13.4	10.7	8.9	14.5	5.7	47.1	19.6	5.6	7.4	19.7	12.6	6.9	17.7	11.1	11.7	30.6	7.1	14.0	6.9	36.4	3.9	15.8	7.1	3.4	14.2	14.0	48.5	10.2	12.9	11.4	14.0	16.5	25.6	2.6	18.7	9.0	7.2	10.3	3.1	8.8	1.1	5.3	24.1	5.2	15.5	7.0	6.6	3.2	12.4	4.7	2.0	36.0	5.3	18.1	0.0	4.1	30.3	15.5	3.1	3.5	22.4	10.5	3.4	6.7	12.7	15.2	3.5	0.8	0.4	3.7	10.1	5.5	3.4	10.0	4.5	8.9	3.1	3.9	7.2	25.3	13.3	10.1	5.9	18.7	0.8	22.5	4.6	12.5	20.4	6.8	6.3	0.5	0.3	22.8	4.1	5.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	35.9	35.6	28.7	24.9	25.8	49.6	35.7	47.1	30.6	36.4	48.5	15.1	44.8	13.7	134.2	2.0	9.2	6.2	5.2	5.7	15.4	16.3	23.2	9.9	41.5	10.4	11.0	14.6	0.9	3.2	9.2	0.0	4.3	0.5	8.1	15.2	10.4	9.0	0.0	41.8	4.0	1.0	11.2	15.3	14.1	0.0	8.5	7.5	41.7	2.8	16.8	32.7	8.4	16.2	5.7	4.6	1.2	28.9	4.5	10.6	22.5	3.9	17.7	3.1	30.2	120.7	5.4	3.6	21.4	2.3	7.1	3.9	4.4	7.0	11.4	13.1	14.2	18.3	1.2	3.3	4.7	9.1	0.8	4.4	7.2	6.2	5.0
NTSR2	NTR2	ENSG00000169006	"Neurotensin receptor 2"	O95665	2	11658178-11670195	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	58	"brain: 85.4;choroid plexus: 43.7"	"Cell type enriched"	"Detected in some"	32	"Astrocytes: 32.7"	"Cancer enriched"	"Detected in single"	15	"glioma: 6.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (5.40e-2)"	"unprognostic (2.30e-2)"			"unprognostic (2.36e-2)"	"unprognostic (5.32e-2)"			"unprognostic (2.23e-1)"	"unprognostic (1.80e-1)"		"unprognostic (2.75e-1)"		"unprognostic (4.98e-1)"	"unprognostic (1.64e-1)"			0.5	0.9	74.8	0.0	84.2	0.0	0.2	67.7	78.2	0.0	43.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.7	75.8	0.0	0.0	0.0	0.0	65.8	85.4	1.1	0.2	0.0	0.2	0.0	68.9	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	60.5	0.0	0.0	0.2	82.9	0.0	0.0	0.0	0.0	0.0	0.0	60.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.8	84.2	67.7	78.2	65.7	75.8	65.8	85.4	68.9	60.5	82.9	60.8	0.0	0.0	0.0	32.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR9A4		ENSG00000258083	"Olfactory receptor family 9 subfamily A member 4"	Q8NGU2	7	141916399-141920625	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 29.7;Excitatory neurons: 4.2;Inhibitory neurons: 5.9;Microglial cells: 3.7;Oligodendrocyte precursor cells: 14.6;Oligodendrocytes: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"U-937: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA					"Cluster 32: U-937 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"																		"unprognostic (2.77e-1)"			0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.0	29.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	14.6	7.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OTOS	OTOSP	ENSG00000178602	Otospiralin	Q8NHW6	2	240139026-240144562	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"pituitary gland: 103.1;thyroid gland: 43.8"	"Cell type enhanced"	"Detected in single"		"Astrocytes: 1.3"	"Cancer enriched"	"Detected in some"	4	"thyroid cancer: 28.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"hippocampal formation: 1.6"	"Low region specificity"	"Detected in many"								"Secreted in other tissues"	NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (8.52e-2)"			"unprognostic (1.73e-1)"	"unprognostic (9.01e-3)"					"unprognostic (1.35e-1)"					"unprognostic (2.72e-1)"	"unprognostic (3.27e-3)"		0.0	0.0	10.9	0.0	11.0	0.0	0.1	11.3	11.5	0.1	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	14.2	0.3	0.2	0.0	0.0	10.5	11.7	0.0	0.0	0.0	103.1	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	12.7	0.0	43.8	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	11.0	11.3	11.5	11.7	14.2	10.5	11.7	11.2	9.7	12.7	12.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PAMR1	"DKFZP586H2123, RAMP"	ENSG00000149090	"Peptidase domain containing associated with muscle regeneration 1"	Q6UXH9	11	35431823-35530300	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Serine protease homolog"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	7	"Astrocytes: 380.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 86.9;ASC TERT1: 354.7;BJ hTERT+: 357.7;fHDF/TERT166: 86.7;HSkMC: 123.1;U-87 MG: 82.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	NA	NA		5600000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (3.38e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.00e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.07e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.32e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (5.08e-5)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (2.08e-1)"	"unprognostic (9.98e-2)"	"unprognostic (8.25e-2)"	32.8	14.9	25.1	0.6	27.4	0.0	15.4	22.0	23.2	59.9	13.9	14.9	4.5	58.2	18.3	10.0	22.6	20.3	23.2	22.5	26.2	7.1	12.6	5.9	1.3	37.9	35.9	3.4	5.3	1.7	6.4	55.9	32.4	21.2	6.6	0.9	5.7	17.9	2.7	19.8	9.9	14.9	46.1	5.7	5.4	0.2	34.1	2.8	7.0	9.0	1.7	28.0	41.3	38.8	0.0	0.0	0.1	0.0	86.9	354.7	0.1	42.8	357.7	4.9	8.3	32.7	0.0	0.0	0.0	86.7	0.1	0.1	0.0	0.0	3.3	0.0	0.8	0.0	0.0	0.0	50.1	0.0	0.0	123.1	1.8	9.7	1.3	0.1	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.7	0.0	0.2	0.0	0.2	0.2	0.0	8.4	0.1	0.0	0.0	0.0	0.0	14.3	2.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.1	0.0	82.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	27.4	22.0	23.2	22.5	26.2	37.9	35.9	32.4	46.1	34.1	38.8	2.5	0.0	0.0	380.3	0.0	19.1	1.4	14.8	1.2	0.1	0.7	19.7	1.3	0.0	2.4	1.8	0.0	2.2	0.0	0.0	0.0	1.4	0.1	4.5	26.2	1.1	0.0	0.0	13.1	0.0	1.4	50.2	1.1	0.8	0.0	0.6	0.0	0.0	2.0	0.0	8.2	0.2	0.0	0.0	5.5	0.1	0.3	0.5	1.8	28.1	0.6	0.0	0.0	9.5	1.4	0.1	0.0	0.0	0.0	0.4	0.2	0.0	1.8	0.2	0.0	1.6	5.8	0.0	0.2	0.1	9.2	3.4	0.6	0.2	0.0	0.2
PAPLN	MGC50452	ENSG00000100767	"Papilin, proteoglycan like sulfated glycoprotein"	O95428	14	73237497-73274640	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 119.8;Endometrial stromal cells: 37.9;Leydig cells: 34.5;Peritubular cells: 44.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"neutrophil: 2.5;plasmacytoid DC: 5.4"	"Group enriched"	"Detected in many"	7	"dendritic cells: 5.4;granulocytes: 2.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 16.1;HSkMC: 30.6;hTCEpi: 11.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA048682, HPA053453"	Uncertain		Approved	Nucleoplasm	"Secreted - unknown location"	NA	NA		76000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA048682: AB_2680492, HPA053453: AB_2682155"	"unprognostic (1.97e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.56e-3)"	"unprognostic (7.42e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.46e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.05e-3)"	"unprognostic (2.69e-2)"	"unprognostic (5.58e-2)"	16.1	6.6	15.7	8.4	17.0	2.3	10.7	12.1	23.5	30.3	15.7	13.4	3.0	20.4	14.9	7.1	23.0	5.6	8.0	14.4	13.3	42.6	3.2	13.4	15.2	14.1	14.6	16.8	4.0	0.4	16.4	4.0	13.1	13.6	4.5	9.5	7.5	7.5	2.1	15.7	17.8	6.3	12.3	29.1	11.3	6.4	14.4	5.1	24.8	1.8	13.6	5.1	9.1	12.3	2.7	2.6	1.0	0.4	1.9	2.3	5.8	0.5	0.0	0.1	0.2	3.4	0.8	0.5	2.7	0.0	0.1	4.3	2.7	2.0	0.3	3.0	3.9	1.2	4.7	0.3	16.1	0.4	2.1	30.6	11.4	0.5	1.7	0.2	0.6	2.5	0.8	0.3	0.0	1.4	0.3	3.0	0.6	0.3	0.8	0.4	0.3	2.8	2.3	0.6	0.3	0.5	6.2	7.0	1.3	7.9	0.2	4.8	0.5	0.7	2.3	0.2	0.3	1.3	0.1	0.3	1.4	1.4	0.6	0.8	0.5	0.3	0.2	0.3	0.1	0.4	0.1	0.2	0.1	0.5	0.2	0.2	2.5	0.3	0.2	5.4	0.3	0.1	15.7	17.0	12.1	23.5	14.4	13.3	14.1	14.6	13.1	12.3	14.4	12.3	0.4	0.0	2.6	119.8	0.3	2.0	0.7	5.1	0.6	1.2	1.8	1.4	1.9	7.2	4.8	5.5	8.4	0.5	5.7	0.4	0.0	4.0	0.3	11.8	37.9	3.4	0.0	0.0	0.3	0.0	1.1	8.3	0.5	16.1	0.0	0.2	3.3	0.1	1.2	0.0	0.9	0.4	2.0	0.3	1.6	1.7	34.5	1.8	1.8	10.3	1.6	15.7	0.0	3.0	0.3	0.4	0.0	44.0	0.2	1.4	0.2	10.2	3.7	3.0	6.6	1.4	1.8	0.6	0.1	0.8	3.0	0.4	0.7	0.1	1.0	0.4
PARD3B	"ALS2CR19, PAR3beta, Par3L"	ENSG00000116117	"Par-3 family cell polarity regulator beta"	Q8TEW8	2	204545475-205620162	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 490.7;Microglial cells: 183.6;Oligodendrocyte precursor cells: 159.3;Oligodendrocytes: 104.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 17.8;BJ hTERT+: 12.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035283	Approved		Supported	"Cell Junctions"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 36: HEL - Hemostasis"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Cell Junctions"		"HPA035283: AB_10671102"	"unprognostic (6.18e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (2.67e-10)"	"unprognostic (1.74e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.09e-2)"	9.1	2.8	6.0	1.7	7.3	0.0	5.5	5.3	5.3	4.9	9.3	12.6	3.6	5.1	3.7	4.0	6.5	4.5	4.0	4.6	9.2	6.9	3.4	5.4	2.1	9.3	12.2	7.3	4.9	9.2	1.9	4.4	8.3	4.8	5.5	2.5	3.0	5.2	2.7	4.5	4.2	5.2	8.4	3.1	4.5	3.8	8.0	1.4	5.6	3.6	2.5	5.9	4.0	7.4	2.5	2.1	6.3	2.3	17.8	8.9	3.4	3.8	12.5	3.5	3.8	6.2	1.7	0.0	4.3	7.8	2.8	0.3	0.8	1.0	3.6	0.2	2.9	8.8	5.2	0.0	1.8	0.0	0.5	3.4	1.7	1.2	5.2	5.3	5.2	0.8	0.2	0.1	4.5	1.0	0.0	0.0	0.8	0.9	0.5	0.0	2.7	2.1	3.7	2.5	0.7	2.0	2.0	1.9	1.7	6.2	3.1	0.0	10.9	2.7	1.7	5.5	1.8	0.0	0.0	0.0	2.6	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	7.3	5.3	5.3	4.6	9.2	9.3	12.2	8.3	8.4	8.0	7.4	9.5	9.6	8.6	490.7	0.5	11.0	3.3	2.4	6.8	0.5	5.6	5.8	10.8	15.7	14.5	29.5	0.0	3.2	0.2	12.4	0.0	8.7	76.6	8.5	4.0	6.8	6.0	0.8	5.6	2.4	0.2	16.2	11.7	7.4	1.3	14.1	8.2	4.5	0.5	5.0	50.8	9.2	2.0	1.0	4.3	26.0	31.1	0.6	7.2	183.6	0.1	9.7	0.0	159.3	104.2	6.5	15.9	57.9	1.4	5.0	9.4	4.8	17.0	0.3	19.7	23.5	9.6	1.4	2.9	3.5	4.7	1.1	1.0	2.3	8.0	5.3
PHF21B	"BHC80L, FLJ34161, PHF4"	ENSG00000056487	"PHD finger protein 21B"	Q96EK2	22	44881162-45010005	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 18.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 96.6;Cone photoreceptor cells: 22.9;Horizontal cells: 28.6;Late spermatids: 41.9;Oligodendrocyte precursor cells: 29.1;Rod photoreceptor cells: 23.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9;prostate cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 11.2;AN3-CA: 10.0;JURKAT: 8.8;SCLC-21H: 8.7;SH-SY5Y: 37.5;U-2 OS: 8.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA053834, HPA074665"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA053834: AB_2682276, HPA074665: "	"unprognostic (1.04e-1)"	"unprognostic (7.76e-2)"		"unprognostic (2.00e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.37e-1)"		"unprognostic (5.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.83e-3)"	"unprognostic (1.86e-3)"	"unprognostic (2.02e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.22e-1)"	0.2	1.2	6.7	0.1	7.9	0.0	0.4	4.8	6.1	9.0	1.5	0.2	0.1	3.2	0.4	0.4	2.5	0.1	0.9	5.1	5.1	2.6	0.0	0.1	0.0	8.5	8.3	4.0	0.5	0.9	18.9	0.0	5.2	5.2	0.0	6.1	0.3	0.5	0.2	0.1	0.2	0.7	4.4	0.1	0.6	5.4	6.8	0.2	2.0	0.3	0.0	0.2	3.2	4.7	0.0	0.0	11.2	10.0	0.0	0.0	0.7	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	2.0	0.1	2.1	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.3	0.6	0.0	0.0	8.8	0.0	0.0	0.1	0.9	1.3	0.0	6.7	0.0	0.4	0.0	2.6	0.2	0.0	0.1	8.7	37.5	0.0	0.0	0.1	0.7	0.0	0.0	0.0	1.5	8.5	0.0	0.2	0.4	0.0	5.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	7.9	4.8	6.1	5.1	5.1	8.5	8.3	5.2	4.4	6.8	4.7	0.0	0.0	0.0	96.6	0.0	0.1	0.6	0.0	0.0	14.1	0.0	0.3	2.0	0.0	0.0	0.0	22.9	0.0	0.0	0.0	1.9	0.0	16.2	0.1	3.2	0.4	0.0	0.0	1.0	0.0	0.0	0.8	0.0	0.3	0.0	0.6	0.0	0.0	0.1	28.6	9.1	0.0	0.0	0.0	0.0	41.9	0.6	0.1	0.0	5.6	0.0	5.0	0.0	29.1	9.3	0.1	0.0	1.9	0.0	1.7	0.0	0.0	0.7	23.3	0.0	1.1	0.5	1.2	2.9	0.0	0.0	0.0	0.3	1.9	0.0	0.1
PHKA1	PHKA	ENSG00000067177	"Phosphorylase kinase regulatory subunit alpha 1"	P46020	X	72578814-72714319	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Calmodulin-binding, Muscle protein"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"parathyroid gland: 32.0;skeletal muscle: 102.6;tongue: 89.2"	"Cell type enriched"	"Detected in many"	4	"Astrocytes: 85.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 39.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001081, HPA075355"	Enhanced		Approved	Vesicles,Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Vesicles, Cytosol"		"HPA001081: AB_1079607, HPA075355: "	"unprognostic (3.68e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (6.84e-4)"	"unprognostic (3.52e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.23e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.76e-1)"	"unprognostic (9.45e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.12e-1)"	3.2	17.7	6.9	1.0	11.4	0.7	4.8	8.9	5.7	2.6	17.0	4.0	1.1	3.3	6.5	5.6	3.8	3.2	7.5	6.0	8.7	2.7	2.3	2.1	1.1	8.8	11.9	8.3	7.6	32.0	9.8	1.8	9.1	6.0	3.3	3.9	7.1	6.4	102.6	3.4	2.1	3.4	7.9	3.4	6.9	2.1	10.4	4.0	6.9	89.2	1.4	4.8	3.5	6.7	15.3	21.2	1.2	12.4	7.2	6.8	12.9	2.8	2.6	0.5	0.1	6.2	13.3	0.0	8.2	0.3	15.1	5.9	24.9	10.3	0.8	39.2	25.1	7.0	17.4	5.7	7.5	0.0	0.0	9.1	10.0	2.4	16.7	12.5	14.5	12.7	11.0	0.0	13.6	11.0	11.1	0.7	16.5	25.2	28.0	0.0	0.0	0.0	3.7	7.2	12.9	15.3	13.4	17.3	0.2	15.4	6.2	0.6	7.5	0.0	6.2	2.7	7.3	17.1	17.1	0.0	5.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	11.4	8.9	5.7	6.0	8.7	8.8	11.9	9.1	7.9	10.4	6.7	5.8	0.0	3.7	85.2	0.5	2.4	6.5	2.3	4.0	2.4	5.2	3.7	6.6	1.5	3.5	11.0	8.4	1.0	0.1	0.8	0.0	1.6	0.4	4.8	1.4	3.5	2.4	4.0	5.3	2.7	1.1	2.5	3.6	2.9	6.3	3.4	5.7	1.9	1.6	3.3	16.0	1.8	4.1	10.4	0.7	0.1	3.1	0.6	1.8	6.5	0.0	1.5	0.0	18.6	0.5	5.4	0.4	8.6	1.3	9.0	0.4	1.6	6.6	3.3	0.0	7.1	1.9	0.4	1.0	5.6	3.4	0.5	0.3	1.9	2.6	8.9
PIRT		ENSG00000233670	"Phosphoinositide interacting regulator of transient receptor potential channels"	P0C851	17	10822470-10838087	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 24.0"	"Cell type enhanced"	"Detected in single"		"Astrocytes: 2.6"	"Cancer enriched"	"Detected in single"	40	"glioma: 5.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA042337			Uncertain	"Plasma membrane,Cytosol"		NA	NA				"Cluster 70: Brain - Nervous system development"		"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol	"Plasma membrane"	"HPA042337: AB_10794795"	"unprognostic (2.95e-1)"		"unprognostic (2.19e-2)"	"unprognostic (7.57e-2)"	"unprognostic (6.58e-3)"						"unprognostic (9.42e-2)"	"unprognostic (2.05e-1)"		"unprognostic (2.85e-3)"				0.0	2.5	7.5	1.1	8.7	0.0	0.0	11.5	6.8	0.0	1.7	4.0	1.0	0.0	0.0	0.1	0.2	0.1	0.0	5.4	11.6	0.0	0.0	0.0	0.0	22.4	16.5	0.0	0.0	0.0	0.0	0.0	14.0	0.1	2.6	0.2	0.0	0.0	0.0	0.3	1.9	0.8	11.8	0.0	1.4	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.5	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	8.7	11.5	6.8	5.4	11.6	22.4	16.5	14.0	11.8	24.0	10.8	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PITPNC1	"RDGB-BETA, RDGBB, RDGBB1"	ENSG00000154217	"Phosphatidylinositol transfer protein cytoplasmic 1"	Q9UKF7	17	67377281-67697261	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 1255.9;Inhibitory neurons: 330.9;Oligodendrocyte precursor cells: 281.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA026563, HPA031250"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol	Nucleoplasm	"HPA026563: AB_1855409, HPA031250: AB_2673808"	"unprognostic (1.33e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.14e-3)"	"unprognostic (4.17e-2)"	"prognostic favorable (4.85e-5)"	"unprognostic (6.57e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.23e-3)"	"unprognostic (1.19e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.34e-2)"	"unprognostic (9.83e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.16e-2)"	25.7	8.9	27.2	5.6	30.1	3.8	18.6	23.5	26.9	8.7	13.2	7.6	1.5	7.8	3.8	9.8	10.9	3.8	13.3	22.7	31.2	21.8	9.8	15.1	8.8	38.4	41.0	15.2	23.1	1.8	13.7	6.0	28.2	11.9	2.2	15.0	14.1	4.4	5.4	4.9	8.7	3.5	28.7	9.4	12.6	2.5	42.7	8.4	9.0	5.0	7.4	12.0	9.2	20.1	4.2	1.0	4.5	6.8	2.8	5.1	3.9	6.0	2.9	0.8	0.4	0.0	6.4	4.6	1.4	3.6	1.7	2.0	6.7	6.0	1.1	9.3	3.0	0.7	7.6	3.4	0.7	1.4	9.8	3.6	2.2	0.9	2.5	0.5	3.2	6.5	0.3	16.9	2.3	7.0	10.9	2.8	6.6	1.8	7.7	15.2	0.9	4.2	9.7	5.4	4.7	13.0	1.7	3.3	4.1	4.8	3.0	4.7	3.7	1.8	1.0	2.4	2.9	13.2	6.2	3.7	14.4	4.6	1.6	0.7	1.4	10.3	11.1	2.6	5.7	0.5	6.9	9.2	0.9	1.3	8.2	8.3	1.7	5.2	4.1	0.1	2.8	4.1	27.2	30.1	23.5	26.9	22.7	31.2	38.4	41.0	28.2	28.7	42.7	20.1	102.6	9.6	1.1	1255.9	9.6	5.4	55.6	4.6	8.0	15.2	7.7	4.1	6.9	21.5	4.6	0.0	2.1	7.9	84.0	5.8	21.5	43.3	0.2	13.7	5.7	59.8	6.0	4.0	88.4	49.1	13.6	18.9	8.2	30.9	5.1	7.7	21.4	10.1	13.8	74.0	330.9	1.3	4.1	21.4	22.3	1.4	5.0	17.7	10.6	103.0	20.2	34.6	84.5	281.5	9.7	38.7	4.4	14.7	28.0	32.9	0.1	21.2	3.4	21.8	26.3	66.5	25.7	0.4	3.8	9.0	4.3	3.4	75.7	2.7	3.8	54.3
PLEKHA7	DKFZp686M22243	ENSG00000166689	"Pleckstrin homology domain containing A7"	Q6IQ23	11	16777297-17014414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 111.0;Gastric mucus-secreting cells: 40.8;Microglial cells: 48.7;Oligodendrocytes: 37.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"eosinophil: 3.7;MAIT T-cell: 2.0"	"Group enriched"	"Detected in many"	6	"granulocytes: 3.7;T-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 116.4;HaCaT: 75.2;OE19: 58.6;RT4: 109.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038610, HPA066103"	Approved		Enhanced	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Cell Junctions"	Cytosol	"HPA038610: AB_10671746, HPA066103: AB_2732738"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.81e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.51e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.13e-2)"	"prognostic favorable (1.89e-15)"	"unprognostic (9.74e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.81e-1)"	"unprognostic (2.65e-2)"	10.3	1.7	10.0	5.5	11.9	0.6	13.3	9.6	7.0	11.2	26.5	18.3	27.3	4.1	3.8	46.0	9.1	7.3	24.0	7.5	14.3	26.4	16.7	8.0	2.3	11.5	17.9	12.7	15.2	17.6	4.2	9.0	11.8	7.0	16.9	27.4	21.5	5.3	2.2	14.1	25.4	3.6	7.3	1.8	23.7	10.1	21.2	4.0	10.9	2.2	6.6	14.0	18.3	10.3	14.2	12.7	11.9	5.5	0.7	0.0	20.7	0.1	0.4	4.9	9.0	22.6	116.4	0.2	5.4	1.9	0.7	75.2	16.9	0.2	3.5	4.2	16.2	39.7	11.2	13.5	0.3	0.1	0.5	0.6	6.4	0.0	0.4	10.7	0.0	14.3	1.7	0.4	2.0	8.7	8.8	0.3	6.1	58.6	12.4	11.5	0.0	3.0	10.9	109.9	8.3	0.9	16.7	44.3	0.6	22.3	11.3	4.1	3.3	0.2	4.1	3.2	2.8	7.6	2.4	16.2	0.1	0.8	0.1	0.1	0.1	3.7	0.3	0.0	2.0	0.1	0.3	0.2	0.1	0.0	0.1	0.2	0.3	0.1	0.0	0.4	0.0	0.2	10.0	11.9	9.6	7.0	7.5	14.3	11.5	17.9	11.8	7.3	21.2	10.3	8.2	3.2	17.0	111.0	0.6	0.6	1.1	1.4	0.6	2.3	6.9	6.1	8.7	7.2	8.6	11.0	25.0	6.7	0.2	12.0	3.9	6.1	16.3	20.5	2.3	4.7	0.0	1.3	19.3	6.0	0.9	1.0	40.8	22.9	2.5	16.1	2.2	2.9	1.8	0.0	26.2	6.5	0.0	1.0	1.4	6.1	0.6	2.7	0.0	48.7	0.8	4.3	1.0	15.6	37.9	10.7	4.1	0.4	1.8	0.8	9.2	10.6	8.0	9.7	0.0	1.0	1.2	0.5	0.5	12.3	0.4	6.0	1.2	2.1	3.1	6.4
PLXNB1	"KIAA0407, PLXN5, SEP"	ENSG00000164050	"Plexin B1"	O43157	3	48403854-48430086	"Plasma proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 121.1;Oligodendrocytes: 70.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 37.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040586	Enhanced				"Intracellular and membrane"	NA	NA		95000000		"Cluster 70: Brain - Nervous system development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA040586: AB_10794034"	"unprognostic (1.31e-3)"	"unprognostic (7.09e-2)"	"unprognostic (9.63e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (5.03e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.29e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.18e-2)"	"prognostic favorable (2.77e-5)"	"unprognostic (4.01e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.98e-2)"	"prognostic favorable (7.60e-4)"	9.0	2.8	26.6	3.3	54.5	1.0	13.7	34.3	28.6	17.1	33.0	19.5	9.7	19.5	5.6	22.9	25.3	10.3	10.4	22.0	28.3	27.6	28.9	11.4	1.6	42.9	43.9	19.1	26.0	6.1	17.9	6.8	41.5	22.9	5.4	4.2	17.3	15.8	1.7	24.6	13.0	7.5	26.5	6.5	14.7	3.9	40.4	5.0	35.8	1.4	2.0	16.3	21.4	61.0	5.5	9.2	16.7	9.9	6.1	4.9	34.1	4.6	2.6	2.6	1.7	11.3	20.7	0.0	16.6	3.2	1.7	16.3	3.6	37.0	0.5	9.7	0.7	0.0	19.9	21.5	8.9	7.5	3.1	8.8	31.5	0.6	7.5	10.1	4.3	3.7	1.4	0.8	2.5	9.5	1.3	6.5	29.7	12.0	2.0	8.4	3.6	1.3	15.6	24.5	8.5	18.4	5.9	34.6	5.3	4.4	18.5	6.2	8.5	2.6	7.8	3.8	5.3	0.3	0.0	0.2	0.5	2.2	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.6	54.5	34.3	28.6	22.0	28.3	42.9	43.9	41.5	26.5	40.4	61.0	3.2	35.3	24.3	121.1	0.7	11.5	15.8	26.1	32.5	2.6	23.3	31.5	17.7	30.0	27.5	46.0	2.1	23.7	0.2	36.2	5.9	18.5	4.3	54.2	9.3	5.0	52.7	3.2	1.4	15.8	2.4	7.2	26.5	41.8	0.0	11.2	5.3	59.7	2.9	3.3	2.6	21.2	30.5	3.1	1.2	5.1	15.2	1.0	1.8	4.7	0.7	24.3	0.0	21.6	70.1	21.9	21.8	15.4	0.3	11.4	21.5	12.7	56.5	5.7	0.0	6.1	13.0	1.4	2.7	22.3	9.7	9.9	1.3	0.5	28.3	11.6
PLXNB3	"PLEXB3, PLEXR, PLXN6"	ENSG00000198753	"Plexin B3"	Q9ULL4	X	153764196-153779346	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 210.2;intestine: 57.2"	"Group enriched"	"Detected in some"	8	"Astrocytes: 43.8;Oligodendrocytes: 72.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"WM-115: 70.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048046	Enhanced					NA	NA		390000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA048046: AB_2680239"	"prognostic unfavorable (6.13e-4)"	"unprognostic (2.60e-1)"	"unprognostic (9.10e-4)"	"unprognostic (2.30e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.76e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.68e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.98e-2)"	14.7	28.8	74.4	2.0	122.8	0.7	16.0	86.1	110.8	10.8	28.7	57.2	2.3	23.6	3.9	7.0	11.9	4.9	9.6	77.4	83.0	1.8	1.1	2.8	0.5	105.0	102.2	1.8	6.5	0.2	3.1	0.4	101.5	16.6	2.0	2.4	26.3	8.5	0.8	10.0	9.3	6.5	71.3	0.7	13.6	11.5	123.9	0.1	1.7	0.4	0.3	20.8	13.0	210.2	9.3	1.1	1.1	0.7	1.2	0.7	0.7	8.5	1.7	1.1	3.0	0.0	0.1	0.0	5.4	2.4	1.6	1.0	0.0	7.2	0.9	0.1	0.0	5.8	12.0	6.6	2.3	0.0	0.6	1.8	5.2	5.2	3.2	19.8	3.4	0.2	0.5	3.1	2.3	7.6	0.1	1.4	0.2	6.3	14.0	2.8	0.9	0.1	1.4	4.2	2.4	7.5	0.4	7.8	20.2	0.2	10.4	0.0	15.0	8.6	4.4	6.8	10.9	3.0	0.8	0.2	18.6	0.5	70.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	74.4	122.8	86.1	110.8	77.4	83.0	105.0	102.2	101.5	71.3	123.9	210.2	0.0	0.0	0.0	43.8	0.1	0.0	0.0	0.0	1.2	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	6.6	72.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0
PNPLA7	"C9orf111, FLJ31318, FLJ43070, FLJ44279, NTE-R1, NTEL1, RP11-48C7.2"	ENSG00000130653	"Patatin like phospholipase domain containing 7"	Q6ZV29	9	137459952-137550402	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 56.2;Excitatory neurons: 23.6;Inhibitory neurons: 21.5;Oligodendrocytes: 21.0"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 9.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 1.0;T-reg: 1.2"	"Group enriched"	"Detected in many"	4	"B-cells: 1.0;T-cells: 1.2"	"Cell line enriched"	"Detected in some"	22	"HMC-1: 83.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009130	Uncertain		Uncertain	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol	"Centriolar satellite"	"HPA009130: AB_2268411"	"unprognostic (1.49e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.38e-2)"	"unprognostic (3.68e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.72e-3)"	"unprognostic (5.14e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.40e-2)"	"prognostic favorable (2.24e-5)"	"unprognostic (1.09e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.42e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.81e-2)"	"unprognostic (3.45e-3)"	9.6	7.0	5.2	2.2	5.3	2.1	11.3	1.9	8.6	17.6	1.2	10.8	2.2	12.3	1.0	2.7	13.0	3.7	6.9	6.6	2.6	6.3	14.0	4.7	4.4	4.6	2.6	21.5	17.9	2.0	8.9	0.6	3.6	22.5	1.4	1.3	15.9	2.7	17.3	14.3	8.4	1.6	2.2	7.0	16.3	2.6	4.2	1.4	17.3	3.4	1.4	10.5	7.6	5.9	0.1	1.0	0.2	0.3	0.8	0.5	0.4	0.8	0.8	0.2	0.2	0.1	0.5	0.6	0.8	0.4	0.4	0.3	0.1	0.0	0.0	1.6	0.9	0.8	1.0	0.3	0.5	0.4	83.7	1.2	0.1	0.3	0.0	1.4	0.1	0.1	0.1	2.3	0.1	1.6	0.2	1.6	0.0	1.2	0.9	2.0	1.3	2.8	0.1	0.3	1.6	0.4	0.1	0.6	0.3	0.2	3.7	1.2	0.6	0.0	0.1	0.4	0.1	0.8	0.2	0.2	1.2	0.8	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.1	0.1	0.2	1.0	0.3	0.2	0.0	0.0	0.0	0.1	1.2	0.2	5.2	5.3	1.9	8.6	6.6	2.6	4.6	2.6	3.6	2.2	4.2	5.9	3.0	9.6	5.9	56.2	4.8	1.5	1.1	0.9	2.2	2.5	6.5	8.3	3.9	4.3	2.6	1.8	6.2	0.2	2.1	6.6	0.0	0.7	0.5	1.7	4.8	1.2	17.3	0.8	23.6	0.0	0.3	3.6	12.2	3.8	7.0	1.2	2.5	10.2	2.6	5.0	21.5	9.2	0.0	4.5	1.0	0.6	4.4	1.2	0.0	9.4	1.3	2.5	1.0	11.6	21.0	0.6	7.1	1.9	1.6	2.5	3.8	1.0	1.6	9.6	0.0	2.3	2.1	3.1	4.0	0.9	3.3	0.0	2.3	0.6	2.0	0.7
POU3F2	"BRN2, OCT7, OTF7, POUF3"	ENSG00000184486	"POU class 3 homeobox 2"	P20265	6	98834574-98839458	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"brain: 17.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 77.4;Excitatory neurons: 8.8;Muller glia cells: 11.1;Oligodendrocyte precursor cells: 27.2;Oligodendrocytes: 13.4"	"Cancer enriched"	"Detected in some"	11	"glioma: 16.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 125.4;SK-MEL-30: 18.3;U-251 MG: 39.9;WM-115: 33.8"	"Low region specificity"	"Detected in all"							"HPA047081, HPA056261"		Approved	Supported	Nucleoplasm		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA047081: , HPA056261: AB_2683081"	"unprognostic (5.94e-4)"	"unprognostic (7.80e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.63e-3)"	"unprognostic (4.77e-1)"	"unprognostic (9.38e-11)"	"unprognostic (4.77e-2)"	"unprognostic (2.84e-2)"	"unprognostic (8.47e-3)"	"unprognostic (4.04e-1)"	0.0	0.0	9.7	0.0	9.6	0.0	0.0	11.4	15.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	13.0	0.0	0.0	0.0	0.0	9.8	17.3	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.1	10.6	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	125.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	5.6	0.0	0.0	0.2	7.6	0.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.6	5.0	0.0	0.1	0.0	1.0	0.0	0.6	0.0	5.5	4.3	1.0	0.0	0.0	0.0	6.9	3.6	0.0	0.0	18.3	0.1	1.0	0.1	0.0	0.7	0.0	0.2	39.9	0.1	0.0	0.0	0.2	0.0	33.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	9.6	11.4	15.5	7.6	13.0	9.8	17.3	9.3	10.5	10.6	12.2	0.1	0.0	0.0	77.4	0.0	0.1	0.4	0.0	0.0	0.2	0.1	0.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	8.8	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.8	0.0	11.1	0.0	27.2	13.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.8	0.4	0.3	1.4	0.0	0.1	0.0	0.4	0.0	0.1	0.3
PRDM16	"KIAA1675, KMT8F, MEL1, MGC166915, PFM13"	ENSG00000142611	"PR/SET domain 16"	Q9HAZ2	1	3069168-3438621	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 16.2"	"Cell type enriched"	"Detected in many"	4	"Astrocytes: 173.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	16	"NK-cell: 2.4"	"Lineage enriched"	"Detected in single"	16	"NK-cells: 2.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.8;HHSteC: 2.0;hTERT-RPE1: 6.7;MCF7: 1.6;OE19: 3.5"	"Region enriched"	"Detected in many"	5	"basal ganglia: 15.7"	"Low region specificity"	"Detected in many"			"HPA050343, HPA060467"			Supported	Nucleoplasm		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA050343: AB_2681099, HPA060467: AB_2684287"	"unprognostic (2.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.31e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.15e-3)"	"unprognostic (5.68e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.07e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.80e-6)"	"unprognostic (2.14e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (4.70e-5)"	"unprognostic (4.06e-2)"	1.6	0.2	3.7	0.5	4.8	0.0	1.1	0.1	4.1	1.3	16.2	1.1	7.4	1.0	2.1	0.3	1.4	1.1	5.4	2.8	0.6	6.8	0.2	2.5	0.5	0.5	1.7	1.5	5.8	0.9	0.6	0.1	0.9	0.7	0.2	0.0	0.4	2.2	0.4	0.5	2.6	0.2	0.0	2.1	9.3	0.7	4.1	0.1	8.0	0.6	0.3	0.9	1.1	1.5	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.3	0.0	0.2	0.0	0.2	0.0	1.3	0.0	0.0	0.1	1.8	0.0	0.0	0.3	2.0	0.0	0.7	0.0	0.0	0.0	0.0	6.7	0.0	0.1	0.0	0.0	0.0	1.6	0.1	0.0	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	3.7	4.8	0.1	4.1	2.8	0.6	0.5	1.7	0.9	0.0	4.1	1.5	4.5	35.3	10.5	173.7	0.1	0.6	0.3	2.1	0.6	0.1	0.2	0.3	5.2	22.8	6.3	7.3	0.0	0.0	0.1	0.2	5.9	10.0	0.3	0.2	0.0	2.1	5.4	0.8	1.2	4.9	4.2	0.6	30.5	0.4	0.0	0.3	0.0	0.0	0.0	1.7	1.0	0.9	0.0	0.0	0.4	0.2	1.5	0.1	0.0	14.0	0.0	1.4	0.0	6.6	1.8	7.1	0.8	1.9	0.1	0.8	0.5	0.2	1.9	0.3	0.0	3.3	9.0	0.3	1.8	0.2	0.0	0.0	0.4	0.0	1.5	0.2
PREX2	"DEP.2, DEPDC2, FLJ12987, P-REX2, PPP1R129"	ENSG00000046889	"Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2"	Q70Z35	8	67952046-68237032	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 717.6;Microglial cells: 120.9;Oligodendrocyte precursor cells: 422.2;Oligodendrocytes: 222.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 14.0;HUVEC TERT2: 19.2;JURKAT: 8.3;NTERA-2: 12.1;RH-30: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015234, HPA075956"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Endoplasmic reticulum"		"HPA015234: AB_1847604, HPA075956: AB_2686769"	"unprognostic (2.25e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.37e-2)"	"unprognostic (4.19e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.53e-2)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (1.61e-7)"	"unprognostic (8.30e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.67e-2)"	"unprognostic (6.64e-2)"	9.3	1.0	11.5	1.2	15.2	0.1	5.5	15.8	9.4	4.4	0.1	2.6	1.7	2.5	1.7	1.7	5.5	3.2	3.8	12.5	10.1	1.6	1.2	4.4	0.8	16.1	13.5	1.9	1.1	1.1	1.9	8.1	13.2	2.5	1.7	3.6	1.3	2.2	2.2	1.7	1.8	2.5	12.6	1.3	1.6	0.9	13.4	0.9	7.3	5.0	1.0	2.7	2.6	14.1	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	8.3	0.0	0.0	0.0	0.0	3.0	0.0	12.1	0.0	0.0	0.0	5.5	0.0	0.7	0.0	3.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.3	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	15.2	15.8	9.4	12.5	10.1	16.1	13.5	13.2	12.6	13.4	14.1	103.3	3.2	5.0	717.6	0.3	4.0	3.6	0.0	0.0	21.8	0.6	0.8	6.1	1.5	3.1	1.8	2.1	0.0	0.6	0.0	0.0	0.2	52.7	15.2	3.2	57.0	0.0	0.0	2.2	0.0	0.0	19.7	0.0	26.2	1.3	0.0	56.4	0.7	0.1	5.0	81.3	0.0	0.0	2.7	5.1	9.6	11.1	0.8	8.8	120.9	0.0	65.8	0.0	422.2	222.1	0.0	0.0	10.5	1.3	0.8	0.0	0.0	0.7	4.1	26.3	3.9	13.8	0.9	1.2	0.5	2.6	0.0	1.1	0.2	0.0	1.6
PRODH	"HSPOX2, PIG6, PRODH1, PRODH2, TP53I6"	ENSG00000100033	"Proline dehydrogenase 1"	O43272	22	18912777-18936553	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase	"Disease variant, Schizophrenia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 49.2;skin 1: 39.8"	"Cell type enriched"	"Detected in some"	7	"Astrocytes: 183.1"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"OE19: 91.3;RPTEC TERT1: 35.9"									HPA020361	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria	"Nucleoplasm, Vesicles"	"HPA020361: AB_10963116"	"unprognostic (2.46e-2)"	"prognostic favorable (1.54e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.94e-2)"	7.9	0.7	5.8	0.4	6.4	0.0	8.5	3.1	9.0	5.0	34.0	3.1	5.6	1.5	0.1	11.6	5.8	0.1	18.6	6.5	2.8	16.7	15.6	20.6	0.2	7.3	4.7	0.5	1.4	0.0	5.4	0.2	2.5	3.2	0.3	0.6	4.2	0.2	49.2	39.8	32.5	0.0	3.3	0.5	3.5	1.7	7.6	0.3	7.4	6.2	0.8	4.2	8.5	3.4	0.0	0.8	0.0	0.3	0.9	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.3	0.0	0.0	2.9	3.9	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.9	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.6	4.5	91.3	0.0	0.0	0.0	0.4	35.9	0.9	0.1	0.2	0.8	1.4	0.3	5.2	1.4	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.8	6.4	3.1	9.0	6.5	2.8	7.3	4.7	2.5	3.3	7.6	3.4	0.1	16.0	25.6	183.1	0.0	5.1	0.3	13.1	0.0	0.0	0.2	0.1	1.8	0.0	11.5	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.6	1.2	0.2	0.4	3.5	0.0	0.5	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.0	2.0	0.0	1.5	0.1	0.0	0.1	21.4	17.8	0.0	0.6	0.0	14.1	2.1	0.0	2.3	0.0	0.0	0.0	8.0	0.1	21.0	0.1	0.0	1.1	0.6	0.2	0.4	1.0	15.2	0.0	0.3	0.0	1.6	0.2
PRTFDC1	HHGP	ENSG00000099256	"Phosphoribosyl transferase domain containing 1"	Q9NRG1	10	24848614-24952606	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 136.1;Oligodendrocyte precursor cells: 111.6;Oligodendrocytes: 148.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"NK-cell: 4.4"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 4.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 75.9;CAPAN-2: 94.3;HEL: 56.2"					"Low region specificity"	"Detected in all"			HPA021458	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA021458: AB_1855793"	"unprognostic (2.61e-1)"	"unprognostic (3.47e-1)"	"unprognostic (3.69e-1)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (9.49e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (9.27e-5)"	"unprognostic (2.25e-2)"	"unprognostic (2.50e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.94e-2)"	5.4	22.2	21.7	4.5	28.7	0.9	7.6	24.9	27.2	12.9	16.1	9.9	17.7	15.8	7.4	5.5	9.8	14.8	10.9	22.4	24.6	4.8	2.8	4.3	4.2	26.7	24.0	20.2	4.6	13.4	11.4	2.9	28.0	7.8	11.3	16.5	9.7	8.2	1.3	1.8	17.1	9.8	25.8	3.2	17.5	2.2	23.7	6.8	5.3	2.8	3.2	7.4	6.3	37.1	19.5	41.3	30.2	12.4	4.9	24.4	0.0	20.2	15.1	14.2	19.3	75.9	94.3	0.0	3.1	23.7	1.2	10.7	34.7	0.0	22.0	0.0	1.4	56.2	7.6	0.1	14.6	0.0	0.0	7.1	0.2	7.7	0.0	13.3	22.6	2.2	18.6	10.5	6.8	0.5	8.8	0.1	20.9	3.3	0.7	9.7	0.1	0.2	12.7	0.5	21.5	0.9	19.3	0.1	0.0	0.6	1.1	4.3	12.2	6.3	15.5	23.1	12.2	0.9	0.0	0.0	16.8	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.2	0.2	0.1	0.0	0.0	0.2	0.0	4.4	0.0	0.1	0.0	0.9	21.7	28.7	24.9	27.2	22.4	24.6	26.7	24.0	28.0	25.8	23.7	37.1	3.5	0.0	0.5	136.1	0.7	2.7	4.6	5.4	2.8	10.2	1.1	5.8	8.6	7.2	3.9	3.7	2.1	1.0	0.8	3.8	5.9	5.8	1.4	1.5	27.3	2.8	5.4	3.0	38.2	0.5	4.9	20.6	12.2	2.2	0.0	25.1	7.5	0.1	7.2	6.7	43.0	7.3	0.0	0.9	3.1	1.0	12.2	7.8	3.6	24.4	1.5	45.8	0.0	111.6	148.2	2.3	2.1	9.8	1.3	1.1	12.2	0.1	1.1	15.9	0.0	16.4	10.4	3.4	6.3	0.4	2.8	0.8	1.0	22.7	11.6	1.5
PSD2	"DKFZp761B0514, EFA6C"	ENSG00000146005	"Pleckstrin and Sec7 domain containing 2"	Q9BQI7	5	139795808-139844466	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 106.3"	"Cell type enriched"	"Detected in some"	4	"Astrocytes: 229.9"	"Cancer enriched"	"Detected in single"	43	"glioma: 19.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"THP-1: 1.1;U-2 OS: 1.1;U-698: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054625			Approved	"Plasma membrane"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"		"HPA054625: "	"unprognostic (3.76e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.34e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.22e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.16e-3)"	"unprognostic (3.40e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.12e-3)"	0.1	0.3	70.8	0.3	91.3	0.2	0.5	86.5	63.1	0.8	22.0	0.2	0.1	0.2	1.6	0.0	0.4	0.2	0.2	58.7	76.3	0.1	0.1	0.1	0.0	90.6	106.2	0.1	0.4	0.0	0.9	0.0	79.2	0.2	0.1	4.1	1.7	0.4	0.3	0.1	0.1	0.1	70.5	0.2	0.1	1.1	106.3	1.0	0.1	0.0	0.1	0.1	0.2	56.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.5	0.9	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.3	1.1	0.0	0.0	0.2	0.0	1.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.8	91.3	86.5	63.1	58.7	76.3	90.6	106.2	79.2	70.5	106.3	56.3	0.0	0.0	0.0	229.9	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	9.1	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	6.5	0.0	2.6	0.0	52.8	24.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.6	0.0	1.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PURG	"PURG-A, PURG-B"	ENSG00000172733	"Purine rich element binding protein G"	Q9UJV8	8	30995802-31033715	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.5;retina: 4.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 61.0;Excitatory neurons: 57.2;Inhibitory neurons: 69.5;Late spermatids: 22.0;Oligodendrocyte precursor cells: 49.3;Oligodendrocytes: 27.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.1;JURKAT: 4.3;NTERA-2: 4.8;SH-SY5Y: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047746	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Plasma membrane"	Nucleoli	"HPA047746: AB_2680145"	"unprognostic (3.37e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.33e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.79e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.30e-2)"	0.3	0.4	7.7	0.2	8.3	0.0	0.2	10.5	9.0	1.3	0.5	0.3	0.1	2.0	0.6	0.2	0.4	0.8	0.4	8.7	7.7	0.4	0.0	0.2	0.2	6.6	6.7	0.5	0.0	0.0	3.0	0.2	7.4	0.5	0.1	4.1	0.3	0.6	0.1	0.0	0.2	1.3	6.1	0.6	0.2	2.6	7.3	0.1	0.2	0.2	0.1	0.2	0.8	6.5	0.0	0.0	6.1	0.1	0.0	0.0	0.0	0.1	0.3	0.5	1.2	0.0	0.0	0.1	0.0	0.0	2.1	0.0	2.0	0.0	0.7	0.0	3.1	1.1	0.0	0.2	0.0	0.0	0.1	0.9	0.0	0.9	0.0	0.7	3.0	4.3	0.3	0.4	0.1	0.0	0.6	0.0	4.8	0.0	0.2	1.6	0.8	0.0	0.0	0.0	0.8	5.7	0.0	0.0	0.0	2.2	0.0	0.0	1.9	2.0	2.5	0.0	0.3	0.2	0.0	0.1	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	8.3	10.5	9.0	8.7	7.7	6.6	6.7	7.4	6.1	7.3	6.5	0.5	0.0	0.0	61.0	0.0	0.0	0.0	0.0	0.0	13.3	0.1	0.3	0.6	0.0	0.0	0.0	2.1	0.0	0.1	0.1	0.0	0.0	17.3	0.2	3.2	0.5	0.0	0.0	57.2	0.0	0.0	1.1	0.0	0.1	0.0	3.6	0.0	0.0	0.0	20.2	69.5	0.0	0.0	0.0	0.3	22.0	0.6	0.1	0.0	12.2	0.0	10.8	0.0	49.3	27.8	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.3	1.3	4.2	1.5	0.0	0.0	0.0	0.1	1.8	0.0	0.0
RANBP3L	FLJ25422	ENSG00000164188	"RAN binding protein 3 like"	Q86VV4	5	36246913-36302114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.9;kidney: 24.6"	"Cell type enriched"	"Detected in some"	7	"Astrocytes: 355.9"	"Group enriched"	"Detected in some"	5	"breast cancer: 1.4;glioma: 3.7;prostate cancer: 4.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"ASC diff: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA037471, HPA037472, HPA061526"	Approved		Uncertain	Nucleoplasm		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA037471: AB_10671756, HPA037472: AB_2675489, HPA061526: AB_2684552"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.41e-3)"	"unprognostic (5.52e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.08e-2)"	"unprognostic (9.56e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.76e-4)"	"unprognostic (1.68e-2)"	"unprognostic (9.13e-2)"	"unprognostic (8.87e-3)"	"unprognostic (5.71e-2)"	3.8	1.7	25.2	0.3	27.0	0.0	7.6	4.6	29.9	1.2	5.4	0.8	0.2	0.7	1.8	0.5	1.2	1.8	1.5	25.1	12.2	24.6	9.9	2.0	0.2	9.9	18.9	2.1	0.4	0.2	2.9	5.0	7.4	13.5	0.4	5.3	0.6	2.9	0.4	0.4	0.4	0.6	12.6	0.2	1.8	4.7	18.6	0.1	2.2	2.9	0.6	6.9	0.8	15.2	0.0	0.0	0.1	0.2	12.1	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.2	27.0	4.6	29.9	25.1	12.2	9.9	18.9	7.4	12.6	18.6	15.2	0.3	0.0	0.0	355.9	0.0	0.0	0.1	0.0	0.6	0.4	4.1	2.3	0.3	0.0	0.0	9.2	0.0	0.0	1.3	0.0	46.9	0.0	0.1	0.1	0.7	0.4	0.0	0.0	5.1	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.4	1.3	1.9	0.0	4.5	0.0	0.0	0.0	0.3	0.8	2.1	0.2	1.8	23.4	0.0	16.1	0.0	5.5	2.8	0.0	0.0	2.2	0.0	1.3	0.0	0.2	0.0	0.6	13.1	0.6	8.3	0.0	0.1	0.0	0.0	0.1	0.0	3.0	0.0	0.1
RFX4		ENSG00000111783	"Regulatory factor X4"	Q33E94	12	106583004-106762803	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 54.1;testis: 75.0"	"Group enriched"	"Detected in some"	5	"Astrocytes: 346.7;Spermatocytes: 98.7"	"Cancer enriched"	"Detected in single"	54	"glioma: 15.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"AF22: 48.0"	"Low region specificity"	"Detected in all"							HPA050527	Enhanced		Approved	Nucleoplasm		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA050527: AB_2681158"	"unprognostic (3.67e-1)"		"unprognostic (4.86e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.09e-1)"		"unprognostic (6.97e-2)"	"unprognostic (7.97e-2)"	"unprognostic (3.04e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.46e-2)"		0.1	0.0	32.0	0.0	36.0	0.0	0.0	32.8	27.6	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	28.8	54.1	0.0	0.0	0.0	0.0	52.7	46.7	0.0	0.1	0.0	9.9	0.0	40.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	40.5	0.0	0.0	75.0	38.8	0.0	0.1	0.0	0.0	0.0	0.0	34.0	0.0	0.3	48.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	3.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	32.0	36.0	32.8	27.6	28.8	54.1	52.7	46.7	40.2	40.5	38.8	34.0	0.0	0.0	0.0	346.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	41.8	0.0	0.1	0.2	0.0	0.0	13.7	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	13.4	0.0	0.0	0.0	0.0	29.2	2.1	0.0	0.0	7.5	0.1	0.1	0.0	27.6	2.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.9	0.1	98.7	2.9	0.0	0.0	0.0	0.2	0.1	0.0	0.0
RGS20	"RGSZ1, ZGAP1"	ENSG00000147509	"Regulator of G protein signaling 20"	O76081	8	53851795-53959303	"Plasma proteins, Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 12.5;choroid plexus: 3.9;retina: 4.9"	"Cell type enriched"	"Detected in some"	7	"Astrocytes: 238.6"	"Cancer enhanced"	"Detected in many"		"melanoma: 12.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 27.7;SK-MEL-30: 30.4;U-87 MG: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070193	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA070193: AB_2732150"	"unprognostic (2.14e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.91e-5)"	"unprognostic (5.03e-5)"	"unprognostic (2.15e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.86e-3)"	"unprognostic (5.28e-2)"	"unprognostic (2.75e-8)"	"unprognostic (3.71e-3)"	"unprognostic (9.78e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.69e-2)"	0.1	0.0	8.5	0.0	12.5	0.0	0.1	6.6	11.3	0.8	3.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	8.2	6.3	0.0	0.0	0.0	0.0	5.4	5.1	0.0	0.0	0.0	0.1	1.2	5.0	0.0	0.0	4.9	0.3	0.0	0.0	2.6	0.0	0.0	5.4	0.0	0.0	0.1	7.3	0.0	1.3	0.0	0.2	0.0	1.0	7.8	14.6	10.1	19.3	0.3	0.7	2.3	0.0	7.9	4.6	6.7	4.0	0.0	8.8	0.0	0.4	2.2	27.7	10.6	0.4	12.8	4.5	0.0	1.5	2.5	1.5	1.7	3.1	0.0	0.9	0.4	8.1	5.5	16.0	14.9	2.6	0.0	0.7	0.0	11.3	0.0	0.0	0.4	0.3	2.1	4.0	0.0	0.6	0.0	12.9	0.9	12.0	1.1	0.6	0.0	30.4	2.8	0.0	0.1	8.5	1.7	0.0	14.4	5.9	2.4	0.0	0.0	28.9	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	12.5	6.6	11.3	8.2	6.3	5.4	5.1	5.0	5.4	7.3	7.8	0.2	0.0	0.0	238.6	0.1	2.0	0.5	10.9	0.6	1.3	0.2	0.0	0.8	0.0	2.7	0.0	31.3	0.7	0.0	0.1	0.0	0.6	0.5	4.2	1.0	0.2	0.0	0.0	3.2	0.4	0.8	0.6	0.0	5.5	0.0	0.0	0.0	0.0	0.2	0.0	6.0	0.0	4.1	0.0	0.0	0.0	0.3	0.1	5.4	9.4	0.0	5.5	0.0	5.0	0.7	1.3	0.0	0.0	0.0	5.1	0.0	0.0	2.6	13.7	0.0	0.1	0.5	0.1	1.3	0.4	0.4	0.7	0.1	0.0	0.0	0.6
RNF182	MGC33993	ENSG00000180537	"Ring finger protein 182"	Q8N6D2	6	13924446-13980310	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.7;choroid plexus: 12.7"	"Cell type enriched"	"Detected in some"	4	"Astrocytes: 85.2"	"Cancer enhanced"	"Detected in many"		"glioma: 5.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 81.3;RPTEC TERT1: 67.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012309	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Golgi apparatus"	Vesicles	"HPA012309: AB_1856349"	"unprognostic (1.29e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (4.66e-5)"	"unprognostic (6.16e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.01e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.21e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.33e-5)"	"unprognostic (6.66e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.26e-1)"	1.1	0.1	12.2	0.1	13.3	8.4	0.6	22.5	17.7	0.8	12.7	0.2	0.2	0.6	1.1	0.3	1.2	0.2	0.3	17.6	12.2	1.1	0.0	3.3	0.2	16.9	17.7	0.3	1.7	5.8	1.8	1.3	16.5	0.4	0.1	8.8	1.3	2.1	0.2	0.4	0.3	0.3	14.2	0.2	0.2	3.7	24.7	1.5	1.3	0.1	0.0	0.3	0.4	12.2	0.2	6.5	12.0	0.0	4.1	5.0	0.7	6.3	8.6	17.0	16.4	0.3	0.1	0.0	0.1	6.8	18.5	0.0	14.3	0.1	30.9	0.0	4.7	0.4	81.3	0.0	0.0	0.1	0.0	2.8	0.0	26.3	0.2	19.5	0.3	3.5	0.5	0.0	11.9	0.2	0.1	2.2	6.9	0.1	23.9	3.8	2.9	1.0	67.3	0.0	14.2	13.7	0.6	0.0	24.8	4.4	0.0	2.4	6.5	20.7	4.4	0.2	14.3	0.0	0.0	0.0	14.1	0.0	30.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	13.3	22.5	17.7	17.6	12.2	16.9	17.7	16.5	14.2	24.7	12.2	0.2	0.0	0.0	85.2	0.1	0.3	0.1	0.0	0.0	19.3	0.2	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.6	0.4	0.1	0.2	0.0	9.7	8.6	0.0	0.1	0.4	0.0	0.1	0.0	5.4	0.0	0.1	0.1	15.2	1.5	0.1	0.0	0.0	0.3	1.4	0.3	0.0	0.0	5.6	0.0	14.7	0.0	2.5	0.4	0.1	0.0	0.0	0.0	0.1	0.0	1.1	0.1	1.3	6.6	0.0	1.3	5.7	3.2	0.0	0.0	0.3	0.3	0.0	0.1	0.1
RORA	"NR1F1, ROR1, ROR2, ROR3, RZRA"	ENSG00000069667	"RAR related orphan receptor A"	P35398	15	60488284-61229302	"Disease related genes, Human disease related genes, Metabolic proteins, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Receptor"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 82.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 2125.3;Excitatory neurons: 627.1;Inhibitory neurons: 1056.8;Microglial cells: 757.0;Oligodendrocyte precursor cells: 1524.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	4	"T-cells: 26.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 73.2;U-266/70: 41.7;U-266/84: 62.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009861, HPA074448"	Approved		Supported	Nucleoli		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoli		"CAB009861: AB_2180141, HPA074448: "	"unprognostic (1.57e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.91e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (5.42e-6)"	"unprognostic (6.94e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.62e-2)"	8.2	38.0	19.9	6.2	11.7	17.5	13.6	51.1	13.1	10.5	10.2	6.9	2.6	6.0	4.7	17.3	6.8	9.1	7.2	3.7	12.6	12.6	28.7	11.2	6.2	7.8	36.0	9.9	14.0	10.1	7.6	2.9	5.9	5.7	3.5	37.8	8.5	5.5	41.4	82.8	6.3	5.4	4.5	9.3	6.2	13.9	49.6	4.3	12.8	20.3	7.5	5.2	9.2	4.2	0.1	0.8	2.7	0.0	3.4	1.7	0.9	1.3	1.5	1.2	1.4	1.8	0.5	0.0	0.6	3.4	3.6	0.5	6.1	2.6	2.2	2.9	5.2	0.0	0.4	2.9	1.3	0.0	0.3	7.8	0.6	3.3	0.0	1.1	11.6	11.2	0.2	73.2	5.1	0.2	0.6	0.0	2.1	1.9	1.1	0.1	2.4	1.1	2.4	0.5	1.9	4.4	0.3	0.6	0.1	7.3	0.0	0.0	0.3	10.1	4.5	4.2	0.1	41.7	62.1	0.2	17.0	0.0	1.2	0.2	0.1	0.0	23.2	0.0	26.7	1.4	17.4	16.0	0.0	0.1	5.4	11.5	0.5	6.5	0.1	0.7	16.3	4.7	19.9	11.7	51.1	13.1	3.7	12.6	7.8	36.0	5.9	4.5	49.6	4.2	32.5	41.7	31.7	2125.3	23.4	185.2	30.1	17.0	55.2	167.5	24.7	16.1	26.3	30.0	23.4	58.8	454.5	0.7	185.3	1.4	13.7	21.4	148.8	26.9	52.9	40.8	18.5	42.5	627.1	12.3	1.9	69.4	11.7	36.1	2.5	7.9	34.2	97.2	0.8	126.2	1056.8	3.3	10.2	9.1	35.8	97.1	46.6	8.3	60.5	757.0	4.7	50.4	250.3	1524.0	114.9	8.2	0.5	87.3	88.7	24.0	0.7	44.6	16.0	160.0	39.5	57.9	32.2	1.9	3.8	73.2	423.4	4.7	237.6	11.5	2.1	61.9
SCARA3	"APC7, CSR, CSR1, MSLR1, MSRL1"	ENSG00000168077	"Scavenger receptor class A member 3"	Q6AZY7	8	27633868-27676776	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 136.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 238.6;Collecting duct cells: 66.2;Cytotrophoblasts: 45.8;Muller glia cells: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 179.9;HeLa: 203.2;HUVEC TERT2: 140.1;U-2 OS: 120.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029861, HPA047386"	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Endoplasmic reticulum"		"HPA029861: AB_2673225, HPA047386: AB_2680024"	"unprognostic (2.24e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.95e-2)"	"unprognostic (6.31e-3)"	"unprognostic (6.03e-3)"	23.8	7.2	53.4	15.7	58.6	0.0	17.6	55.6	57.8	58.7	29.9	34.5	5.0	87.9	9.5	23.7	86.8	30.5	13.9	50.3	68.1	11.3	3.9	15.2	13.4	136.5	89.5	13.8	4.1	1.5	9.6	19.5	79.2	25.6	8.5	8.8	35.7	66.5	2.6	17.5	15.4	68.1	80.3	2.8	14.7	3.2	79.2	15.9	51.3	8.0	23.0	31.1	20.7	71.4	1.8	61.0	9.4	0.2	49.9	179.9	40.0	23.8	38.2	25.8	19.1	22.7	15.8	0.0	52.7	50.3	21.1	44.5	0.1	44.9	12.7	0.2	5.1	17.8	203.2	0.8	5.3	0.0	0.1	75.6	2.9	40.2	2.3	35.0	140.1	4.6	0.0	0.2	15.0	11.8	0.2	0.1	12.3	0.0	22.3	0.1	0.0	0.3	8.2	27.4	0.2	5.9	5.7	32.0	0.1	4.8	31.1	0.5	49.9	20.7	120.1	77.2	12.8	0.1	0.1	0.2	35.7	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.4	58.6	55.6	57.8	50.3	68.1	136.5	89.5	79.2	80.3	79.2	71.4	2.3	0.0	0.5	238.6	0.0	3.6	16.2	4.8	14.8	1.0	12.6	19.8	2.2	8.6	6.0	66.2	0.0	45.8	0.6	0.1	0.0	0.4	2.9	3.8	10.1	6.4	0.0	0.0	38.4	0.8	20.4	25.1	1.5	2.0	0.0	5.3	15.4	0.4	4.7	0.0	30.4	0.1	0.0	0.3	2.1	1.3	15.8	0.5	17.8	21.5	0.6	52.4	0.0	19.1	18.1	2.2	0.1	6.4	0.0	5.4	0.0	0.0	6.5	1.5	6.6	1.8	14.7	0.2	1.5	6.2	3.8	8.2	0.3	1.9	0.3	10.3
SFMBT2	KIAA1617	ENSG00000198879	"Scm like with four mbt domains 2"	Q5VUG0	10	7158624-7411486	"Predicted intracellular proteins"		Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 27.7"	"Cell type enriched"	"Detected in many"	4	"Microglial cells: 618.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 23.0;REH: 21.0;RPMI-8226: 20.2;SH-SY5Y: 16.6;THP-1: 25.0;U-937: 16.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035447, HPA035448, HPA070388"	Uncertain		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nuclear speckles"		"HPA035447: AB_2674628, HPA035448: AB_10669904, HPA070388: "	"unprognostic (4.36e-2)"	"unprognostic (2.29e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.65e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.51e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.17e-3)"	"unprognostic (5.37e-3)"	"unprognostic (7.29e-2)"	3.8	4.1	13.0	5.9	13.1	6.6	5.5	10.2	9.8	3.4	5.1	2.8	2.0	4.0	3.7	1.1	4.0	3.5	4.0	7.5	17.6	3.0	1.3	4.7	7.3	20.4	15.0	9.1	1.3	5.7	6.4	3.4	17.1	6.6	3.2	18.0	2.3	3.1	4.2	1.7	4.0	3.3	12.7	9.0	3.1	1.8	27.7	4.5	6.8	2.6	5.8	4.1	4.2	19.0	0.0	4.0	0.3	0.0	0.0	0.0	4.9	0.1	0.0	0.0	0.0	0.0	1.1	7.6	0.0	0.0	0.0	1.9	7.6	0.0	0.0	0.4	7.9	0.0	13.0	0.0	0.7	8.0	1.1	1.1	0.4	0.0	0.3	0.0	0.1	10.0	11.5	23.0	0.0	3.5	7.0	14.3	1.6	0.0	0.0	21.0	2.2	20.2	0.0	0.8	2.0	16.6	0.0	0.1	0.0	2.1	1.3	25.0	0.0	0.0	2.6	0.4	0.2	10.1	13.3	0.0	1.1	16.5	0.3	0.1	0.2	1.1	0.7	2.3	0.4	0.0	0.2	0.5	0.4	0.0	1.0	0.6	0.1	0.9	4.6	3.1	0.0	0.2	13.0	13.1	10.2	9.8	7.5	17.6	20.4	15.0	17.1	12.7	27.7	19.0	8.2	0.0	5.2	148.2	10.2	1.5	1.5	0.0	1.2	8.1	9.3	8.6	9.7	1.5	0.6	0.0	81.3	7.7	22.1	0.1	0.0	0.4	0.2	0.8	15.8	10.1	4.2	6.1	77.3	0.2	2.5	4.2	2.0	3.5	4.5	7.1	5.7	1.1	15.5	0.0	103.9	0.0	0.0	15.7	9.9	0.8	5.0	26.3	5.4	618.3	11.4	12.4	15.5	26.2	113.7	0.1	0.0	2.2	25.8	11.4	0.0	0.3	0.7	34.1	0.0	4.4	2.6	0.3	3.9	0.2	1.3	4.4	25.8	2.5	0.2	0.6
SFXN5	"BBG-TCC, SLC56A5"	ENSG00000144040	"Sideroflexin 5"	Q8TD22	2	72942036-73075619	"Predicted intracellular proteins, Predicted membrane proteins"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 63.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 405.2;Early spermatids: 96.4;Late spermatids: 168.4"	"Cancer enhanced"	"Detected in all"		"glioma: 13.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015473, HPA056866"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Mitochondria"		"HPA015473: AB_1856794, HPA056866: AB_2683261"	"unprognostic (7.75e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (2.26e-6)"	"unprognostic (1.57e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.50e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.43e-2)"	3.2	11.7	52.1	4.6	45.5	13.7	2.5	40.0	63.6	3.2	21.9	6.1	6.9	3.1	16.6	3.1	4.2	4.0	3.5	48.0	45.2	11.4	29.4	3.6	3.9	51.5	49.2	2.6	2.4	2.0	3.5	3.7	41.4	4.2	5.7	6.2	2.2	4.5	7.7	4.5	6.5	3.9	42.6	5.6	4.6	2.4	57.0	4.9	3.7	4.6	3.0	3.8	2.3	37.4	4.2	9.1	13.7	11.5	3.0	5.0	5.4	8.4	5.4	13.3	6.9	13.7	10.7	2.3	8.8	8.9	9.2	3.7	10.8	11.1	6.0	10.2	6.7	10.7	11.0	18.7	4.4	5.9	11.1	5.8	3.5	9.0	1.1	4.9	7.4	3.2	9.5	2.9	4.3	8.7	1.5	9.5	17.1	8.1	6.6	10.6	12.2	3.1	8.1	10.5	9.0	2.7	8.6	4.3	3.5	7.7	2.2	5.3	6.8	4.1	13.5	6.1	10.2	4.0	4.1	3.1	15.0	10.3	5.3	4.7	6.0	3.5	0.6	2.6	0.9	1.6	0.3	0.7	2.7	2.4	0.4	0.5	4.6	4.3	3.2	1.9	0.7	1.7	52.1	45.5	40.0	63.6	48.0	45.2	51.5	49.2	41.4	42.6	57.0	37.4	7.1	0.0	4.4	405.2	4.8	4.7	4.3	7.6	4.6	26.8	6.9	5.5	5.8	7.2	4.8	36.8	33.3	12.4	6.8	18.4	3.9	5.1	96.4	5.1	13.1	7.6	13.8	13.7	84.4	9.1	2.4	8.9	9.2	11.2	0.0	42.8	9.3	61.3	12.4	20.2	57.4	8.6	2.0	8.7	9.6	168.4	10.5	9.6	8.8	43.1	19.7	65.8	10.3	40.2	29.9	8.0	6.5	11.3	7.1	3.6	17.5	22.2	3.2	42.3	13.1	12.2	8.8	11.2	15.7	7.3	9.2	4.2	6.3	15.9	8.8	2.3
SLC1A2	"EAAT2, GLT-1"	ENSG00000110436	"Solute carrier family 1 member 2"	P43004	11	35251205-35420063	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 782.3;choroid plexus: 202.7"	"Cell type enriched"	"Detected in many"	7	"Astrocytes: 4607.2"	"Cancer enriched"	"Detected in some"	5	"glioma: 28.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.1;BJ hTERT+: 2.4;fHDF/TERT166: 1.7;Hep G2: 2.9;NTERA-2: 3.1;SCLC-21H: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002574, HPA009172, HPA067499"	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"			"CAB002574: AB_564087, HPA009172: AB_1849764, HPA067499: "	"unprognostic (8.00e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.39e-2)"	"unprognostic (9.27e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.35e-1)"	"unprognostic (8.33e-4)"	"unprognostic (6.34e-2)"	"unprognostic (8.06e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.49e-2)"	0.6	4.6	546.9	0.6	731.2	0.4	3.8	388.1	782.3	1.2	202.7	0.2	0.5	1.0	0.3	0.2	0.3	0.2	0.9	631.1	432.5	0.2	34.9	0.6	1.9	450.6	533.6	0.1	9.5	0.1	2.6	1.1	384.2	0.3	0.1	60.1	4.6	0.1	0.3	1.3	0.2	0.3	409.7	0.5	2.1	1.7	498.7	0.2	0.3	0.5	1.6	0.3	0.6	453.4	0.0	0.1	0.5	0.0	0.2	2.1	0.0	0.5	2.4	0.1	0.1	0.0	0.0	0.0	0.0	1.7	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.3	2.9	0.1	0.3	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.2	0.0	1.1	0.0	0.1	0.5	0.0	0.3	0.1	0.1	0.2	0.0	0.3	0.0	0.0	0.5	0.0	0.1	1.3	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.2	0.1	0.5	0.2	0.1	0.1	0.1	0.1	546.9	731.2	388.1	782.3	631.1	432.5	450.6	533.6	384.2	409.7	498.7	453.4	0.4	3.2	4.8	4607.2	0.4	2.9	0.0	0.0	0.0	109.9	8.1	2.4	3.1	0.0	0.0	0.0	148.0	25.6	0.3	0.1	0.0	0.1	96.6	1.8	11.7	1.6	0.0	0.0	83.7	3.4	1.0	3.1	1.1	1.5	0.0	0.7	0.0	6.7	3.3	6.7	81.5	0.0	0.0	0.0	3.0	97.9	0.0	0.6	1.8	194.9	31.6	10.1	0.0	634.9	12.3	0.4	0.0	0.0	0.1	0.3	0.0	0.1	0.8	161.2	0.0	0.3	1.8	0.5	1.3	0.0	1.1	269.4	0.2	0.0	0.0	0.1
SLC1A3	"EA6, EAAT1, GLAST"	ENSG00000079215	"Solute carrier family 1 member 3"	P43003	5	36596588-36688334	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	10	"brain: 776.8;choroid plexus: 400.6;retina: 221.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1735.2;Microglial cells: 332.6;Muller glia cells: 472.6;Oligodendrocyte precursor cells: 237.7;Oligodendrocytes: 249.0"	"Cancer enriched"	"Detected in all"	21	"glioma: 168.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"classical monocyte: 1.5;intermediate monocyte: 1.2;myeloid DC: 1.6"	"Group enriched"	"Detected in many"	16	"dendritic cells: 1.6;monocytes: 1.5"	"Cell line enhanced"	"Detected in many"		"AF22: 50.0;CACO-2: 112.6;HaCaT: 71.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002573, HPA037467, HPA037468"	Enhanced	Supported	Approved	Nucleoli,Vesicles		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoli, Vesicles"		"CAB002573: AB_564088, HPA037467: AB_10795027, HPA037468: AB_10671371"	"unprognostic (1.23e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.17e-3)"	"unprognostic (3.28e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-2)"	30.7	16.4	500.4	7.4	544.2	3.3	17.7	549.4	776.8	8.7	400.6	3.0	0.5	1.6	1.1	10.5	6.0	8.0	45.4	514.6	502.5	2.2	3.8	10.2	17.4	477.6	510.1	12.6	5.0	2.2	18.1	20.3	502.4	3.2	1.1	221.1	4.7	4.7	14.1	6.0	3.2	4.1	495.4	9.3	2.2	1.2	532.8	3.6	3.4	9.2	5.4	7.0	5.3	494.9	1.3	0.2	50.0	5.3	5.9	14.3	37.7	0.3	0.0	2.4	4.9	112.6	5.6	0.0	27.8	2.3	1.0	71.4	16.9	9.1	2.2	1.8	33.0	0.0	0.5	0.0	2.5	1.3	0.6	26.9	34.5	14.4	5.3	1.8	0.0	1.1	0.0	0.2	8.7	0.2	0.1	0.1	6.0	0.1	5.9	0.0	0.5	0.0	0.1	3.1	4.7	0.0	5.1	14.6	2.1	24.4	0.2	3.1	0.0	6.2	10.3	0.1	20.7	0.0	0.0	0.3	21.7	37.7	12.6	0.0	1.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	500.4	544.2	549.4	776.8	514.6	502.5	477.6	510.1	502.4	495.4	532.8	494.9	1.1	3.2	0.5	1735.2	0.7	10.7	14.3	19.0	83.1	7.1	3.7	3.4	36.0	0.0	3.1	0.0	2.1	32.9	0.1	0.0	0.0	0.8	0.7	16.3	1.2	8.9	0.0	0.8	2.6	0.0	15.9	7.8	2.0	11.7	0.0	0.2	1.1	0.5	41.2	3.3	4.7	0.0	0.0	77.6	5.9	4.1	4.4	59.6	7.2	332.6	3.3	472.6	0.0	237.7	249.0	0.3	0.0	0.0	0.7	5.2	0.0	0.0	5.3	19.1	6.6	2.6	3.1	0.3	0.3	32.7	7.1	9.2	1.0	20.7	0.0	3.6
SLC25A18		ENSG00000182902	"Solute carrier family 25 member 18"	Q9H1K4	22	17563450-17590995	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 143.8;choroid plexus: 90.7;liver: 111.5"	"Group enriched"	"Detected in many"	4	"Astrocytes: 195.2;Hepatocytes: 72.8"	"Group enriched"	"Detected in some"	5	"glioma: 10.6;liver cancer: 11.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.8;BEWO: 8.5"	"Low region specificity"	"Detected in all"							HPA068110			Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria	Nucleoplasm	"HPA068110: "	"unprognostic (2.15e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.72e-2)"	"unprognostic (8.70e-4)"	"unprognostic (1.44e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.62e-1)"	14.4	1.0	130.1	0.3	132.1	0.1	7.2	116.5	141.1	2.5	90.7	2.9	0.3	2.9	0.2	0.3	3.8	0.9	2.8	119.4	123.3	1.9	111.5	1.2	0.3	121.7	129.2	1.2	1.1	0.2	1.5	0.1	112.5	7.8	0.1	1.9	0.5	0.4	6.2	1.2	1.9	0.5	106.5	4.8	1.5	4.2	143.8	0.3	0.6	4.0	0.1	0.8	1.4	110.7	0.3	0.6	2.2	0.4	3.8	0.0	8.5	0.3	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.0	2.5	0.7	0.0	0.0	0.0	0.3	1.0	0.3	0.3	0.5	1.5	0.3	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.4	0.3	0.0	0.4	0.1	0.5	2.0	0.9	1.4	2.9	0.8	0.0	0.1	0.4	0.8	0.3	0.2	0.4	0.7	1.6	2.5	1.0	0.1	0.1	0.3	0.2	0.3	0.9	1.2	0.0	1.8	0.2	0.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	130.1	132.1	116.5	141.1	119.4	123.3	121.7	129.2	112.5	106.5	143.8	110.7	1.0	28.9	10.3	195.2	0.3	0.0	0.3	0.1	0.6	0.6	0.3	0.0	1.5	5.7	7.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.6	0.4	0.9	1.7	0.0	10.7	2.0	0.0	0.3	4.7	0.0	0.7	6.3	8.5	3.6	72.8	0.3	0.0	3.0	0.3	0.0	4.1	0.3	0.6	0.9	3.9	0.0	10.3	0.1	2.2	1.0	13.0	11.5	0.0	0.0	2.6	0.1	4.3	0.1	0.8	15.8	3.4	0.0	2.7	2.5	4.8	5.9	0.0	0.1	1.8	2.6	2.6	0.0	0.2
SLC39A12	FLJ30499	ENSG00000148482	"Solute carrier family 39 member 12"	Q504Y0	10	17951839-18043292	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"choroid plexus: 353.4"	"Group enriched"	"Detected in some"	31	"Astrocytes: 133.5;Muller glia cells: 69.5"	"Cancer enriched"	"Detected in single"	8	"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"		"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (1.43e-2)"				"unprognostic (2.67e-1)"	"unprognostic (3.30e-1)"		"unprognostic (8.70e-2)"	"unprognostic (1.02e-1)"		"unprognostic (8.35e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.40e-6)"	"unprognostic (1.94e-1)"	"unprognostic (8.11e-2)"	"unprognostic (3.76e-2)"		0.1	0.0	27.6	0.0	27.7	0.0	0.7	25.3	39.9	0.0	353.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.5	27.1	0.0	0.1	0.1	0.0	29.9	35.8	0.0	0.1	0.0	1.3	0.1	28.1	0.0	0.1	15.7	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.1	0.0	0.2	36.6	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.6	27.7	25.3	39.9	36.5	27.1	29.9	35.8	28.1	22.0	36.6	23.1	0.1	0.0	0.0	133.5	0.0	0.0	0.0	0.0	0.0	0.7	2.4	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.7	0.2	0.0	0.0	0.4	0.8	0.3	0.2	0.0	2.8	0.0	69.5	0.0	1.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0
SLC4A4	"hhNMC, HNBC1, NBC1, NBC2, pNBC, SLC4A5"	ENSG00000080493	"Solute carrier family 4 member 4"	Q9Y6R1	4	71062667-71572087	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 119.5;pancreas: 260.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 819.1;Cholangiocytes: 133.0;Distal enterocytes: 282.9;Ductal cells: 129.2;Proximal tubular cells: 211.0"	"Group enriched"	"Detected in many"	5	"glioma: 23.9;pancreatic cancer: 22.5;prostate cancer: 47.4;renal cancer: 19.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 13.0;fHDF/TERT166: 6.1;HBF TERT88: 5.7;hTERT-RPE1: 6.0;RPTEC TERT1: 15.4;U-138 MG: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022493, HPA035628, HPA035629, HPA079220"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"			"CAB022493: , HPA035628: AB_2674708, HPA035629: AB_2674709, HPA079220: "	"unprognostic (3.92e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (7.69e-4)"	"unprognostic (5.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.18e-4)"	"unprognostic (7.00e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.04e-1)"	5.1	0.7	30.0	2.2	43.6	0.5	1.0	47.0	32.5	11.5	0.0	41.1	54.3	0.4	0.3	1.2	0.9	29.4	6.2	21.5	37.9	119.5	21.7	6.9	0.2	38.6	28.0	0.8	260.3	17.2	5.8	2.7	24.8	34.7	41.2	5.1	2.5	1.1	2.2	0.1	14.6	1.7	38.2	0.8	18.6	0.5	38.5	3.5	22.0	3.5	0.0	4.5	0.4	33.2	0.0	3.5	1.0	0.0	0.0	0.0	0.1	13.0	1.9	2.2	1.6	0.0	0.1	0.0	0.1	6.1	0.5	0.0	0.2	0.0	5.7	0.0	1.7	0.9	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	6.0	0.0	0.7	0.0	0.5	1.2	0.0	4.8	0.2	0.1	0.2	0.0	0.0	0.0	0.9	15.4	4.1	0.9	0.1	0.0	0.0	0.2	1.3	0.0	0.0	0.0	7.7	0.7	5.5	0.6	0.0	0.0	0.0	5.1	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.1	0.6	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	30.0	43.6	47.0	32.5	21.5	37.9	38.6	28.0	24.8	38.2	38.5	33.2	1.5	3.2	37.1	819.1	2.2	0.0	4.3	3.2	0.6	3.2	0.9	0.3	24.0	133.0	31.1	25.8	0.0	0.3	7.2	282.9	15.6	129.2	11.5	2.8	0.5	1.3	8.5	4.0	51.4	24.2	0.1	4.9	33.1	5.8	1.3	0.6	3.9	35.8	0.2	0.0	93.4	65.6	2.0	0.6	0.2	1.5	0.0	2.3	1.8	34.7	1.0	3.9	1.0	29.1	3.7	16.2	60.8	0.0	1.7	40.8	31.8	211.0	10.4	1.5	6.6	1.0	6.2	0.1	1.0	5.5	0.0	0.3	6.8	2.4	68.1	12.3
SLC6A11	GAT3	ENSG00000132164	"Solute carrier family 6 member 11"	P48066	3	10816201-10940714	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 153.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 85.2;Excitatory neurons: 13.7;Inhibitory neurons: 25.8;Muller glia cells: 26.4;Oligodendrocyte precursor cells: 23.1"	"Cancer enhanced"	"Detected in many"		"glioma: 7.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.2;HaCaT: 13.5;Hep G2: 16.0;hTCEpi: 11.9;NTERA-2: 6.7;T-47d: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037981	Supported	Supported	Uncertain	Nucleoplasm,Vesicles		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Vesicles	"HPA037981: AB_10671383"	"unprognostic (6.04e-2)"	"unprognostic (8.01e-2)"		"unprognostic (1.21e-7)"	"unprognostic (8.60e-2)"	"unprognostic (8.68e-2)"	"unprognostic (9.72e-3)"	"unprognostic (6.39e-3)"	"unprognostic (9.77e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.92e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.51e-3)"	"unprognostic (6.06e-2)"	"unprognostic (4.44e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.31e-2)"	0.0	0.0	50.5	0.0	78.7	0.0	1.1	57.3	32.6	0.7	9.6	0.0	0.0	0.5	0.1	8.2	0.5	0.0	0.0	22.6	96.6	0.0	0.1	0.0	0.0	60.0	128.4	0.0	0.1	0.5	0.3	0.4	61.9	0.7	0.0	11.0	1.0	0.0	0.2	5.7	0.0	0.1	41.8	0.4	0.0	1.4	153.3	0.0	0.0	0.0	0.1	0.4	1.8	21.1	5.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	13.5	0.0	2.2	0.0	0.0	0.2	0.3	0.0	16.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.9	4.5	3.9	0.1	0.0	0.1	5.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.5	78.7	57.3	32.6	22.6	96.6	60.0	128.4	61.9	41.8	153.3	21.1	0.0	0.0	0.0	85.2	0.0	1.3	0.7	0.3	4.0	8.4	0.9	0.9	1.4	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	13.7	0.0	7.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	25.8	0.0	0.0	0.0	0.8	0.9	3.4	0.2	0.0	6.5	0.0	26.4	0.0	23.1	0.8	0.2	0.0	6.8	0.0	0.5	0.0	0.0	0.0	1.5	0.0	0.6	0.1	0.6	1.8	10.6	3.7	1.0	0.1	0.0	0.0	1.7
SLC7A10	asc-1	ENSG00000130876	"Solute carrier family 7 member 10"	Q9NS82	19	33208664-33225850	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"adipose tissue: 31.8;brain: 12.7;breast: 12.7"	"Cell type enriched"	"Detected in some"	4	"Astrocytes: 40.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 1.9;HHSteC: 1.1;HSkMC: 1.6;THP-1: 3.9;U-2 OS: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041884, HPA057036"	Uncertain		Uncertain	Nucleoplasm,Nucleoli		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nucleoli"		"HPA041884: AB_10794494, HPA057036: AB_2683317"	"unprognostic (1.85e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.79e-6)"	"unprognostic (1.16e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.98e-3)"	"unprognostic (4.64e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.28e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.34e-3)"	"unprognostic (8.91e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.18e-2)"	31.8	0.3	7.9	0.1	9.7	0.0	12.7	10.1	11.1	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.3	9.2	0.5	0.0	0.0	0.2	8.5	12.4	0.0	0.1	0.0	0.0	0.2	8.4	0.0	0.0	0.5	0.8	0.0	0.1	0.2	0.5	0.0	6.0	0.0	0.1	0.5	12.7	0.0	0.5	0.4	0.3	0.3	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	3.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	9.7	10.1	11.1	7.3	9.2	8.5	12.4	8.4	6.0	12.7	5.1	0.1	0.0	0.0	40.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.8	0.0	2.4	0.0	9.5	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.1	0.1	0.1	0.0	0.0	0.0
SLC7A11	xCT	ENSG00000151012	"Solute carrier family 7 member 11"	Q9UPY5	4	138164097-138242349	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 368.6;Microglial cells: 148.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 84.2;TIME: 95.2;WM-115: 138.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064215			Approved	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Vesicles		"HPA064215: AB_2685213"	"unprognostic (3.55e-3)"	"unprognostic (4.64e-3)"	"unprognostic (2.43e-2)"	"unprognostic (7.18e-3)"	"unprognostic (2.59e-1)"	"unprognostic (8.80e-3)"	"unprognostic (2.07e-8)"	"unprognostic (1.98e-2)"	"unprognostic (1.09e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (1.90e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.22e-8)"	"unprognostic (3.81e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.54e-2)"	0.2	0.1	18.8	2.2	17.5	1.0	0.4	16.5	16.5	0.9	7.2	0.7	0.4	0.3	6.7	2.6	4.5	1.6	1.7	16.2	26.5	0.1	0.2	1.7	0.4	24.3	22.8	0.5	2.7	0.3	0.8	0.7	19.0	0.6	1.0	4.2	0.7	0.1	0.0	0.6	0.4	0.1	19.8	0.4	4.9	0.8	20.1	0.3	4.6	0.0	0.8	2.7	0.5	20.1	5.2	42.1	18.4	14.5	3.9	5.0	5.1	23.2	15.9	5.2	11.8	4.7	17.7	9.7	29.5	80.8	27.6	6.7	10.0	19.8	21.7	18.5	2.1	6.9	37.7	10.7	59.6	18.1	6.3	11.9	84.2	14.6	64.6	7.6	65.1	9.6	9.5	24.4	27.3	3.7	2.5	1.7	3.6	25.1	11.9	2.8	6.1	11.5	3.1	20.1	7.6	1.5	10.1	2.9	35.4	3.9	4.4	38.1	95.2	6.7	18.8	10.2	18.3	20.5	10.3	9.7	11.4	9.7	138.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	18.8	17.5	16.5	16.5	16.2	26.5	24.3	22.8	19.0	19.8	20.1	20.1	0.5	0.0	8.4	368.6	2.5	4.6	7.5	8.8	1.8	7.3	2.2	1.3	5.4	1.5	8.1	0.0	2.1	3.6	28.5	7.9	0.0	4.4	3.2	3.2	2.3	27.8	27.0	0.8	12.5	25.1	0.7	5.7	65.2	18.3	4.5	1.0	2.9	0.4	0.6	1.7	7.3	19.8	22.4	0.3	63.5	0.8	2.5	18.3	5.4	148.9	51.7	47.9	0.0	12.1	8.6	30.4	1.5	2.2	4.1	58.5	0.4	0.1	7.3	2.0	0.0	2.1	4.0	1.1	0.7	1.9	3.1	1.1	0.9	7.0	4.2	37.6
SLC9C2	"MGC43026, SLC9A11"	ENSG00000162753	"Solute carrier family 9 member C2 (putative)"	Q5TAH2	1	173500460-173603072	"Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.3;choroid plexus: 1.9;testis: 6.0"	"Cell type enriched"	"Detected in some"	4	"Astrocytes: 27.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA059122, HPA079529"	Enhanced		Approved	"Nuclear speckles,Plasma membrane"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"	"Nuclear speckles"	"HPA059122: , HPA079529: "	"unprognostic (2.10e-1)"	"unprognostic (2.69e-1)"		"unprognostic (8.52e-2)"	"unprognostic (5.88e-3)"	"unprognostic (3.24e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.21e-2)"	"unprognostic (4.92e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.18e-6)"	"unprognostic (1.66e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.81e-1)"	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.2	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	1.3	1.2	0.2	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.1	6.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.5	0.2	0.2	0.5	0.3	1.3	1.2	0.8	0.8	0.4	0.6	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.6	0.0	1.3	0.0	6.2	0.1	1.3	0.1	0.0	0.1	6.2	1.7	0.1	0.4	0.0	0.0	5.0	0.0	0.5	0.3	0.0	0.1	0.0	0.5	0.4	1.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	4.7	0.0	0.7	0.0	1.5	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.1	0.1	5.4	0.4	0.0	0.0	0.1	0.0	1.3	0.0	0.0
SLCO1C1	"OATP-F, OATP1, OATP1C1, SLC21A14"	ENSG00000139155	"Solute carrier organic anion transporter family member 1C1"	Q9NYB5	12	20695332-20753386	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 22.2;choroid plexus: 28.3;pituitary gland: 8.1"	"Cell type enriched"	"Detected in some"	12	"Astrocytes: 292.2"	"Cancer enriched"	"Detected in single"	17	"glioma: 4.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	15	"HeLa: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (1.15e-1)"	"unprognostic (8.18e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.64e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.32e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.37e-4)"	"unprognostic (1.56e-3)"	"unprognostic (1.51e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.76e-2)"	1.6	0.1	14.1	0.1	19.6	0.0	0.4	12.9	22.2	0.0	28.3	0.2	0.1	0.0	0.2	0.1	0.0	0.7	0.5	16.4	13.5	0.1	0.0	0.1	0.2	12.8	13.9	0.0	0.1	0.2	8.1	0.0	12.9	0.1	0.2	2.8	0.1	0.0	0.0	0.2	0.3	0.1	12.4	0.0	0.1	1.5	16.6	0.1	0.7	0.5	0.2	0.2	0.0	14.5	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	19.6	12.9	22.2	16.4	13.5	12.8	13.9	12.9	12.4	16.6	14.5	2.4	0.0	0.0	292.2	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	9.5	0.0	0.1	1.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.8	0.1	0.0	0.0	0.0	13.4	1.8	0.0	0.0	23.4	0.1	4.8	0.0	3.5	0.5	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.2	0.0	1.0	5.3	0.5	0.2	0.0	0.0	0.0	0.0	1.2	0.4	0.0
SNCAIP	SYPH1	ENSG00000064692	"Synuclein alpha interacting protein"	Q9Y6H5	5	122311354-122464219	"Disease related genes, Predicted intracellular proteins"			"Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 19.5;ovary: 37.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 84.5;Early spermatids: 68.1;Endometrial stromal cells: 56.9;Inhibitory neurons: 62.8;Oligodendrocyte precursor cells: 30.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	50	"basophil: 7.6"	"Lineage enriched"	"Detected in single"	50	"granulocytes: 7.6"	"Cell line enhanced"	"Detected in some"		"AF22: 5.2;BJ hTERT+: 5.1;HBF TERT88: 3.2;OE19: 3.0;RPMI-8226: 5.2"	"Low region specificity"	"Detected in all"							HPA064687	Uncertain		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Cytoplasmic bodies"	Nucleoplasm	"HPA064687: AB_2685324"	"unprognostic (7.28e-3)"	"unprognostic (1.02e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.47e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.52e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.82e-3)"	"unprognostic (5.77e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.44e-1)"	3.1	1.0	2.5	2.5	7.8	0.3	1.4	7.2	3.0	17.2	10.1	1.1	1.2	19.5	1.3	0.6	5.1	2.5	1.3	2.9	2.9	1.7	0.1	1.2	2.1	4.6	5.2	37.5	0.5	0.2	1.2	2.0	4.2	1.9	1.1	0.5	0.4	2.7	0.3	1.8	0.7	12.0	3.0	5.2	1.0	4.5	5.7	1.7	0.8	1.6	1.5	4.1	2.5	4.3	0.0	0.0	5.2	0.1	0.0	0.0	0.1	2.2	5.1	0.8	0.4	0.0	0.1	0.1	0.1	2.2	0.4	0.0	2.1	0.3	3.2	1.9	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.2	0.0	0.6	0.1	0.0	0.8	0.0	0.0	0.0	0.1	2.5	3.0	0.0	0.1	0.0	5.2	0.2	0.6	0.9	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.2	0.5	0.3	0.4	0.0	0.0	0.2	0.2	0.0	0.1	7.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.5	7.8	7.2	3.0	2.9	2.9	4.6	5.2	4.2	3.0	5.7	4.3	6.1	0.0	0.5	84.5	0.0	1.8	3.8	0.5	1.8	0.4	0.4	1.0	0.8	1.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	6.1	68.1	4.6	56.9	7.1	0.0	0.0	21.8	0.0	0.1	5.6	0.0	1.4	1.3	0.1	18.9	0.2	0.3	0.0	62.8	0.0	0.0	0.8	0.4	16.6	5.3	0.6	1.8	13.1	0.0	0.5	0.0	30.7	1.9	0.4	0.7	5.7	0.0	3.0	0.0	0.3	14.9	0.0	0.0	0.5	2.3	4.1	2.1	1.8	2.7	0.1	0.4	0.1	0.2	1.5
SNTB1	"59-DAP, A1B, BSYN2, SNT2, SNT2B1, TIP-43"	ENSG00000172164	"Syntrophin beta 1"	Q13884	8	120535745-120813273	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 70.2;Hepatocytes: 66.8;Microglial cells: 45.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 84.9;OE19: 78.5;U-266/70: 77.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA024659	Uncertain				"Intracellular and membrane"	NA	NA		25000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA024659: AB_1857713"	"unprognostic (1.32e-1)"	"unprognostic (2.77e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.76e-2)"	"unprognostic (6.41e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.72e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-1)"	7.9	66.4	7.5	5.5	6.5	18.9	8.0	5.8	5.9	5.6	42.9	6.2	5.7	4.4	2.7	8.4	6.0	4.3	4.9	6.1	11.8	12.6	89.3	15.4	7.3	7.2	11.4	2.5	45.0	1.4	2.6	8.6	7.8	4.8	6.4	4.8	34.8	3.4	28.2	9.8	6.3	3.1	6.0	11.9	24.1	9.8	9.1	3.4	61.4	32.4	3.5	3.9	3.6	6.5	0.1	1.8	0.7	0.0	11.3	22.9	0.1	6.0	36.7	1.8	2.7	12.0	1.6	0.0	10.7	6.8	0.0	0.1	2.0	0.0	1.3	5.6	6.5	0.0	0.3	84.9	1.2	16.9	0.0	11.4	0.0	10.1	0.0	14.9	0.4	10.4	0.0	32.3	5.9	3.3	0.0	13.7	2.1	78.5	8.7	0.0	43.8	0.1	34.4	2.0	0.1	0.4	2.4	12.5	30.2	0.7	1.5	30.5	0.0	23.7	1.4	0.0	2.0	77.2	33.0	34.8	18.4	49.0	26.7	1.8	0.8	2.7	2.2	0.4	0.5	0.5	0.4	1.1	0.6	0.2	1.1	1.1	0.1	1.6	0.3	0.0	0.0	0.6	7.5	6.5	5.8	5.9	6.1	11.8	7.2	11.4	7.8	6.0	9.1	6.5	1.9	12.8	27.2	70.2	4.7	0.4	0.7	0.9	1.8	2.4	8.5	6.0	2.0	2.8	9.0	5.5	2.1	0.8	8.4	1.3	9.8	1.5	9.3	2.4	5.8	4.2	0.0	14.1	2.4	10.9	2.2	9.8	11.2	6.2	1.3	8.8	13.2	66.8	11.3	0.0	3.1	3.9	16.2	29.9	4.3	4.2	4.7	18.1	1.8	45.9	12.1	16.0	18.6	2.5	12.2	4.3	1.9	13.2	2.8	1.1	0.1	3.3	13.8	0.7	13.1	3.9	14.3	1.1	0.2	10.1	1.0	0.3	12.0	11.0	4.1	0.6
SPATA1	SP-2	ENSG00000122432	"Spermatogenesis associated 1"	Q5VX52	1	84506300-84566194	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"testis: 2.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 6.4;Astrocytes: 12.7;Microglial cells: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 21: Non-specific - Transcription"		"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (6.00e-3)"	"unprognostic (1.20e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.82e-2)"	"unprognostic (8.84e-3)"	"unprognostic (7.54e-2)"	"unprognostic (2.77e-3)"	"unprognostic (5.52e-4)"	"unprognostic (2.03e-1)"	"unprognostic (5.81e-8)"	"unprognostic (1.63e-1)"	"unprognostic (5.34e-1)"	"unprognostic (7.71e-2)"	"unprognostic (3.79e-4)"	0.0	0.0	0.1	0.0	0.2	0.4	0.1	0.3	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.1	0.3	0.1	0.1	0.3	0.0	0.1	0.0	0.4	0.1	0.0	0.3	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.1	2.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.1	0.0	0.1	0.3	0.1	0.4	0.0	0.1	0.3	2.5	6.4	4.8	12.7	1.7	0.0	0.0	0.0	0.0	0.0	3.5	2.7	3.0	0.0	2.5	5.5	0.0	0.0	2.8	2.9	1.9	0.9	0.0	2.6	3.1	1.3	0.0	0.0	5.4	1.4	0.0	0.9	0.0	2.4	0.0	1.7	0.0	0.0	0.0	0.0	3.1	0.7	0.0	0.0	0.0	0.0	0.0	1.9	0.0	8.4	1.6	0.0	0.0	4.5	5.0	0.3	2.2	0.0	0.3	0.0	0.0	1.8	0.7	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.0	0.7	1.3	0.0
SPON1	"f-spondin, KIAA0762"	ENSG00000262655	"Spondin 1"	Q9HCB6	11	13962723-14268133	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 101.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 399.9;Endometrial stromal cells: 78.9;Muller glia cells: 141.9"	"Cancer enriched"	"Detected in all"	5	"ovarian cancer: 199.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"MAIT T-cell: 3.3"	"Lineage enriched"	"Detected in single"	33	"T-cells: 3.3"	"Group enriched"	"Detected in some"	36	"EFO-21: 213.7;RPTEC TERT1: 604.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038584, HPA077546"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Actin filaments,Microtubule ends,Cytokinetic bridge"	"Secreted to blood"	Yes	No	11500000	28000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoli, Microtubule ends"	"Nucleoplasm, Actin filaments, Cytokinetic bridge"	"HPA038584: AB_10697394, HPA077546: AB_2732351"	"unprognostic (1.66e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.93e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.12e-4)"	"unprognostic (7.22e-3)"	"unprognostic (7.89e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (1.88e-4)"	54.2	16.9	25.8	18.6	33.7	0.1	19.5	26.3	22.3	43.8	7.8	31.8	31.6	36.5	15.2	17.3	63.1	101.4	30.6	28.2	28.3	12.2	2.0	49.2	1.6	25.6	33.6	23.9	4.6	0.8	10.0	41.3	26.4	16.9	46.6	63.8	7.0	8.8	0.8	8.8	28.4	46.9	14.9	8.3	28.8	2.5	34.0	1.7	5.2	1.6	1.2	51.5	12.5	21.8	0.1	0.1	0.4	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	9.8	0.2	0.2	213.7	0.0	0.2	0.4	0.0	0.0	0.0	0.3	1.9	0.0	0.1	0.1	0.0	0.0	0.1	11.4	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	2.7	0.0	0.1	1.7	0.0	0.1	604.1	0.1	0.1	0.2	0.0	0.0	0.0	4.1	0.0	0.1	2.6	0.2	0.7	0.5	0.3	0.3	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.3	0.0	0.6	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	25.8	33.7	26.3	22.3	28.2	28.3	25.6	33.6	26.4	14.9	34.0	21.8	0.2	0.0	2.3	399.9	13.5	0.0	17.3	0.0	1.2	13.5	2.0	5.5	1.9	5.7	0.0	0.0	2.1	3.4	4.8	38.9	3.9	4.3	1.5	36.1	78.9	2.5	16.7	0.0	17.0	2.0	4.2	41.2	0.5	61.5	2.5	1.8	2.5	0.2	1.9	1.7	16.8	24.0	0.0	0.3	0.0	1.3	4.4	1.0	0.0	11.2	0.5	141.9	20.6	62.4	1.6	6.8	20.6	30.1	0.9	9.0	18.4	2.1	0.7	26.8	6.6	5.8	7.0	0.4	0.8	0.6	0.0	4.9	7.8	1.1	40.9	9.4
ST7	"ETS7q, FAM4A, FAM4A1, HELG, RAY1, SEN4, TSG7"	ENSG00000004866	"Suppression of tumorigenicity 7"	Q9NRC1	7	116953238-117230176	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 184.1;Early spermatids: 131.4;Excitatory neurons: 191.5;Inhibitory neurons: 176.0;Oligodendrocyte precursor cells: 111.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 115.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038325, HPA038326"	Approved		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Cytosol	"HPA038325: AB_10671740, HPA038326: AB_10672644"	"unprognostic (3.40e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.18e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.48e-2)"	"prognostic favorable (3.39e-5)"	"unprognostic (1.80e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.41e-2)"	"unprognostic (3.40e-2)"	13.5	21.7	22.6	6.7	22.0	17.8	15.2	50.6	24.7	19.9	11.1	13.6	12.1	14.5	35.8	9.7	18.6	12.3	22.4	21.8	22.6	29.4	41.3	26.1	7.6	15.0	17.4	17.4	32.9	19.0	24.5	20.9	15.9	13.8	12.4	12.6	21.7	21.2	12.5	11.5	11.0	12.6	14.6	10.4	17.3	8.7	22.5	8.6	28.4	11.2	8.6	12.6	11.1	19.7	29.4	17.2	28.2	24.4	31.0	20.5	12.3	23.0	30.2	24.4	35.2	24.0	32.8	7.7	25.5	21.4	34.7	24.6	24.2	24.5	31.3	11.1	33.9	23.4	26.5	20.2	21.8	27.4	39.4	16.1	24.3	30.7	21.8	21.6	24.9	5.2	36.0	54.6	22.3	18.1	0.2	21.0	26.9	40.1	19.3	6.7	18.8	33.6	25.5	16.2	42.2	33.8	27.8	115.5	32.0	20.6	10.1	23.3	19.1	27.6	11.0	30.5	23.3	34.7	28.2	29.6	22.9	24.0	28.6	1.5	3.1	0.4	7.3	1.2	5.1	2.2	4.4	6.2	5.7	1.0	2.9	3.0	0.0	7.0	1.1	5.6	10.3	3.0	22.6	22.0	50.6	24.7	21.8	22.6	15.0	17.4	15.9	14.6	22.5	19.7	6.3	22.4	38.1	184.1	5.0	7.5	8.6	8.8	10.8	12.2	9.0	7.4	13.5	12.8	12.9	5.5	0.0	21.1	6.4	3.1	5.9	6.0	131.4	7.1	5.9	9.5	3.6	15.8	191.5	13.4	22.8	10.6	12.8	14.2	19.6	3.5	8.6	24.5	8.7	3.3	176.0	6.8	8.2	14.4	6.0	53.5	11.1	7.9	7.2	44.0	7.5	12.8	4.1	111.1	46.9	8.8	3.6	6.0	10.3	6.7	3.6	17.3	6.3	1.3	0.0	9.9	12.1	12.8	5.8	7.4	5.5	21.2	4.6	4.6	5.3	8.8
STK3	"KRS1, MST2"	ENSG00000104375	"Serine/threonine kinase 3"	Q13188	8	98371228-98942827	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 152.7;Oligodendrocytes: 189.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"dendritic cells: 7.9;granulocytes: 8.8;monocytes: 8.5"	"Cell line enhanced"	"Detected in many"		"A-431: 85.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007120, CAB025316"	Uncertain		Approved	"Intermediate filaments,Rods & Rings"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Intermediate filaments, Rods & Rings"		"CAB025316: , HPA007120: AB_10601664"	"unprognostic (7.88e-3)"	"unprognostic (1.96e-1)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.12e-3)"	"unprognostic (9.68e-3)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (6.71e-2)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (9.21e-5)"	"unprognostic (9.16e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.72e-2)"	15.1	14.4	5.6	7.9	7.0	3.5	14.1	6.6	7.4	17.4	7.2	13.1	5.5	24.9	14.3	10.2	17.0	14.2	9.1	5.1	6.3	15.6	14.3	11.1	5.5	7.7	6.7	25.0	10.0	16.1	6.4	18.5	7.4	16.5	6.7	12.0	10.7	17.6	11.4	9.6	8.3	17.2	6.3	6.8	8.5	11.4	7.1	5.1	11.9	8.6	5.5	13.6	13.7	7.9	85.3	15.7	16.2	22.0	51.2	25.4	16.4	28.8	25.6	26.3	22.8	11.7	35.7	0.0	25.6	28.7	14.1	33.4	11.4	24.8	42.2	20.5	14.8	22.9	7.2	8.0	17.5	7.7	19.0	17.0	41.9	13.5	36.6	17.2	11.5	13.4	9.8	12.2	19.4	10.7	19.3	9.4	4.9	58.0	6.1	17.1	14.1	7.5	29.9	10.7	4.3	9.6	18.4	21.1	18.2	21.0	17.8	12.3	8.7	17.9	11.5	27.1	16.3	9.8	15.5	6.2	15.9	9.5	29.0	2.0	8.3	4.6	1.3	8.5	1.4	1.8	0.7	1.8	7.9	1.1	1.0	0.6	8.8	2.0	5.4	3.3	0.1	2.8	5.6	7.0	6.6	7.4	5.1	6.3	7.7	6.7	7.4	6.3	7.1	7.9	25.9	38.5	37.4	132.9	6.0	43.7	44.8	25.3	23.3	6.9	29.0	15.5	16.6	31.5	37.7	29.5	14.6	43.6	2.5	11.7	23.5	21.5	118.3	23.7	65.8	31.3	9.1	16.2	34.3	18.9	56.1	39.8	9.7	28.9	17.1	13.3	24.3	23.7	19.2	10.1	33.5	7.8	26.4	17.0	25.1	77.1	91.0	18.6	24.9	152.7	13.8	15.0	3.1	60.3	189.9	24.9	13.1	74.1	6.2	42.1	32.3	25.0	29.0	15.6	39.5	43.8	39.7	16.7	12.6	12.3	40.5	64.7	5.9	47.0	13.8	36.0
STON2	"STN2, STNB2"	ENSG00000140022	"Stonin 2"	Q8WXE9	14	81260656-81436465	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 79.8"	"Cell type enriched"	"Detected in many"	4	"Astrocytes: 253.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"intermediate monocyte: 1.2"	"Lineage enriched"	"Detected in single"	4	"monocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"HEL: 113.4;HMC-1: 60.9;Karpas-707: 58.3;RT4: 46.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003086	Enhanced		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoli, Cytosol"		"HPA003086: AB_2302748"	"unprognostic (5.28e-2)"	"unprognostic (9.83e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (4.96e-4)"	"unprognostic (2.50e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.30e-1)"	"unprognostic (9.88e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.37e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.44e-1)"	3.4	0.8	65.6	1.2	64.8	5.5	9.6	31.2	44.7	4.6	14.1	4.4	4.0	1.2	5.1	14.3	10.7	5.9	3.0	60.1	79.8	14.3	3.0	5.0	1.0	36.5	68.3	2.8	0.9	0.3	10.0	2.5	39.5	2.1	5.0	10.2	5.6	2.7	13.2	8.0	4.3	1.7	27.0	16.3	5.7	3.3	60.9	2.5	10.8	17.4	2.9	6.3	9.5	53.7	4.7	3.1	12.1	0.2	0.0	0.1	13.4	0.0	0.1	0.0	0.3	10.0	4.2	0.0	5.5	0.0	3.4	30.6	16.5	39.8	0.0	0.8	5.5	113.4	19.9	4.2	0.0	0.0	60.9	1.7	33.5	0.0	11.0	0.0	0.0	6.1	40.2	58.3	1.2	6.8	5.4	0.0	11.9	11.5	2.4	0.1	17.6	3.4	8.4	46.0	28.1	1.7	13.7	0.6	0.0	9.9	1.7	0.3	0.3	2.4	8.8	9.7	2.6	6.0	11.9	0.1	8.4	0.4	2.6	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	1.1	65.6	64.8	31.2	44.7	60.1	79.8	36.5	68.3	39.5	27.0	60.9	53.7	6.3	3.2	0.5	253.4	0.1	13.6	13.2	20.5	30.7	0.6	11.8	8.1	1.1	2.8	6.8	18.4	12.5	1.4	0.1	4.8	7.9	0.6	0.4	56.0	1.2	5.0	0.0	12.2	0.9	0.5	0.4	8.3	7.1	16.1	0.0	12.5	4.2	0.9	3.4	3.3	4.4	3.2	14.2	18.0	6.1	1.6	10.2	13.5	1.8	23.4	2.3	23.9	0.0	12.1	15.2	3.2	2.7	8.6	1.0	6.8	4.6	20.6	5.8	6.1	0.0	36.1	3.2	1.0	5.9	24.3	8.8	15.5	0.9	6.3	2.7	33.2
TGFB2		ENSG00000092969	"Transforming growth factor beta 2"	P61812	1	218345336-218444619	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins"		"Growth factor, Mitogen"	"Aortic aneurysm, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 76.9;Astrocytes: 119.1;Muller glia cells: 87.1"	"Cancer enhanced"	"Detected in all"		"glioma: 11.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 59.6;hTERT-RPE1: 155.6;U-2 OS: 58.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006134			Approved	Vesicles	"Secreted to blood"	NA	Yes	4890000			"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	Vesicles		"HPA006134: "	"unprognostic (7.24e-2)"	"unprognostic (7.23e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.86e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.04e-2)"	1.5	1.2	8.2	1.1	11.6	0.1	4.0	9.2	14.9	7.1	7.1	2.4	0.6	6.5	4.5	1.8	3.9	2.0	6.4	11.5	11.1	1.4	0.6	7.8	0.6	18.5	12.7	4.6	1.8	1.1	2.1	12.9	10.7	17.0	0.9	10.5	8.5	11.2	4.8	2.1	0.7	5.1	8.4	2.6	1.2	0.9	10.0	0.4	2.6	2.1	0.8	3.0	3.0	11.0	4.0	20.2	1.8	15.1	4.3	2.1	0.0	2.9	0.4	30.1	21.2	5.5	46.7	0.0	59.6	0.2	25.8	11.1	1.2	2.3	32.0	0.1	0.2	0.0	1.7	0.0	46.7	0.0	0.0	1.9	5.3	4.1	15.8	155.6	8.1	0.0	0.0	0.0	29.6	0.3	0.0	0.0	1.6	0.0	1.8	0.0	8.8	0.0	10.1	0.0	0.3	0.1	34.8	3.9	0.7	39.7	2.9	1.1	38.3	21.3	58.4	17.9	30.7	0.0	0.1	0.1	9.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	11.6	9.2	14.9	11.5	11.1	18.5	12.7	10.7	8.4	10.0	11.0	2.2	76.9	6.3	119.1	0.5	8.7	8.7	35.3	4.0	9.9	8.4	5.8	4.1	14.3	29.8	5.5	0.0	0.4	0.2	0.0	0.0	40.2	19.3	2.1	6.7	8.1	0.0	0.0	8.6	16.9	13.9	28.8	0.0	6.8	1.3	0.9	4.2	0.0	1.4	1.7	36.0	0.0	8.2	0.6	13.2	28.0	8.1	3.2	12.4	30.0	1.0	87.1	0.0	3.5	1.0	21.5	0.0	13.9	1.2	15.0	0.0	0.8	12.3	3.0	0.0	27.7	19.7	0.3	0.8	0.6	2.8	0.5	0.5	0.8	0.0	2.1
TMC1	"DFNA36, DFNB11, DFNB7"	ENSG00000165091	"Transmembrane channel like 1"	Q8TDI8	9	72521608-72838297	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Hearing, Ion transport, Transport"	"Ion channel"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"cervix: 1.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 19.2;Early spermatids: 7.9;Endometrial stromal cells: 5.5;Microglial cells: 5.6;Urothelial cells: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;HAP1: 5.2;NTERA-2: 1.9;SuSa: 1.0;U-266/70: 1.3;U-266/84: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (6.36e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.19e-3)"	"unprognostic (3.97e-1)"	"unprognostic (5.67e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.94e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.31e-1)"	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.5	0.5	1.0	0.1	0.0	0.0	0.1	0.8	0.1	0.1	0.0	0.0	0.4	0.6	0.7	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.4	0.6	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.5	0.5	0.4	0.6	0.6	0.6	0.6	0.5	0.4	0.7	1.3	0.0	0.0	19.2	0.0	0.3	2.9	0.1	0.6	0.2	0.1	0.1	0.4	0.0	0.0	1.8	0.0	4.0	0.1	0.4	0.0	0.2	7.9	1.4	5.5	1.2	0.0	0.0	1.5	0.6	2.8	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	1.2	0.0	0.0	0.0	0.0	2.6	0.3	0.1	0.0	5.6	0.6	1.1	0.0	1.5	1.3	0.5	2.2	0.0	0.0	3.1	0.0	3.0	0.0	0.0	0.0	0.3	0.2	1.8	3.1	0.5	0.0	2.6	0.1	0.5	0.0	6.8
TMEM164	"FLJ22679, RP13-360B22.2"	ENSG00000157600	"Transmembrane protein 164"	Q5U3C3	X	110002631-110182734	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 84.5;Distal enterocytes: 53.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 59.7"	"Lineage enriched"	"Detected in many"	18	"granulocytes: 59.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038784	Approved		Approved	"Vesicles,Cell Junctions"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Vesicles	"Cell Junctions"	"HPA038784: AB_10670790"	"unprognostic (2.14e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.65e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (8.17e-6)"	"unprognostic (9.85e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.95e-1)"	"unprognostic (7.66e-2)"	"prognostic favorable (3.14e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.81e-2)"	"unprognostic (4.19e-3)"	16.9	10.3	11.4	9.6	11.8	19.0	12.3	6.8	9.7	5.5	14.3	18.8	21.5	5.3	6.0	13.8	8.1	5.1	22.7	9.0	12.1	11.1	2.0	17.9	6.7	13.5	13.0	13.8	25.4	8.3	9.6	5.2	11.2	8.9	21.2	3.6	9.8	14.4	27.5	20.3	19.2	6.9	8.2	8.4	14.0	1.9	12.3	12.6	13.8	19.3	8.0	5.8	6.8	8.6	10.8	24.3	19.5	12.8	23.7	17.3	11.9	5.3	12.4	11.0	7.1	19.1	16.6	8.6	35.2	8.3	27.1	15.6	17.1	27.9	10.8	23.9	11.7	58.5	13.0	8.1	13.9	26.1	80.1	24.0	48.4	19.9	27.2	30.2	21.8	15.2	18.4	10.2	19.7	21.6	27.4	33.1	17.5	36.9	17.3	12.4	15.1	7.2	17.5	11.3	18.2	20.3	34.0	33.1	15.9	18.1	9.6	25.7	49.0	9.3	6.8	11.0	7.7	5.9	7.9	6.9	24.3	32.0	25.3	59.7	3.3	14.2	0.6	2.9	1.6	0.2	0.7	0.6	2.7	0.6	0.4	0.5	16.3	2.3	1.8	0.5	1.0	1.8	11.4	11.8	6.8	9.7	9.0	12.1	13.5	13.0	11.2	8.2	12.3	8.6	2.9	3.2	36.1	84.5	3.7	4.8	3.7	4.7	4.6	1.2	11.7	9.1	21.3	11.5	6.9	16.5	2.1	2.7	3.5	53.0	3.9	4.6	0.5	6.7	3.8	6.0	27.6	14.5	22.9	11.4	6.3	3.1	7.7	10.7	3.8	4.3	6.4	1.7	13.6	0.0	31.4	12.7	10.2	25.1	9.4	1.3	1.8	12.5	1.8	24.4	28.1	1.0	4.1	34.2	7.6	13.5	15.0	1.5	1.6	9.0	31.9	3.3	5.4	1.3	0.0	6.4	4.1	0.2	0.3	10.4	8.0	2.7	5.2	3.8	21.2	12.3
TMPRSS5	"MGC141886, MGC148044"	ENSG00000166682	"Transmembrane serine protease 5"	Q9H3S3	11	113687547-113706373	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 50.6;choroid plexus: 20.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 26.4;Excitatory neurons: 5.4;Horizontal cells: 5.0;Oligodendrocytes: 15.5"	"Cancer enhanced"	"Detected in some"		"glioma: 5.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.0;CAPAN-2: 3.2;OE19: 2.0;WM-115: 2.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010992			Approved	Nucleoplasm		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA010992: AB_1858152"	"unprognostic (1.53e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.08e-1)"	"unprognostic (5.19e-3)"	"unprognostic (8.49e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.04e-3)"	1.3	0.5	28.1	0.2	34.7	1.4	2.0	24.9	39.0	0.8	20.8	0.7	0.1	0.5	0.2	0.5	0.7	0.7	1.0	28.2	27.0	1.0	1.0	0.7	0.2	34.0	29.8	0.6	0.5	0.0	1.6	0.2	33.1	0.8	0.3	1.1	9.6	0.3	2.6	2.1	0.7	0.3	28.5	0.8	0.8	2.1	32.1	0.3	0.6	0.5	0.3	0.7	1.0	50.6	0.2	0.3	2.0	1.1	0.2	0.1	0.3	0.5	0.2	0.3	0.4	1.1	3.2	0.1	1.4	0.2	0.3	0.4	0.1	0.2	0.1	0.2	0.6	0.4	0.3	0.0	0.1	0.5	0.4	0.2	0.2	0.2	0.5	0.2	0.3	0.7	0.4	0.2	0.4	0.0	0.4	0.6	0.2	2.0	0.1	0.4	0.2	0.0	0.3	0.2	0.3	0.4	0.2	0.0	1.6	0.2	0.2	0.2	0.2	0.4	0.7	0.3	0.3	0.2	0.1	0.0	0.1	0.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	34.7	24.9	39.0	28.2	27.0	34.0	29.8	33.1	28.5	32.1	50.6	0.2	0.0	0.0	26.4	0.2	0.3	0.2	0.0	0.0	0.5	1.0	0.9	0.5	0.0	0.1	1.8	2.1	0.0	0.2	0.2	0.0	0.3	0.1	0.3	0.2	0.3	0.0	1.3	5.4	0.9	0.0	0.3	0.0	0.4	0.0	0.4	0.4	0.2	0.1	5.0	2.8	0.0	0.0	0.0	0.3	0.3	0.3	0.1	0.0	2.8	0.1	3.2	0.0	3.5	15.5	0.6	0.0	0.0	0.3	0.2	0.0	0.0	0.1	1.3	0.0	0.5	0.1	1.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.2
TNIK	KIAA0551	ENSG00000154310	"TRAF2 and NCK interacting kinase"	Q9UKE5	3	171058414-171460408	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Neurogenesis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1074.4;Excitatory neurons: 248.4;Inhibitory neurons: 360.8;Oligodendrocyte precursor cells: 374.5;Oligodendrocytes: 205.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 65.2;HMC-1: 71.3;WM-115: 52.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012128, HPA012297"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		160000	"Cluster 52: Eosinophils - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Cytosol	"HPA012128: AB_1858226, HPA012297: AB_1858225"	"unprognostic (2.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.90e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.23e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.91e-1)"	"unprognostic (7.81e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.34e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.97e-2)"	1.4	4.4	25.7	6.2	33.7	4.4	2.1	4.1	17.5	1.3	0.0	8.2	21.0	3.4	0.9	4.1	2.8	5.1	9.4	20.8	15.7	3.8	3.1	8.9	6.7	25.5	18.7	1.5	3.7	0.5	8.4	1.9	6.3	3.5	6.7	19.4	1.9	4.6	23.2	1.0	21.3	4.3	19.0	4.5	7.0	7.7	20.1	7.0	6.3	23.6	5.3	4.8	2.1	10.7	0.9	1.2	43.4	4.7	0.8	0.1	10.4	9.3	2.5	7.3	4.8	41.5	16.9	0.0	3.4	9.0	6.9	14.1	6.3	2.6	7.3	0.3	9.8	65.2	3.7	0.0	19.0	13.0	71.3	6.1	5.9	4.3	0.9	15.7	43.6	10.5	23.3	0.1	1.1	1.1	4.1	13.5	18.2	30.6	17.9	0.0	11.8	16.6	12.0	0.1	2.1	2.3	5.8	0.4	9.6	4.1	20.4	2.9	0.5	0.0	7.9	20.5	7.1	0.1	0.0	0.1	1.8	13.8	52.1	4.6	0.1	10.5	3.5	0.0	4.4	0.0	4.2	3.2	0.0	0.2	5.8	3.1	0.1	2.4	0.1	0.0	5.3	1.0	25.7	33.7	4.1	17.5	20.8	15.7	25.5	18.7	6.3	19.0	20.1	10.7	0.7	6.4	50.4	1074.4	4.9	2.5	1.6	1.3	9.1	19.2	8.4	6.5	28.6	21.5	7.1	9.2	14.6	6.3	32.5	19.6	5.9	12.1	48.6	1.1	2.5	1.6	13.2	13.5	248.4	7.7	1.3	9.1	21.4	0.3	83.5	0.4	2.5	8.1	2.9	0.0	360.8	10.3	0.0	6.5	1.9	38.0	2.5	10.4	1.8	57.1	1.6	65.0	51.5	374.5	205.5	7.1	21.6	6.4	11.7	0.7	56.2	17.3	1.8	28.7	0.0	12.4	6.2	3.1	1.0	10.3	1.6	2.5	47.4	9.9	16.6	3.2
TPCN1	"FLJ20612, KIAA1169, TPC1"	ENSG00000186815	"Two pore segment channel 1"	Q9ULQ1	12	113221050-113298585	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 174.3;Microglial cells: 79.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 148.6;hTERT-RPE1: 121.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039757	Approved					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA039757: AB_10795156"	"unprognostic (7.87e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.34e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.32e-3)"	"unprognostic (4.53e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.47e-3)"	27.7	48.8	37.7	18.2	54.3	12.5	29.1	70.2	40.5	36.9	48.5	30.4	19.4	30.6	19.3	38.4	35.5	21.7	68.0	34.7	33.4	50.9	27.8	29.5	17.0	43.5	48.3	41.5	52.0	30.8	37.9	18.8	46.6	28.7	19.5	11.5	36.1	27.3	36.7	22.2	31.4	18.6	35.4	28.6	19.1	14.5	44.0	8.5	55.5	24.8	18.2	25.3	26.4	45.9	15.3	45.0	5.1	6.5	38.5	43.3	14.9	21.2	148.6	10.9	13.1	33.5	50.7	34.5	30.9	21.6	35.7	18.8	11.9	37.6	14.7	4.1	9.2	12.9	23.5	18.7	49.9	4.5	28.1	41.5	18.6	21.3	37.2	121.7	16.9	9.8	15.0	11.9	13.5	18.3	1.3	68.3	8.4	18.6	22.3	2.5	6.2	67.3	34.9	54.4	6.5	9.8	17.0	43.2	17.1	10.3	13.9	41.4	7.1	16.0	7.8	22.3	13.3	20.0	13.1	29.6	47.2	10.9	12.3	6.9	14.6	1.3	1.8	2.4	2.0	3.4	2.4	2.3	9.9	5.2	3.3	2.1	0.5	8.5	0.3	5.0	1.2	4.7	37.7	54.3	70.2	40.5	34.7	33.4	43.5	48.3	46.6	35.4	44.0	45.9	8.3	9.6	19.6	174.3	9.0	4.6	6.0	15.4	2.8	19.6	17.0	11.2	34.4	12.8	24.4	27.6	16.7	7.2	3.1	35.9	1.9	13.2	13.2	15.0	21.8	8.1	28.8	9.0	24.5	18.7	3.2	20.2	23.0	19.1	31.1	7.7	15.7	18.3	21.5	50.5	26.6	26.8	14.2	17.9	4.7	11.3	21.5	23.7	7.2	79.6	13.7	17.2	3.1	25.1	61.7	11.5	20.3	21.4	4.6	15.9	29.0	19.7	27.9	13.7	0.0	49.8	18.5	3.6	3.3	10.6	4.0	6.6	5.9	13.2	20.3	22.2
TRIM66	"C11orf29, KIAA0298, TIF1D"	ENSG00000166436	"Tripartite motif containing 66"	O15016	11	8612037-8682694	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 47.7;Early spermatids: 46.0;Late spermatids: 27.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027420	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA027420: AB_1858316"	"unprognostic (1.26e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.43e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.37e-3)"	"unprognostic (8.01e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.49e-2)"	"unprognostic (6.79e-2)"	"prognostic favorable (8.89e-4)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (3.96e-4)"	"unprognostic (1.67e-1)"	"unprognostic (4.26e-1)"	"unprognostic (4.67e-2)"	"unprognostic (4.31e-1)"	4.4	5.9	4.5	4.0	5.6	2.8	4.6	2.8	4.6	3.9	5.2	4.4	3.5	3.8	8.2	5.2	4.2	3.0	2.4	3.0	5.1	4.9	10.9	3.6	5.3	4.1	5.4	3.6	8.9	3.1	9.5	1.5	4.0	4.2	4.6	3.6	4.3	3.3	3.6	11.9	5.5	3.5	3.3	5.7	5.4	17.3	5.4	4.5	6.2	3.1	5.2	4.2	4.2	3.6	5.3	4.9	2.9	10.2	6.0	4.5	3.6	3.2	3.7	2.2	2.9	6.5	9.9	5.2	2.2	2.9	2.1	7.2	3.1	2.8	2.7	6.1	2.4	5.0	9.2	3.6	2.5	4.5	3.9	7.1	2.8	1.9	6.6	2.4	2.9	13.1	2.7	5.5	2.9	5.8	2.1	3.4	1.8	2.7	4.6	3.0	2.2	2.1	3.1	6.7	2.1	2.0	4.6	3.2	2.2	2.8	4.2	1.0	2.3	4.2	3.8	2.5	2.8	2.3	3.7	6.4	2.8	4.6	2.4	0.0	0.5	0.6	0.7	0.1	0.4	0.6	0.7	0.9	0.7	0.8	0.7	1.1	0.3	0.8	1.3	1.3	0.6	0.3	4.5	5.6	2.8	4.6	3.0	5.1	4.1	5.4	4.0	3.3	5.4	3.6	3.0	3.2	5.6	47.7	4.0	1.8	2.3	3.6	2.2	8.0	5.1	5.6	1.9	4.3	5.1	5.5	12.5	3.6	3.1	4.5	0.0	3.4	46.0	5.0	4.0	3.2	6.0	5.7	14.2	3.2	1.8	2.6	5.1	3.7	1.3	6.7	5.0	9.8	2.6	11.8	17.1	4.2	0.0	5.2	2.2	27.3	1.8	3.8	0.0	13.1	5.9	4.3	3.1	9.5	22.6	3.9	3.9	2.2	3.1	1.6	8.3	2.4	5.4	9.0	13.1	6.5	2.5	14.6	7.2	3.8	1.1	1.4	3.3	8.0	4.4	1.0
TRPS1	"GC79, LGCR"	ENSG00000104447	"Transcriptional repressor GATA binding 1"	Q9UHF7	8	115408496-115809673	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 60.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 758.7;Breast glandular cells: 243.2;Oligodendrocyte precursor cells: 280.5;Oligodendrocytes: 294.0"	"Cancer enriched"	"Detected in many"	8	"breast cancer: 49.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 4.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 47.4;SK-BR-3: 78.1;T-47d: 244.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060380, HPA071767"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 6: T47d - Mammary gland"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA060380: AB_2684270, HPA071767: AB_2732185"	"unprognostic (4.34e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.87e-1)"	"prognostic favorable (9.42e-4)"	"unprognostic (2.23e-3)"	"unprognostic (2.08e-1)"	"unprognostic (9.31e-2)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (3.16e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.78e-2)"	"unprognostic (3.07e-3)"	4.4	3.1	15.5	5.7	14.3	7.6	60.8	10.5	14.7	10.9	10.1	5.9	0.9	9.9	3.4	14.2	5.5	10.0	3.8	17.0	13.5	5.4	2.1	4.7	4.9	32.5	31.5	5.2	1.1	5.3	2.6	2.8	24.2	9.4	2.7	4.1	12.0	8.4	2.6	10.6	2.1	10.6	18.4	4.2	2.7	12.5	27.5	2.4	5.7	3.3	4.0	5.1	14.1	16.3	3.1	0.6	5.9	0.3	5.4	19.8	0.6	4.9	11.3	3.1	5.2	0.5	4.9	2.4	0.0	12.7	2.6	0.1	22.9	4.3	3.5	0.3	6.9	0.1	10.3	0.2	7.2	0.0	0.3	9.5	4.4	8.6	15.8	8.9	2.7	0.3	1.1	37.7	6.0	47.4	0.2	0.0	1.1	1.1	4.8	0.2	0.2	30.0	4.9	0.3	5.2	3.9	2.5	78.1	3.2	2.8	244.8	2.1	0.2	13.7	6.9	4.0	9.7	10.1	0.3	4.5	14.4	0.0	9.2	0.0	4.5	0.0	0.9	1.9	0.9	0.5	1.0	1.0	1.7	0.8	0.9	0.9	0.8	1.0	1.4	0.6	0.5	0.8	15.5	14.3	10.5	14.7	17.0	13.5	32.5	31.5	24.2	18.4	27.5	16.3	10.0	6.4	3.0	758.7	13.3	9.4	20.0	10.3	34.1	9.2	243.2	125.1	4.6	2.8	9.2	18.4	43.8	0.1	18.7	0.1	11.7	2.9	95.0	58.5	35.7	7.5	0.0	5.5	128.3	2.9	0.2	26.8	4.6	63.5	12.7	0.3	3.6	1.1	16.5	0.0	148.2	0.0	8.2	55.2	104.1	163.2	25.1	55.5	21.4	171.4	32.5	10.6	5.2	280.5	294.0	2.7	0.0	28.2	10.1	16.9	0.0	23.7	8.9	35.9	6.6	60.2	28.2	1.8	8.3	73.6	12.5	0.3	25.6	19.5	0.0	11.2
USP40	FLJ10785	ENSG00000085982	"Ubiquitin specific peptidase 40"	Q9NVE5	2	233475520-233566782	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 79.3;Oligodendrocytes: 127.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005821	Uncertain		Approved	"Vesicles,Focal adhesion sites"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 64: Astrocytes - Nervous system maintenance"	Vesicles	"Focal adhesion sites"	"HPA005821: AB_1080526"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.53e-2)"	11.8	12.0	10.4	7.5	17.0	3.4	13.9	12.8	11.4	10.0	16.5	9.4	10.5	10.6	24.0	10.4	11.5	11.6	8.2	10.2	12.0	14.2	13.2	12.5	7.2	19.4	14.2	15.9	14.0	16.8	8.5	12.4	19.0	13.5	9.5	14.2	12.9	10.4	9.6	19.7	10.1	8.5	12.3	9.9	13.1	14.7	16.2	10.1	16.4	7.6	7.8	9.6	7.5	25.4	17.3	19.9	17.6	12.0	25.2	23.0	15.7	16.4	12.4	14.7	16.0	14.3	20.2	0.4	4.7	26.4	38.6	30.3	13.3	29.7	20.6	0.0	9.0	13.3	17.4	24.3	22.3	5.8	8.9	22.2	21.1	22.2	30.9	26.2	17.3	8.1	22.0	3.2	21.4	14.0	6.2	8.5	7.9	17.8	16.0	0.0	36.3	8.1	17.9	27.6	9.6	10.3	13.5	13.5	16.9	12.9	15.4	12.9	17.3	20.9	13.1	8.9	20.6	6.0	4.9	0.8	27.1	10.2	18.6	0.0	1.0	0.0	0.5	1.1	0.2	0.4	0.5	0.4	1.5	0.7	0.7	0.7	0.1	0.5	0.9	1.9	0.8	0.5	10.4	17.0	12.8	11.4	10.2	12.0	19.4	14.2	19.0	12.3	16.2	25.4	11.8	32.1	35.5	79.3	7.9	7.4	9.1	13.6	15.4	18.1	17.0	14.7	10.7	10.0	19.9	16.5	25.0	21.2	6.7	9.9	7.9	9.4	8.4	19.8	18.3	11.1	15.0	5.7	25.9	12.6	10.6	11.9	21.4	21.3	9.5	23.4	12.8	25.4	8.2	23.5	38.2	10.9	4.1	11.6	3.6	10.7	6.8	9.1	3.6	40.3	5.9	11.9	4.1	48.2	127.7	10.5	12.6	8.2	10.9	12.9	13.9	14.6	21.0	19.4	13.1	17.5	10.6	30.2	20.9	17.2	10.5	15.7	5.5	21.1	12.1	10.0
ZC3H12C	"KIAA1726, MCPIP3"	ENSG00000149289	"Zinc finger CCCH-type containing 12C"	Q9C0D7	11	110093392-110171841	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 102.2;Oligodendrocyte precursor cells: 52.3;Oligodendrocytes: 56.1;Suprabasal keratinocytes: 66.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	36	"basophil: 5.9"	"Lineage enriched"	"Detected in single"	36	"granulocytes: 5.9"	"Cell line enhanced"	"Detected in many"		"HSkMC: 23.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038836, HPA038837"	Approved		Approved	"Nuclear membrane,Golgi apparatus"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nuclear membrane, Golgi apparatus"		"HPA038836: AB_2676229, HPA038837: AB_10675953"	"unprognostic (1.22e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.13e-3)"	"unprognostic (6.96e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.77e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.30e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.34e-2)"	"unprognostic (8.90e-2)"	"prognostic favorable (9.90e-6)"	"unprognostic (4.42e-3)"	"unprognostic (2.32e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.11e-1)"	4.6	4.2	4.0	2.4	6.7	3.2	2.5	6.5	3.9	4.0	2.7	4.6	1.7	3.7	1.7	3.2	3.2	4.7	4.4	4.2	4.9	3.4	4.0	4.0	1.5	6.8	5.6	6.7	3.5	4.7	3.2	2.6	5.5	3.5	3.7	4.1	2.3	3.3	10.5	5.9	2.6	4.4	4.1	1.8	2.4	3.4	5.4	1.5	8.1	13.2	1.4	5.4	2.1	6.5	6.1	3.6	14.0	0.0	6.4	14.8	2.7	2.3	15.7	4.1	6.8	4.6	5.6	0.1	8.7	7.1	10.3	5.8	2.8	8.5	8.1	23.2	2.0	9.7	4.5	1.7	7.2	0.0	4.4	23.8	8.0	7.2	11.7	8.1	5.8	0.0	0.9	1.3	8.6	0.9	0.0	0.0	2.2	0.1	12.7	0.0	4.9	0.6	4.6	12.4	6.4	11.5	5.6	0.4	10.5	2.7	3.5	3.6	9.8	9.1	4.4	4.8	5.2	0.5	0.0	0.0	5.5	1.7	10.8	5.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.0	6.7	6.5	3.9	4.2	4.9	6.8	5.6	5.5	4.1	5.4	6.5	21.1	35.3	8.6	102.2	1.1	47.4	4.8	19.1	7.4	8.8	3.5	5.0	15.5	2.8	9.1	5.5	4.2	1.5	0.2	17.0	0.0	6.1	10.6	8.6	6.7	14.9	8.9	2.1	23.8	3.5	0.5	8.9	5.6	14.1	0.0	5.2	13.6	6.4	10.9	15.2	50.0	8.1	0.0	5.7	39.3	11.8	9.6	9.9	23.2	26.2	3.9	5.6	0.0	52.3	56.1	3.4	15.2	8.2	0.6	21.0	5.7	6.6	8.9	2.7	0.0	9.1	5.7	4.6	0.8	3.2	66.5	0.8	1.1	5.6	8.0	7.8
ZHX3	"KIAA0395, TIX1"	ENSG00000174306	"Zinc fingers and homeoboxes 3"	Q9H4I2	20	41178448-41317672	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 370.5;Early spermatids: 106.3;Excitatory neurons: 99.0;Inhibitory neurons: 96.5;Oligodendrocyte precursor cells: 139.7;Oligodendrocytes: 142.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046498			Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA046498: AB_2679676"	"unprognostic (6.26e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.40e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.42e-1)"	"unprognostic (7.25e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (2.53e-5)"	"unprognostic (3.06e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (7.52e-4)"	"prognostic unfavorable (1.84e-5)"	14.4	15.4	33.8	6.5	32.8	3.4	13.3	31.6	27.4	11.6	16.4	19.8	8.6	15.8	5.7	13.6	15.7	8.4	12.2	30.2	27.7	26.4	17.2	11.6	4.5	37.6	32.1	16.3	11.9	15.4	7.8	4.9	29.9	10.6	8.0	10.8	5.7	11.9	28.5	11.0	11.4	12.1	29.4	4.3	15.5	35.0	36.0	7.0	19.0	20.1	4.8	18.1	11.0	28.6	22.5	6.3	6.6	14.2	52.6	56.3	7.6	31.0	35.4	28.3	19.1	11.4	2.9	15.6	14.7	58.5	7.6	7.0	7.9	39.2	30.0	4.3	7.1	6.6	8.6	8.8	21.6	7.6	7.9	34.6	18.7	21.3	27.3	19.2	12.3	11.7	6.2	10.6	38.3	45.0	11.9	4.5	2.9	10.4	23.0	5.8	18.6	6.2	38.6	6.7	23.0	8.3	20.7	12.0	7.4	5.7	11.6	10.5	19.9	70.2	10.8	25.0	15.5	12.2	8.0	6.9	28.9	11.0	11.4	0.1	0.1	0.4	0.2	0.1	0.4	0.6	0.2	0.1	0.2	0.6	0.4	0.3	0.1	0.6	0.2	0.1	0.2	0.1	33.8	32.8	31.6	27.4	30.2	27.7	37.6	32.1	29.9	29.4	36.0	28.6	29.8	19.2	16.4	370.5	4.7	2.9	3.9	2.6	2.8	19.5	6.3	4.7	12.7	17.2	5.8	22.0	4.2	0.6	3.8	5.5	11.7	3.7	106.3	12.3	33.2	15.1	14.9	3.8	99.0	2.7	2.7	20.5	6.6	26.3	1.3	3.7	16.4	31.6	3.0	40.4	96.5	5.6	4.1	3.5	1.7	32.3	18.6	3.5	1.8	52.5	1.9	28.6	1.0	139.7	142.4	4.6	1.3	24.5	2.7	2.6	12.6	27.0	3.2	7.1	26.3	41.2	10.9	11.0	5.2	6.3	3.7	0.4	2.7	19.7	4.7	2.3
ZIC2	HPE5	ENSG00000043355	"Zic family member 2"	O95409	13	99981784-99986765	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Disease variant, Holoprosencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	32	"brain: 123.4;choroid plexus: 35.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 28.1;Cone photoreceptor cells: 6.2;Microglial cells: 29.0;Muller glia cells: 10.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 123.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 86.2;HDLM-2: 43.5;HEK 293: 66.1;NTERA-2: 80.5;SCLC-21H: 179.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 113.3"	HPA055031			Supported	"Nuclear bodies"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nuclear bodies"		"HPA055031: AB_2682676"	"unprognostic (6.43e-6)"	"prognostic favorable (2.64e-4)"	"unprognostic (5.73e-2)"	"unprognostic (1.99e-2)"	"unprognostic (4.39e-1)"	"unprognostic (3.12e-2)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (4.66e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.36e-3)"	"unprognostic (7.42e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.26e-1)"	"unprognostic (2.11e-1)"		"unprognostic (5.36e-3)"	0.0	0.2	17.0	0.0	19.0	0.0	0.0	123.4	16.2	0.0	35.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	16.0	10.4	0.1	0.0	0.0	0.0	20.9	14.8	0.0	0.0	0.0	1.2	0.0	22.5	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	8.8	0.0	0.0	1.2	27.1	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.5	4.9	86.2	5.5	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.5	5.8	0.0	7.3	0.0	4.6	0.1	3.9	0.0	0.0	43.5	66.1	6.4	4.0	4.4	0.0	0.0	4.3	0.0	6.2	0.0	3.9	0.4	0.0	2.2	6.5	0.0	0.0	2.9	0.4	34.3	80.5	0.0	2.0	19.8	3.3	0.1	0.4	2.2	179.7	0.0	2.8	0.5	0.0	3.3	4.2	33.5	0.0	20.2	0.0	3.6	5.8	0.6	0.0	0.0	4.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	19.0	123.4	16.2	16.0	10.4	20.9	14.8	22.5	8.8	27.1	11.3	0.2	0.0	0.0	28.1	0.0	0.0	0.0	0.0	0.6	0.3	0.2	0.3	0.7	0.0	0.0	1.8	6.2	0.0	0.0	0.7	0.0	0.0	0.4	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	29.0	0.0	10.3	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.1	1.5	0.6	0.4	0.1	0.0	0.0	0.0	0.0	0.0
ZIC5		ENSG00000139800	"Zic family member 5"	Q96T25	13	99962964-99971909	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.1;choroid plexus: 8.1"	"Group enriched"	"Detected in some"	7	"Astrocytes: 20.5;Microglial cells: 15.0;Spermatocytes: 6.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 22.0;HEK 293: 12.7;NTERA-2: 15.1;SCLC-21H: 85.5"	"Group enriched"	"Detected in all"	5	"basal ganglia: 18.9;cerebellum: 18.4;thalamus: 5.3"	"Region enriched"	"Detected in all"	7	"cerebellum: 39.7"	HPA074045			Uncertain	Nucleoplasm,Vesicles		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Vesicles"		"HPA074045: "	"unprognostic (2.78e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.38e-4)"	"unprognostic (2.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.87e-2)"		"unprognostic (1.13e-1)"	"unprognostic (3.12e-2)"		"unprognostic (4.94e-2)"	0.0	0.0	2.8	0.0	3.5	0.0	0.0	17.1	11.2	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	2.1	0.0	0.0	0.0	0.0	2.8	2.1	0.0	0.0	0.0	0.2	0.0	3.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	3.6	3.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	2.2	22.0	1.8	0.0	0.0	4.1	0.0	0.0	0.0	0.0	1.0	2.1	0.0	3.1	0.0	1.1	0.0	4.5	0.0	0.0	4.0	12.7	0.0	2.1	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.9	3.3	0.0	0.0	1.7	0.0	1.7	15.1	0.0	0.3	1.9	0.8	0.0	0.0	0.0	85.5	0.0	2.4	2.0	0.0	1.6	0.0	2.8	0.0	1.2	0.0	0.4	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	3.5	17.1	11.2	3.9	2.1	2.8	2.1	3.0	1.8	3.1	2.6	0.1	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	15.0	0.0	1.9	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	6.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZNF334	bA179N14.1	ENSG00000198185	"Zinc finger protein 334"	Q9HCZ1	20	46499630-46513559	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 43.1;Inhibitory neurons: 29.1;Oligodendrocyte precursor cells: 33.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 15.5;BEWO: 19.4;NTERA-2: 10.4;SCLC-21H: 12.9;SuSa: 22.0"	"Low region specificity"	"Detected in all"							HPA050022	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Cytosol	"HPA050022: AB_2680994"	"unprognostic (3.04e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.74e-4)"	"unprognostic (9.08e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.62e-2)"	"unprognostic (8.25e-2)"	"unprognostic (8.12e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.88e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.71e-3)"	3.5	7.9	9.3	0.9	9.8	1.4	6.9	15.1	10.3	7.9	10.2	3.7	2.0	6.7	9.3	2.1	9.5	4.1	2.5	8.2	10.5	6.9	5.5	3.4	1.4	11.6	10.6	15.8	8.9	1.7	16.1	5.1	9.7	12.6	2.3	15.7	6.4	5.8	0.9	2.0	3.6	3.3	9.3	3.2	5.2	7.7	10.7	2.9	12.3	1.7	1.1	5.1	5.5	10.2	0.1	0.0	15.5	0.1	1.0	0.1	19.4	1.4	0.1	1.2	0.1	0.0	4.0	0.0	0.0	0.4	4.8	0.0	0.0	0.3	0.6	0.0	3.3	5.1	0.1	5.7	4.1	0.1	0.0	4.9	0.0	1.3	0.0	0.7	0.1	0.1	3.5	0.0	0.1	0.0	0.0	9.1	10.4	2.6	1.3	0.0	0.0	0.1	4.2	3.9	12.9	7.3	0.0	0.4	0.2	22.0	0.1	4.5	0.0	0.2	6.9	0.1	0.0	1.2	6.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.0	0.0	0.0	9.3	9.8	15.1	10.3	8.2	10.5	11.6	10.6	9.7	9.3	10.7	10.2	1.2	9.6	4.5	43.1	0.2	0.1	3.5	1.1	2.8	11.0	5.6	4.3	1.9	1.5	5.5	3.7	2.1	4.1	0.0	0.4	5.9	4.5	0.6	2.5	6.2	1.7	0.0	2.1	15.7	1.3	3.7	3.9	7.7	1.3	2.5	11.1	2.2	0.9	1.7	10.1	29.1	1.2	0.0	0.0	0.3	1.4	2.8	1.2	0.0	3.7	0.0	7.8	0.0	33.2	7.5	1.7	0.3	1.9	0.2	2.2	0.6	3.4	7.9	12.3	0.0	5.1	2.4	5.7	7.5	1.4	0.0	1.0	0.2	6.5	1.8	1.6
ZNF346	"JAZ, Zfp346"	ENSG00000113761	"Zinc finger protein 346"	Q9UL40	5	177022696-177081189	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 31.0;Excitatory neurons: 36.7;Inhibitory neurons: 35.1;Oligodendrocyte precursor cells: 29.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018485	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA018485: AB_1859213"	"unprognostic (1.89e-1)"	"unprognostic (4.25e-2)"	"unprognostic (5.71e-3)"	"prognostic unfavorable (9.54e-5)"	"unprognostic (9.85e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (1.88e-7)"	"unprognostic (2.69e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (1.20e-4)"	"unprognostic (5.11e-2)"	"unprognostic (7.86e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.44e-2)"	5.9	8.1	8.5	5.0	8.4	6.4	6.3	13.5	10.0	9.7	6.5	7.6	4.6	8.4	7.7	8.5	8.4	4.6	6.9	8.2	7.7	8.1	7.3	5.3	7.8	5.7	5.8	13.4	8.0	7.2	10.4	5.0	5.3	8.3	5.1	11.1	6.5	7.1	8.1	7.7	6.1	9.0	4.5	8.1	6.2	9.7	8.6	10.1	10.4	6.5	9.5	7.4	7.8	7.2	6.5	11.7	18.7	25.4	9.6	8.7	16.1	11.3	11.5	17.8	19.7	14.8	9.8	17.1	12.5	10.8	15.3	8.5	17.7	18.0	16.9	54.3	14.1	11.1	13.7	13.2	11.5	18.0	10.2	9.7	10.1	16.9	12.3	10.5	20.8	18.4	13.4	10.2	8.2	21.8	25.2	9.6	8.2	8.1	19.0	25.6	12.9	7.8	12.4	7.6	24.0	10.3	13.9	10.3	8.9	9.0	14.5	10.0	11.0	14.4	11.5	10.0	12.3	9.6	10.6	18.5	5.7	16.1	11.8	0.8	4.0	6.6	8.2	4.0	5.3	5.3	5.8	5.4	4.2	8.4	7.2	7.4	4.2	18.3	4.0	3.9	6.4	4.9	8.5	8.4	13.5	10.0	8.2	7.7	5.7	5.8	5.3	4.5	8.6	7.2	5.2	0.0	6.0	31.0	7.1	2.9	2.9	4.3	8.0	11.4	4.3	5.3	4.1	7.2	3.2	5.5	6.2	9.5	3.3	2.6	9.8	6.0	2.4	3.6	7.5	7.7	4.8	15.2	36.7	5.8	5.8	5.9	1.5	3.2	2.5	9.6	4.2	2.9	5.7	8.4	35.1	4.1	8.2	2.9	1.7	5.4	5.0	3.1	3.6	12.2	3.5	7.8	1.0	29.1	20.9	4.0	2.2	6.4	8.6	1.0	4.7	4.1	1.1	6.0	0.0	6.1	5.8	12.9	10.9	5.5	4.8	3.3	6.7	10.1	3.2	1.4
ZNF404		ENSG00000176222	"Zinc finger protein 404"	Q494X3	19	43872365-43901385	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 21.5;Oligodendrocytes: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-2 OS: 43.7"					"Low region specificity"	"Detected in all"			"HPA032014, HPA063607"	Uncertain		Supported	"Nucleoli,Nucleoli rim,Intermediate filaments"		NA	Yes			"Cluster 40: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoli, Nucleoli rim"	"Intermediate filaments"	"HPA032014: AB_10602591, HPA063607: AB_2732705"	"unprognostic (3.76e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.92e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.68e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.03e-5)"	"unprognostic (1.46e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.80e-3)"	2.4	3.2	9.2	1.1	10.3	0.6	2.7	9.7	11.3	3.8	8.3	5.8	0.6	2.4	9.6	2.0	6.4	2.4	9.1	8.8	9.3	3.9	2.3	2.1	3.6	9.9	9.7	6.8	2.4	2.5	14.3	2.9	9.9	6.1	1.8	18.0	2.8	2.3	2.6	3.1	2.7	2.0	9.7	5.4	3.2	4.6	10.3	2.3	4.2	1.9	1.6	4.6	2.9	12.0	3.4	0.5	3.4	0.4	8.4	11.8	2.0	4.6	2.2	2.9	4.0	0.3	1.2	0.0	4.7	2.2	0.1	0.4	0.6	2.3	3.9	0.5	3.3	1.2	0.1	1.3	3.0	0.3	0.9	7.1	5.5	2.1	2.0	9.8	2.5	0.0	0.1	0.0	2.7	0.3	0.0	0.1	2.8	0.1	0.7	0.0	1.8	0.7	2.8	2.2	1.8	1.4	1.9	0.8	2.4	6.1	0.1	1.3	1.1	4.1	43.7	3.7	2.7	5.8	8.1	0.0	5.8	0.0	2.4	0.0	0.0	0.4	0.1	0.0	0.1	0.1	0.3	0.0	0.1	0.3	0.3	0.3	0.0	0.5	0.0	0.2	0.3	0.1	9.2	10.3	9.7	11.3	8.8	9.3	9.9	9.7	9.9	9.7	10.3	12.0	1.3	0.0	3.2	21.5	1.5	0.0	0.7	1.1	0.6	3.6	1.3	1.9	7.0	0.0	0.9	0.0	0.0	1.5	0.3	0.2	0.0	0.7	1.5	1.6	3.2	1.5	2.4	0.4	6.9	0.2	1.1	1.6	0.5	1.1	7.0	2.9	1.1	0.5	0.7	5.0	6.9	0.6	4.1	0.3	0.3	0.3	0.9	0.7	0.0	1.9	0.4	3.8	2.1	3.0	19.4	0.2	0.5	3.4	0.1	0.8	0.7	0.4	1.9	3.3	0.0	0.4	1.3	1.7	3.2	0.4	0.0	1.0	1.5	0.5	0.9	0.5
ZNF680	FLJ90430	ENSG00000173041	"Zinc finger protein 680"	Q8NEM1	7	64519878-64563075	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 116.9;Oligodendrocytes: 89.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA003173			Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA003173: AB_1080744"	"unprognostic (1.65e-1)"	"unprognostic (3.21e-2)"	"unprognostic (6.88e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.52e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.46e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.05e-3)"	5.9	13.7	8.8	3.8	10.6	2.4	13.1	15.0	15.5	6.1	3.3	3.8	2.8	4.9	5.7	3.6	5.0	5.3	11.3	8.5	9.4	8.4	20.1	4.9	6.5	9.3	10.4	10.9	4.8	3.7	4.0	4.6	9.7	10.1	5.1	4.8	4.2	5.4	11.6	5.8	3.3	4.5	9.6	6.7	6.3	4.2	10.1	6.6	24.9	15.2	5.4	4.5	4.1	12.4	5.6	3.2	12.8	15.3	6.2	6.9	8.0	4.4	3.6	7.9	9.8	4.4	10.6	10.6	10.7	4.2	9.0	3.8	10.5	4.9	12.9	2.0	7.4	8.1	6.7	4.0	2.6	10.8	7.1	4.6	5.8	7.0	7.9	9.9	7.5	14.6	14.8	0.0	11.1	4.4	16.8	17.1	15.0	5.0	3.9	13.0	12.7	32.1	10.8	17.6	10.1	13.8	13.5	12.7	4.9	23.5	12.7	4.6	4.0	9.6	4.8	4.5	7.8	9.1	12.3	29.9	0.5	9.8	8.6	2.8	0.5	0.6	1.5	0.7	1.2	2.2	2.1	1.8	0.9	1.5	2.2	2.1	0.2	4.6	0.6	0.7	0.6	0.8	8.8	10.6	15.0	15.5	8.5	9.4	9.3	10.4	9.7	9.6	10.1	12.4	10.2	12.8	5.1	116.9	15.4	4.2	10.7	9.4	19.9	12.5	17.5	9.5	13.3	14.3	11.6	25.8	4.2	12.0	11.5	2.8	9.8	8.9	0.9	8.9	9.1	11.0	0.0	7.2	57.7	9.1	10.7	13.4	11.7	6.4	7.0	34.0	23.9	21.5	5.3	1.7	60.5	4.4	16.2	10.1	6.4	2.4	27.7	6.2	7.2	41.2	7.3	23.8	23.7	59.8	89.2	5.8	3.1	22.2	6.3	9.5	3.1	7.1	6.8	9.3	19.7	15.2	9.7	13.7	15.1	6.5	5.3	7.1	11.2	16.5	5.3	9.4
ZNRF3	"BK747E2.3, FLJ22057, KIAA1133, RNF203"	ENSG00000183579	"Zinc and ring finger 3"	Q9ULT6	22	28883572-29057488	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"Astrocytes: 504.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 46.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036702, HPA036703"	Uncertain		Uncertain	"Golgi apparatus"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Golgi apparatus"		"HPA036702: , HPA036703: AB_10672227"	"unprognostic (1.07e-1)"	"unprognostic (2.13e-3)"	"unprognostic (7.48e-3)"	"unprognostic (5.72e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.68e-2)"	"unprognostic (5.18e-2)"	"unprognostic (3.94e-1)"	"unprognostic (9.55e-5)"	"unprognostic (6.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.55e-2)"	2.8	7.1	11.3	1.3	11.2	0.3	2.6	8.1	13.8	4.4	1.0	3.9	3.0	5.1	13.4	3.4	4.8	2.1	2.6	12.1	5.5	8.2	6.6	4.3	0.5	13.2	9.2	5.9	3.3	8.7	2.7	5.0	4.2	7.2	3.4	1.1	7.5	7.7	3.8	5.3	2.7	4.6	5.1	1.2	4.4	5.0	13.6	1.3	4.1	1.9	0.6	3.2	3.3	6.2	5.8	13.7	12.5	3.5	2.3	2.6	23.7	3.5	1.7	2.7	2.6	20.8	3.2	0.1	5.4	1.8	4.9	9.8	8.7	5.5	3.3	7.8	8.9	2.3	2.5	46.1	2.0	6.9	2.3	2.7	5.0	4.3	4.3	2.3	2.4	4.1	5.0	3.2	3.9	5.6	0.2	3.5	4.6	7.3	5.4	6.9	8.2	5.3	11.6	8.5	20.6	7.6	6.2	6.1	3.5	3.8	4.1	3.1	2.3	10.3	8.8	8.2	5.8	4.3	6.3	8.1	4.4	3.9	5.5	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	11.3	11.2	8.1	13.8	12.1	5.5	13.2	9.2	4.2	5.1	13.6	6.2	4.2	12.8	23.6	504.1	0.3	12.6	5.2	4.9	15.9	3.7	5.7	9.5	7.5	8.6	5.3	12.9	0.0	28.1	0.5	2.1	1.9	5.0	12.7	8.0	8.0	5.8	8.4	4.0	62.9	2.5	2.5	5.8	5.6	15.5	0.0	5.4	2.2	17.6	3.5	1.7	37.4	9.4	0.0	1.0	3.1	15.0	10.8	0.8	0.0	82.4	0.0	6.0	0.0	54.8	34.4	3.7	2.1	12.8	0.6	9.6	2.4	11.6	4.9	3.9	0.0	16.0	6.6	4.6	3.2	7.8	7.5	7.7	0.7	14.5	12.9	2.8
ZXDC	"FLJ13861, MGC11349"	ENSG00000070476	"ZXD family zinc finger C"	Q2QGD7	3	126437601-126475891	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 39.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 84.5;Oligodendrocyte precursor cells: 67.8;Oligodendrocytes: 99.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 4.4"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.1;granulocytes: 1.7;monocytes: 4.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049593			Approved	Nucleoli		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoli		"HPA049593: AB_2680828"	"unprognostic (3.06e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.53e-2)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (3.06e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.12e-3)"	6.9	5.2	6.8	6.2	9.4	39.4	6.3	8.7	9.6	8.1	9.2	5.3	5.0	7.8	5.2	7.3	8.8	6.0	5.6	6.6	5.9	6.3	7.6	7.0	7.9	9.6	8.1	10.7	14.9	10.1	3.9	7.5	8.7	7.2	5.4	7.6	8.0	6.6	16.2	9.7	5.9	6.5	6.7	8.8	6.7	6.4	8.3	10.0	8.5	9.8	6.0	6.1	5.6	14.4	15.2	7.6	9.4	8.9	10.1	7.8	16.7	6.7	7.4	9.7	8.6	11.6	6.4	11.2	11.2	6.1	8.9	12.3	12.6	7.9	7.6	6.0	10.8	8.8	9.2	7.7	10.7	13.6	13.7	6.2	15.1	6.0	10.6	9.6	10.0	13.0	9.6	14.6	8.2	8.9	13.1	7.5	13.4	10.0	7.6	14.1	6.4	14.3	6.8	10.9	17.1	9.5	13.0	9.5	18.2	6.2	12.9	11.9	10.2	8.9	11.4	13.4	8.3	12.1	6.1	14.6	9.7	10.5	10.0	1.7	0.4	0.8	0.5	0.2	0.2	0.1	0.3	0.4	0.7	0.4	0.5	0.4	1.2	0.3	4.4	1.1	0.2	0.2	6.8	9.4	8.7	9.6	6.6	5.9	9.6	8.1	8.7	6.7	8.3	14.4	10.1	25.6	15.6	84.5	11.9	6.2	8.3	4.5	10.8	30.1	6.8	6.5	5.5	12.8	7.9	5.5	45.9	7.2	10.0	8.6	7.9	4.8	1.7	8.1	7.9	7.7	3.6	12.0	51.3	6.1	2.6	7.8	9.2	12.2	2.5	16.8	7.9	14.3	5.7	13.5	44.3	6.9	0.0	5.4	4.4	0.8	7.5	9.0	1.8	47.8	7.3	23.0	7.2	67.8	99.2	4.4	5.2	7.5	12.9	6.0	8.4	9.5	7.7	30.4	0.0	13.5	8.9	3.3	9.0	9.0	4.3	6.3	11.1	10.5	6.6	6.3